primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
160490676,16049067,39,C,DULAGLUTIDE.,DULAGLUTIDE,1,,EVERY WEDNESDAY SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Chronic kidney disease,,2020,Q1,6,F,2015.0,20200123.0,20190307,20200130,EXP,,US-ASTRAZENECA-2018SF33709,ASTRAZENECA,,54.0,YR,,F,Y,78.5,KG,20200130.0,,,US,US,2020,Q1,Adult
160490676,16049067,39,C,DULAGLUTIDE.,DULAGLUTIDE,1,,EVERY WEDNESDAY SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Hyperparathyroidism secondary,,2020,Q1,6,F,2015.0,20200123.0,20190307,20200130,EXP,,US-ASTRAZENECA-2018SF33709,ASTRAZENECA,,54.0,YR,,F,Y,78.5,KG,20200130.0,,,US,US,2020,Q1,Adult
160490676,16049067,39,C,DULAGLUTIDE.,DULAGLUTIDE,1,,EVERY WEDNESDAY SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Nephrogenic anaemia,,2020,Q1,6,F,2015.0,20200123.0,20190307,20200130,EXP,,US-ASTRAZENECA-2018SF33709,ASTRAZENECA,,54.0,YR,,F,Y,78.5,KG,20200130.0,,,US,US,2020,Q1,Adult
160490676,16049067,39,C,DULAGLUTIDE.,DULAGLUTIDE,1,,EVERY WEDNESDAY SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Renal failure,,2020,Q1,6,F,2015.0,20200123.0,20190307,20200130,EXP,,US-ASTRAZENECA-2018SF33709,ASTRAZENECA,,54.0,YR,,F,Y,78.5,KG,20200130.0,,,US,US,2020,Q1,Adult
160490676,16049067,39,C,DULAGLUTIDE.,DULAGLUTIDE,1,,EVERY WEDNESDAY SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Renal injury,,2020,Q1,6,F,2015.0,20200123.0,20190307,20200130,EXP,,US-ASTRAZENECA-2018SF33709,ASTRAZENECA,,54.0,YR,,F,Y,78.5,KG,20200130.0,,,US,US,2020,Q1,Adult
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Back pain,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Blood pressure fluctuation,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Blood pressure increased,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Cataract,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Condition aggravated,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Dehydration,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Diarrhoea,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Dyspnoea,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Feeding disorder,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Gastroenteritis viral,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Heart rate decreased,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Heart rate irregular,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Malaise,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Nausea,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Off label use,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Oxygen saturation increased,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Pain in extremity,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Product use issue,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Therapeutic product effect incomplete,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
164922183,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Vomiting,,2020,Q1,3,F,,20200317.0,20190628,20200323,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20200323.0,,MD,CA,CA,2020,Q1,Elderly
167286412,16728641,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, EVERY WEEK",,,U,,,,,7.5,MG,,/wk,2020,Q1,Colitis ulcerative,,2020,Q1,2,F,,20200124.0,20190822,20200205,EXP,,CA-AUROBINDO-AUR-APL-2019-054419,AUROBINDO,,73.0,YR,,F,Y,,,20200205.0,,CN,CA,CA,2020,Q1,Elderly
167477482,16747748,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,Y,,,,,1.5,MG,INJECTION,/wk,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,201902.0,20190819.0,20190827,20200116,EXP,,PHHY2019CZ110078,NOVARTIS,,71.0,YR,,M,Y,,,20200116.0,,HP,CZ,CZ,2020,Q1,Elderly
167477482,16747748,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,Y,,,,,1.5,MG,INJECTION,/wk,2020,Q1,Drug ineffective,,2020,Q1,2,F,201902.0,20190819.0,20190827,20200116,EXP,,PHHY2019CZ110078,NOVARTIS,,71.0,YR,,M,Y,,,20200116.0,,HP,CZ,CZ,2020,Q1,Elderly
167582213,16758221,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK",,,Y,,,,,1.5,MG,INJECTION,/wk,2020,Q1,Arthritis,,2020,Q1,3,F,201902.0,20200122.0,20190830,20200204,EXP,,CZ-AUROBINDO-AUR-APL-2019-031096,AUROBINDO,KOSKOVA M.. BENEFITS OF TREATMENT WITH DULAGLUTIDE IN A TYPE 2 DIABETES PATIENT WITH LONG-TERM UNSATISFACTORY GLYCAEMIC CONTROL.. KAZUISTIKY V DIABETOLOGII. 2019;17(1):34-5,71.0,YR,,M,Y,,,20200204.0,,MD,CZ,CZ,2020,Q1,Elderly
167582213,16758221,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK",,,Y,,,,,1.5,MG,INJECTION,/wk,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,3,F,201902.0,20200122.0,20190830,20200204,EXP,,CZ-AUROBINDO-AUR-APL-2019-031096,AUROBINDO,KOSKOVA M.. BENEFITS OF TREATMENT WITH DULAGLUTIDE IN A TYPE 2 DIABETES PATIENT WITH LONG-TERM UNSATISFACTORY GLYCAEMIC CONTROL.. KAZUISTIKY V DIABETOLOGII. 2019;17(1):34-5,71.0,YR,,M,Y,,,20200204.0,,MD,CZ,CZ,2020,Q1,Elderly
167582213,16758221,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK",,,Y,,,,,1.5,MG,INJECTION,/wk,2020,Q1,Drug ineffective,,2020,Q1,3,F,201902.0,20200122.0,20190830,20200204,EXP,,CZ-AUROBINDO-AUR-APL-2019-031096,AUROBINDO,KOSKOVA M.. BENEFITS OF TREATMENT WITH DULAGLUTIDE IN A TYPE 2 DIABETES PATIENT WITH LONG-TERM UNSATISFACTORY GLYCAEMIC CONTROL.. KAZUISTIKY V DIABETOLOGII. 2019;17(1):34-5,71.0,YR,,M,Y,,,20200204.0,,MD,CZ,CZ,2020,Q1,Elderly
167582213,16758221,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK",,,Y,,,,,1.5,MG,INJECTION,/wk,2020,Q1,Hypokinesia,,2020,Q1,3,F,201902.0,20200122.0,20190830,20200204,EXP,,CZ-AUROBINDO-AUR-APL-2019-031096,AUROBINDO,KOSKOVA M.. BENEFITS OF TREATMENT WITH DULAGLUTIDE IN A TYPE 2 DIABETES PATIENT WITH LONG-TERM UNSATISFACTORY GLYCAEMIC CONTROL.. KAZUISTIKY V DIABETOLOGII. 2019;17(1):34-5,71.0,YR,,M,Y,,,20200204.0,,MD,CZ,CZ,2020,Q1,Elderly
167582213,16758221,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK",,,Y,,,,,1.5,MG,INJECTION,/wk,2020,Q1,Spinal pain,,2020,Q1,3,F,201902.0,20200122.0,20190830,20200204,EXP,,CZ-AUROBINDO-AUR-APL-2019-031096,AUROBINDO,KOSKOVA M.. BENEFITS OF TREATMENT WITH DULAGLUTIDE IN A TYPE 2 DIABETES PATIENT WITH LONG-TERM UNSATISFACTORY GLYCAEMIC CONTROL.. KAZUISTIKY V DIABETOLOGII. 2019;17(1):34-5,71.0,YR,,M,Y,,,20200204.0,,MD,CZ,CZ,2020,Q1,Elderly
167777813,16777781,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,Y,U,,,125469.0,1.5,MG,,,2020,Q1,Atrioventricular block complete,,2020,Q1,3,F,20190812.0,20200227.0,20190905,20200311,EXP,GB-MHRA-EYC 00206271,GB-ELI_LILLY_AND_COMPANY-GB201908013655,ELI LILLY AND CO,,66.0,YR,,M,Y,100.0,KG,20200311.0,,PH,GB,GB,2020,Q1,Elderly
167777813,16777781,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,Y,U,,,125469.0,1.5,MG,,,2020,Q1,Cardiac arrest,,2020,Q1,3,F,20190812.0,20200227.0,20190905,20200311,EXP,GB-MHRA-EYC 00206271,GB-ELI_LILLY_AND_COMPANY-GB201908013655,ELI LILLY AND CO,,66.0,YR,,M,Y,100.0,KG,20200311.0,,PH,GB,GB,2020,Q1,Elderly
168188794,16818879,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,Y,U,,,,1.5,MG,INJECTION,/wk,2020,Q1,Arthritis,,2020,Q1,4,F,2018.0,20200226.0,20190917,20200303,EXP,,CZ-MYLANLABS-2019M1086400,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,MD,CZ,CZ,2020,Q1,Elderly
168188794,16818879,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,Y,U,,,,1.5,MG,INJECTION,/wk,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,4,F,2018.0,20200226.0,20190917,20200303,EXP,,CZ-MYLANLABS-2019M1086400,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,MD,CZ,CZ,2020,Q1,Elderly
168188794,16818879,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,Y,U,,,,1.5,MG,INJECTION,/wk,2020,Q1,Drug ineffective,,2020,Q1,4,F,2018.0,20200226.0,20190917,20200303,EXP,,CZ-MYLANLABS-2019M1086400,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,MD,CZ,CZ,2020,Q1,Elderly
168188794,16818879,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,Y,U,,,,1.5,MG,INJECTION,/wk,2020,Q1,Hypertension,,2020,Q1,4,F,2018.0,20200226.0,20190917,20200303,EXP,,CZ-MYLANLABS-2019M1086400,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,MD,CZ,CZ,2020,Q1,Elderly
168188794,16818879,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,Y,U,,,,1.5,MG,INJECTION,/wk,2020,Q1,Hypokinesia,,2020,Q1,4,F,2018.0,20200226.0,20190917,20200303,EXP,,CZ-MYLANLABS-2019M1086400,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,MD,CZ,CZ,2020,Q1,Elderly
168188794,16818879,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,Y,U,,,,1.5,MG,INJECTION,/wk,2020,Q1,Spinal pain,,2020,Q1,4,F,2018.0,20200226.0,20190917,20200303,EXP,,CZ-MYLANLABS-2019M1086400,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,MD,CZ,CZ,2020,Q1,Elderly
169234843,16923484,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,0.75MG/0.5ML,,,,,,,,,,INJECTION,,2020,Q1,Dizziness,,2020,Q1,3,F,2019.0,20200108.0,20191016,20200117,PER,,US-NEUROCRINE BIOSCIENCES INC.-2019NBI02943,NEUROCRINE BIOSCIENCES,,62.0,YR,,F,Y,,,20200117.0,,MD,US,US,2020,Q1,Adult
169234843,16923484,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,0.75MG/0.5ML,,,,,,,,,,INJECTION,,2020,Q1,Feeling abnormal,,2020,Q1,3,F,2019.0,20200108.0,20191016,20200117,PER,,US-NEUROCRINE BIOSCIENCES INC.-2019NBI02943,NEUROCRINE BIOSCIENCES,,62.0,YR,,F,Y,,,20200117.0,,MD,US,US,2020,Q1,Adult
169234843,16923484,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,0.75MG/0.5ML,,,,,,,,,,INJECTION,,2020,Q1,Tardive dyskinesia,,2020,Q1,3,F,2019.0,20200108.0,20191016,20200117,PER,,US-NEUROCRINE BIOSCIENCES INC.-2019NBI02943,NEUROCRINE BIOSCIENCES,,62.0,YR,,F,Y,,,20200117.0,,MD,US,US,2020,Q1,Adult
169234843,16923484,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,0.75MG/0.5ML,,,,,,,,,,INJECTION,,2020,Q1,Vision blurred,,2020,Q1,3,F,2019.0,20200108.0,20191016,20200117,PER,,US-NEUROCRINE BIOSCIENCES INC.-2019NBI02943,NEUROCRINE BIOSCIENCES,,62.0,YR,,F,Y,,,20200117.0,,MD,US,US,2020,Q1,Adult
171040262,17104026,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200131.0,20191203,20200212,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20200212.0,,MD,CZ,CZ,2020,Q1,Adult
171040262,17104026,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,,20200131.0,20191203,20200212,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20200212.0,,MD,CZ,CZ,2020,Q1,Adult
171040262,17104026,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Weight increased,,2020,Q1,2,F,,20200131.0,20191203,20200212,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20200212.0,,MD,CZ,CZ,2020,Q1,Adult
171215482,17121548,2,I,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,,,,,,1.5,MG,INJECTION,/wk,2020,Q1,Accidental overdose,,2020,Q1,2,F,20190503.0,20200108.0,20191206,20200113,EXP,IT-MINISAL02-564000,IT-MYLANLABS-2019M1119457,MYLAN,,47.0,YR,,F,Y,,,20200113.0,,MD,IT,IT,2020,Q1,Adult
171215482,17121548,2,I,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,,,,,,1.5,MG,INJECTION,/wk,2020,Q1,Drug interaction,,2020,Q1,2,F,20190503.0,20200108.0,20191206,20200113,EXP,IT-MINISAL02-564000,IT-MYLANLABS-2019M1119457,MYLAN,,47.0,YR,,F,Y,,,20200113.0,,MD,IT,IT,2020,Q1,Adult
171215482,17121548,2,I,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,,,,,,1.5,MG,INJECTION,/wk,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,20190503.0,20200108.0,20191206,20200113,EXP,IT-MINISAL02-564000,IT-MYLANLABS-2019M1119457,MYLAN,,47.0,YR,,F,Y,,,20200113.0,,MD,IT,IT,2020,Q1,Adult
172014661,17201466,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,D,D, UNKNOWN,,,0.75,MG,,QW,2020,Q1,Cholelithiasis,,2020,Q1,1,I,,,20191224,20191224,DIR,,,FDA-CTU,,48.0,YR,,M,N,124.0,KG,20191224.0,N,PH,US,US,2020,Q1,Adult
172030274,17203027,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,(1.5 MG/0.5 ML) SUNDAYS,,,,,,,,1.0,DF,,,2020,Q1,Acute respiratory failure,,2020,Q1,4,F,20191104.0,20200102.0,20191226,20200109,PER,,NVSC2019US079162,NOVARTIS,,57.0,YR,,F,Y,99.34,KG,20200109.0,,HP,US,US,2020,Q1,Adult
172030274,17203027,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,(1.5 MG/0.5 ML) SUNDAYS,,,,,,,,1.0,DF,,,2020,Q1,Hypoxia,,2020,Q1,4,F,20191104.0,20200102.0,20191226,20200109,PER,,NVSC2019US079162,NOVARTIS,,57.0,YR,,F,Y,99.34,KG,20200109.0,,HP,US,US,2020,Q1,Adult
172030274,17203027,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,(1.5 MG/0.5 ML) SUNDAYS,,,,,,,,1.0,DF,,,2020,Q1,Streptococcus test positive,,2020,Q1,4,F,20191104.0,20200102.0,20191226,20200109,PER,,NVSC2019US079162,NOVARTIS,,57.0,YR,,F,Y,99.34,KG,20200109.0,,HP,US,US,2020,Q1,Adult
172258721,17225872,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,UNKNOWN,/wk,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,,20191224.0,20200102,20200102,EXP,,IE-JNJFOC-20191245477,JOHNSON AND JOHNSON,"RAFEY M, FINUCANE F, BUTT A, COFFEY B, REDDINGTON L, DEVITT A, LAPPIN D. PROLONGED ACIDOSIS IS A FEATURE OF SGLT2I-INDUCED EUGLYCAEMIC DIABETIC KETOACIDOSIS. ENDOCRINOLOGY, DIABETES AND METABOLISM CASE REPORTS. 2019;.",44.0,YR,,M,Y,,,20200102.0,,HP,IE,IE,2020,Q1,Adult
172264391,17226439,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,Y,,,,,,,INJECTION,,2020,Q1,Abdominal adhesions,,2020,Q1,1,I,20191201.0,20191223.0,20200102,20200102,EXP,,GB-BAUSCH-BL-2019-066698,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20200102.0,,MD,GB,GB,2020,Q1,Elderly
172264391,17226439,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,Y,,,,,,,INJECTION,,2020,Q1,Small intestinal obstruction,,2020,Q1,1,I,20191201.0,20191223.0,20200102,20200102,EXP,,GB-BAUSCH-BL-2019-066698,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20200102.0,,MD,GB,GB,2020,Q1,Elderly
172265681,17226568,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK UNK, UNKNOWN",,,Y,U,,,125469.0,,,,,2020,Q1,Abdominal adhesions,,2020,Q1,1,I,20191201.0,20191223.0,20200102,20200102,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201912011446,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20200102.0,,CN,GB,GB,2020,Q1,Elderly
172265681,17226568,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK UNK, UNKNOWN",,,Y,U,,,125469.0,,,,,2020,Q1,Small intestinal obstruction,,2020,Q1,1,I,20191201.0,20191223.0,20200102,20200102,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201912011446,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20200102.0,,CN,GB,GB,2020,Q1,Elderly
172278761,17227876,9,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Abdominal adhesions,,2020,Q1,1,I,20191201.0,20191221.0,20200103,20200103,EXP,,GB-AUROBINDO-AUR-APL-2019-109548,AUROBINDO,,69.0,YR,,F,Y,,,20200103.0,,MD,GB,GB,2020,Q1,Elderly
172278761,17227876,9,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Small intestinal obstruction,,2020,Q1,1,I,20191201.0,20191221.0,20200103,20200103,EXP,,GB-AUROBINDO-AUR-APL-2019-109548,AUROBINDO,,69.0,YR,,F,Y,,,20200103.0,,MD,GB,GB,2020,Q1,Elderly
172401942,17240194,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U, D138479C,,,1.5,MG,INJECTION,,2020,Q1,Accidental underdose,,2020,Q1,2,F,20200102.0,20200109.0,20200107,20200122,EXP,,US-ELI_LILLY_AND_COMPANY-US202001000569,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20200122.0,,CN,US,US,2020,Q1,Adult
172401942,17240194,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U, D138479C,,,1.5,MG,INJECTION,,2020,Q1,Off label use,,2020,Q1,2,F,20200102.0,20200109.0,20200107,20200122,EXP,,US-ELI_LILLY_AND_COMPANY-US202001000569,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20200122.0,,CN,US,US,2020,Q1,Adult
172442031,17244203,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,Y,,,,,1.5,MG,,/wk,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,1,I,201904.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066812,BAUSCH AND LOMB,,63.0,YR,,F,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442031,17244203,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,Y,,,,,1.5,MG,,/wk,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,201904.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066812,BAUSCH AND LOMB,,63.0,YR,,F,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442031,17244203,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,Y,,,,,1.5,MG,,/wk,2020,Q1,Treatment noncompliance,,2020,Q1,1,I,201904.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066812,BAUSCH AND LOMB,,63.0,YR,,F,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172498552,17249855,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,2,F,20200102.0,20200107.0,20200109,20200123,EXP,,US-ELI_LILLY_AND_COMPANY-US202001000651,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200123.0,,CN,US,US,2020,Q1,Elderly
172571321,17257132,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Colitis,,2020,Q1,1,I,,20191229.0,20200110,20200110,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-40855,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,,,20200110.0,,CN,CA,CA,2020,Q1,Elderly
172571321,17257132,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Colitis ulcerative,,2020,Q1,1,I,,20191229.0,20200110,20200110,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-40855,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,,,20200110.0,,CN,CA,CA,2020,Q1,Elderly
172571321,17257132,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Decreased activity,,2020,Q1,1,I,,20191229.0,20200110,20200110,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-40855,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,,,20200110.0,,CN,CA,CA,2020,Q1,Elderly
172571321,17257132,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Frequent bowel movements,,2020,Q1,1,I,,20191229.0,20200110,20200110,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-40855,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,,,20200110.0,,CN,CA,CA,2020,Q1,Elderly
172571321,17257132,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Rectal haemorrhage,,2020,Q1,1,I,,20191229.0,20200110,20200110,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-40855,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,,,20200110.0,,CN,CA,CA,2020,Q1,Elderly
172722331,17272233,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,?          OTHER DOSE:0.75MG;?,,,Y,D,,,,,,,QW,2020,Q1,Abdominal pain,,2020,Q1,1,I,20190807.0,,20191223,20191223,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191017.0,N,PH,US,US,2020,Q1,Elderly
172722331,17272233,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,?          OTHER DOSE:0.75MG;?,,,Y,D,,,,,,,QW,2020,Q1,Diarrhoea,,2020,Q1,1,I,20190807.0,,20191223,20191223,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191017.0,N,PH,US,US,2020,Q1,Elderly
172722331,17272233,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,?          OTHER DOSE:0.75MG;?,,,Y,D,,,,,,,QW,2020,Q1,Nausea,,2020,Q1,1,I,20190807.0,,20191223,20191223,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191017.0,N,PH,US,US,2020,Q1,Elderly
172722331,17272233,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,?          OTHER DOSE:0.75MG;?,,,Y,D,,,,,,,QW,2020,Q1,Vomiting,,2020,Q1,1,I,20190807.0,,20191223,20191223,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191017.0,N,PH,US,US,2020,Q1,Elderly
172730051,17273005,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q1,Abdominal pain,,2020,Q1,1,I,20190807.0,,20191223,20191223,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191017.0,N,PH,US,US,2020,Q1,Elderly
172730051,17273005,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q1,Diarrhoea,,2020,Q1,1,I,20190807.0,,20191223,20191223,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191017.0,N,PH,US,US,2020,Q1,Elderly
172730051,17273005,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q1,Nausea,,2020,Q1,1,I,20190807.0,,20191223,20191223,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191017.0,N,PH,US,US,2020,Q1,Elderly
172730051,17273005,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q1,Vomiting,,2020,Q1,1,I,20190807.0,,20191223,20191223,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191017.0,N,PH,US,US,2020,Q1,Elderly
172736101,17273610,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q1,Nausea,,2020,Q1,1,I,20191023.0,,20191224,20191224,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20191218.0,N,PH,US,US,2020,Q1,Elderly
172736101,17273610,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,20191023.0,,20191224,20191224,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20191218.0,N,PH,US,US,2020,Q1,Elderly
172757551,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q1,Anxiety,,2020,Q1,1,I,20190623.0,20200102.0,20200116,20200116,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,,F,Y,63.0,KG,20200116.0,,HP,GB,GB,2020,Q1,Elderly
172757551,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q1,Arthralgia,,2020,Q1,1,I,20190623.0,20200102.0,20200116,20200116,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,,F,Y,63.0,KG,20200116.0,,HP,GB,GB,2020,Q1,Elderly
172757551,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q1,Depression,,2020,Q1,1,I,20190623.0,20200102.0,20200116,20200116,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,,F,Y,63.0,KG,20200116.0,,HP,GB,GB,2020,Q1,Elderly
172757551,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,1,I,20190623.0,20200102.0,20200116,20200116,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,,F,Y,63.0,KG,20200116.0,,HP,GB,GB,2020,Q1,Elderly
172757551,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q1,Feeling of body temperature change,,2020,Q1,1,I,20190623.0,20200102.0,20200116,20200116,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,,F,Y,63.0,KG,20200116.0,,HP,GB,GB,2020,Q1,Elderly
172757551,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q1,Lacrimation increased,,2020,Q1,1,I,20190623.0,20200102.0,20200116,20200116,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,,F,Y,63.0,KG,20200116.0,,HP,GB,GB,2020,Q1,Elderly
172757551,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q1,Night sweats,,2020,Q1,1,I,20190623.0,20200102.0,20200116,20200116,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,,F,Y,63.0,KG,20200116.0,,HP,GB,GB,2020,Q1,Elderly
172757551,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q1,Pain,,2020,Q1,1,I,20190623.0,20200102.0,20200116,20200116,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,,F,Y,63.0,KG,20200116.0,,HP,GB,GB,2020,Q1,Elderly
172757551,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q1,Palpitations,,2020,Q1,1,I,20190623.0,20200102.0,20200116,20200116,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,,F,Y,63.0,KG,20200116.0,,HP,GB,GB,2020,Q1,Elderly
172757551,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q1,Skin burning sensation,,2020,Q1,1,I,20190623.0,20200102.0,20200116,20200116,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,,F,Y,63.0,KG,20200116.0,,HP,GB,GB,2020,Q1,Elderly
172757551,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q1,Suicide attempt,,2020,Q1,1,I,20190623.0,20200102.0,20200116,20200116,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,,F,Y,63.0,KG,20200116.0,,HP,GB,GB,2020,Q1,Elderly
172757551,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q1,Vision blurred,,2020,Q1,1,I,20190623.0,20200102.0,20200116,20200116,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,,F,Y,63.0,KG,20200116.0,,HP,GB,GB,2020,Q1,Elderly
172757551,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,20190623.0,20200102.0,20200116,20200116,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,,F,Y,63.0,KG,20200116.0,,HP,GB,GB,2020,Q1,Elderly
172849941,17284994,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,U,,,125469.0,,,INJECTION,,2020,Q1,Abdominal pain upper,,2020,Q1,1,I,,20200109.0,20200117,20200117,EXP,,US-ELI_LILLY_AND_COMPANY-US202001004528,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20200117.0,,CN,US,US,2020,Q1,Adult
172849941,17284994,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,U,,,125469.0,,,INJECTION,,2020,Q1,Constipation,,2020,Q1,1,I,,20200109.0,20200117,20200117,EXP,,US-ELI_LILLY_AND_COMPANY-US202001004528,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20200117.0,,CN,US,US,2020,Q1,Adult
172849941,17284994,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,U,,,125469.0,,,INJECTION,,2020,Q1,Eating disorder,,2020,Q1,1,I,,20200109.0,20200117,20200117,EXP,,US-ELI_LILLY_AND_COMPANY-US202001004528,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20200117.0,,CN,US,US,2020,Q1,Adult
172884831,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Abscess,,2020,Q1,1,I,,20200113.0,20200120,20200120,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200120.0,,CN,CA,CA,2020,Q1,Adult
172884831,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Blood glucose fluctuation,,2020,Q1,1,I,,20200113.0,20200120,20200120,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200120.0,,CN,CA,CA,2020,Q1,Adult
172884831,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Cardiac disorder,,2020,Q1,1,I,,20200113.0,20200120,20200120,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200120.0,,CN,CA,CA,2020,Q1,Adult
172884831,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Constipation,,2020,Q1,1,I,,20200113.0,20200120,20200120,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200120.0,,CN,CA,CA,2020,Q1,Adult
172884831,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Headache,,2020,Q1,1,I,,20200113.0,20200120,20200120,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200120.0,,CN,CA,CA,2020,Q1,Adult
172884831,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Hypoaesthesia,,2020,Q1,1,I,,20200113.0,20200120,20200120,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200120.0,,CN,CA,CA,2020,Q1,Adult
172884831,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Night sweats,,2020,Q1,1,I,,20200113.0,20200120,20200120,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200120.0,,CN,CA,CA,2020,Q1,Adult
172884831,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Swelling,,2020,Q1,1,I,,20200113.0,20200120,20200120,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200120.0,,CN,CA,CA,2020,Q1,Adult
172884831,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Swelling face,,2020,Q1,1,I,,20200113.0,20200120,20200120,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200120.0,,CN,CA,CA,2020,Q1,Adult
172884831,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Taste disorder,,2020,Q1,1,I,,20200113.0,20200120,20200120,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200120.0,,CN,CA,CA,2020,Q1,Adult
172884831,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Thirst decreased,,2020,Q1,1,I,,20200113.0,20200120,20200120,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200120.0,,CN,CA,CA,2020,Q1,Adult
172884831,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Weight increased,,2020,Q1,1,I,,20200113.0,20200120,20200120,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200120.0,,CN,CA,CA,2020,Q1,Adult
172915631,17291563,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,MONDAY,,,,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,/wk,2020,Q1,Blood lactic acid increased,,2020,Q1,1,I,20191203.0,20200116.0,20200121,20200121,EXP,GB-MHRA-MIDB-7C88D228-EE99-404E-9CE8-2BA2A3F0F4F2,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-002748",BOEHRINGER INGELHEIM,,55.0,YR,,M,Y,,,20200121.0,,PH,GB,GB,2020,Q1,Adult
172915631,17291563,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,MONDAY,,,,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,/wk,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20191203.0,20200116.0,20200121,20200121,EXP,GB-MHRA-MIDB-7C88D228-EE99-404E-9CE8-2BA2A3F0F4F2,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-002748",BOEHRINGER INGELHEIM,,55.0,YR,,M,Y,,,20200121.0,,PH,GB,GB,2020,Q1,Adult
172974522,17297452,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q1,Product dose omission,,2020,Q1,2,F,,20200123.0,20200122,20200221,EXP,,US-ELI_LILLY_AND_COMPANY-US202001009231,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20200221.0,,CN,US,US,2020,Q1,Adult
172974522,17297452,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q1,Visual impairment,,2020,Q1,2,F,,20200123.0,20200122,20200221,EXP,,US-ELI_LILLY_AND_COMPANY-US202001009231,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20200221.0,,CN,US,US,2020,Q1,Adult
172974522,17297452,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,, D131483D,,,0.75,MG,INJECTION,,2020,Q1,Product dose omission,,2020,Q1,2,F,,20200123.0,20200122,20200221,EXP,,US-ELI_LILLY_AND_COMPANY-US202001009231,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20200221.0,,CN,US,US,2020,Q1,Adult
172974522,17297452,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,, D131483D,,,0.75,MG,INJECTION,,2020,Q1,Visual impairment,,2020,Q1,2,F,,20200123.0,20200122,20200221,EXP,,US-ELI_LILLY_AND_COMPANY-US202001009231,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20200221.0,,CN,US,US,2020,Q1,Adult
173047991,17304799,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Abscess,,2020,Q1,1,I,,20200113.0,20200123,20200123,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200123.0,,CN,CA,CA,2020,Q1,Adult
173047991,17304799,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Blood glucose fluctuation,,2020,Q1,1,I,,20200113.0,20200123,20200123,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200123.0,,CN,CA,CA,2020,Q1,Adult
173047991,17304799,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Cardiac disorder,,2020,Q1,1,I,,20200113.0,20200123,20200123,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200123.0,,CN,CA,CA,2020,Q1,Adult
173047991,17304799,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Constipation,,2020,Q1,1,I,,20200113.0,20200123,20200123,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200123.0,,CN,CA,CA,2020,Q1,Adult
173047991,17304799,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Headache,,2020,Q1,1,I,,20200113.0,20200123,20200123,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200123.0,,CN,CA,CA,2020,Q1,Adult
173047991,17304799,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Hypoaesthesia,,2020,Q1,1,I,,20200113.0,20200123,20200123,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200123.0,,CN,CA,CA,2020,Q1,Adult
173047991,17304799,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Night sweats,,2020,Q1,1,I,,20200113.0,20200123,20200123,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200123.0,,CN,CA,CA,2020,Q1,Adult
173047991,17304799,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Swelling,,2020,Q1,1,I,,20200113.0,20200123,20200123,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200123.0,,CN,CA,CA,2020,Q1,Adult
173047991,17304799,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Swelling face,,2020,Q1,1,I,,20200113.0,20200123,20200123,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200123.0,,CN,CA,CA,2020,Q1,Adult
173047991,17304799,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Taste disorder,,2020,Q1,1,I,,20200113.0,20200123,20200123,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200123.0,,CN,CA,CA,2020,Q1,Adult
173047991,17304799,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Thirst decreased,,2020,Q1,1,I,,20200113.0,20200123,20200123,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200123.0,,CN,CA,CA,2020,Q1,Adult
173047991,17304799,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q1,Weight increased,,2020,Q1,1,I,,20200113.0,20200123,20200123,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200123.0,,CN,CA,CA,2020,Q1,Adult
173054691,17305469,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,Y,,,,,,,INJECTION,,2020,Q1,Abdominal adhesions,,2020,Q1,1,I,20191201.0,20200117.0,20200123,20200123,EXP,,GB-PFIZER INC-2020024248,PFIZER,,69.0,YR,,F,Y,,,20200123.0,,MD,GB,GB,2020,Q1,Elderly
173054691,17305469,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,Y,,,,,,,INJECTION,,2020,Q1,Small intestinal obstruction,,2020,Q1,1,I,20191201.0,20200117.0,20200123,20200123,EXP,,GB-PFIZER INC-2020024248,PFIZER,,69.0,YR,,F,Y,,,20200123.0,,MD,GB,GB,2020,Q1,Elderly
173064691,17306469,8,C,DULAGLUTIDE/DULAGLUTIDE,,2,Subcutaneous,MONDAY,,,,,,,,1.5,MG,INJECTION,/wk,2020,Q1,Blood lactic acid increased,,2020,Q1,1,I,20191203.0,20200117.0,20200123,20200123,EXP,GB-MHRA-MIDB-7C88D228-EE99-404E-9CE8-2BA2A3F0F4F2,GB-EMD SERONO-E2B_90074299,EMD SERONO INC,,55.0,YR,,M,Y,,,20200123.0,,PH,GB,GB,2020,Q1,Adult
173064691,17306469,8,C,DULAGLUTIDE/DULAGLUTIDE,,2,Subcutaneous,MONDAY,,,,,,,,1.5,MG,INJECTION,/wk,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20191203.0,20200117.0,20200123,20200123,EXP,GB-MHRA-MIDB-7C88D228-EE99-404E-9CE8-2BA2A3F0F4F2,GB-EMD SERONO-E2B_90074299,EMD SERONO INC,,55.0,YR,,M,Y,,,20200123.0,,PH,GB,GB,2020,Q1,Adult
173146191,17314619,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,0.75,MG,,QW,2020,Q1,Anion gap increased,,2020,Q1,1,I,20191222.0,,20200123,20200123,DIR,,,FDA-CTU,,47.0,YR,,F,N,66.8,KG,20200123.0,N,,US,US,2020,Q1,Adult
173146191,17314619,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,0.75,MG,,QW,2020,Q1,Blood glucose increased,,2020,Q1,1,I,20191222.0,,20200123,20200123,DIR,,,FDA-CTU,,47.0,YR,,F,N,66.8,KG,20200123.0,N,,US,US,2020,Q1,Adult
173146191,17314619,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,0.75,MG,,QW,2020,Q1,Blood urea decreased,,2020,Q1,1,I,20191222.0,,20200123,20200123,DIR,,,FDA-CTU,,47.0,YR,,F,N,66.8,KG,20200123.0,N,,US,US,2020,Q1,Adult
173146191,17314619,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,0.75,MG,,QW,2020,Q1,Glucose urine present,,2020,Q1,1,I,20191222.0,,20200123,20200123,DIR,,,FDA-CTU,,47.0,YR,,F,N,66.8,KG,20200123.0,N,,US,US,2020,Q1,Adult
173146191,17314619,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,0.75,MG,,QW,2020,Q1,Herpes zoster,,2020,Q1,1,I,20191222.0,,20200123,20200123,DIR,,,FDA-CTU,,47.0,YR,,F,N,66.8,KG,20200123.0,N,,US,US,2020,Q1,Adult
173146191,17314619,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,0.75,MG,,QW,2020,Q1,Urine ketone body present,,2020,Q1,1,I,20191222.0,,20200123,20200123,DIR,,,FDA-CTU,,47.0,YR,,F,N,66.8,KG,20200123.0,N,,US,US,2020,Q1,Adult
173146191,17314619,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,0.75,MG,,QW,2020,Q1,Vomiting,,2020,Q1,1,I,20191222.0,,20200123,20200123,DIR,,,FDA-CTU,,47.0,YR,,F,N,66.8,KG,20200123.0,N,,US,US,2020,Q1,Adult
173159481,17315948,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,/wk,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,,20200115.0,20200124,20200124,EXP,,GR-ASTRAZENECA-2020SE07100,ASTRAZENECA,,51.0,YR,,F,Y,88.0,KG,20200124.0,,HP,GR,GR,2020,Q1,Adult
173159481,17315948,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,/wk,2020,Q1,Off label use,,2020,Q1,1,I,,20200115.0,20200124,20200124,EXP,,GR-ASTRAZENECA-2020SE07100,ASTRAZENECA,,51.0,YR,,F,Y,88.0,KG,20200124.0,,HP,GR,GR,2020,Q1,Adult
173182031,17318203,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,MONDAY (PRE-FILLED DISPOSABLE),,,,,,,,1.5,MG,SOLUTION FOR INJECTION,/wk,2020,Q1,Blood lactic acid increased,,2020,Q1,1,I,20191203.0,20200116.0,20200124,20200124,EXP,GB-MHRA-MIDB-7C88D228-EE99-404E-9CE8-2BA2A3F0F4F2,GB-BAUSCH-BL-2020-001627,BAUSCH AND LOMB,,55.0,YR,,M,Y,,,20200124.0,,PH,GB,GB,2020,Q1,Adult
173182031,17318203,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,MONDAY (PRE-FILLED DISPOSABLE),,,,,,,,1.5,MG,SOLUTION FOR INJECTION,/wk,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20191203.0,20200116.0,20200124,20200124,EXP,GB-MHRA-MIDB-7C88D228-EE99-404E-9CE8-2BA2A3F0F4F2,GB-BAUSCH-BL-2020-001627,BAUSCH AND LOMB,,55.0,YR,,M,Y,,,20200124.0,,PH,GB,GB,2020,Q1,Adult
173237341,17323734,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM,WEEKLY (MONDAY)",,,,, UNKNOWN,,,1.5,MG,SOLUTION FOR INJECTION,,2020,Q1,Blood lactic acid increased,,2020,Q1,1,I,20191203.0,20200114.0,20200127,20200127,EXP,GB-MHRA-ADR 24464395,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0074,EMCURE,,55.0,YR,,M,Y,,,20200127.0,,PH,GB,GB,2020,Q1,Adult
173237341,17323734,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM,WEEKLY (MONDAY)",,,,, UNKNOWN,,,1.5,MG,SOLUTION FOR INJECTION,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20191203.0,20200114.0,20200127,20200127,EXP,GB-MHRA-ADR 24464395,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-0074,EMCURE,,55.0,YR,,M,Y,,,20200127.0,,PH,GB,GB,2020,Q1,Adult
173358982,17335898,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, WEEKLY (1/W)",,,,,,,125469.0,0.75,MG,SOLUTION FOR INJECTION,/wk,2020,Q1,Cholelithiasis,,2020,Q1,2,F,20170505.0,20200227.0,20200128,20200310,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202001007948,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20200310.0,,MD,JP,JP,2020,Q1,Elderly
173375971,17337597,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,.2143 MILLIGRAM DAILY;,,,,, UNKNOWN,,,1.5,MG,SOLUTION FOR INJECTION,/wk,2020,Q1,Blood lactic acid increased,,2020,Q1,1,I,20191203.0,20200122.0,20200129,20200129,EXP,GB-MHRA-MIDB-7C88D228-EE99-404E-9CE8-2BA2A3F0F4F2,GB-TEVA-2020-GB-1175625,TEVA,,55.0,YR,,M,Y,,,20200129.0,,PH,GB,GB,2020,Q1,Adult
173375971,17337597,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,.2143 MILLIGRAM DAILY;,,,,, UNKNOWN,,,1.5,MG,SOLUTION FOR INJECTION,/wk,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20191203.0,20200122.0,20200129,20200129,EXP,GB-MHRA-MIDB-7C88D228-EE99-404E-9CE8-2BA2A3F0F4F2,GB-TEVA-2020-GB-1175625,TEVA,,55.0,YR,,M,Y,,,20200129.0,,PH,GB,GB,2020,Q1,Adult
173377802,17337780,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2020,Q1,Diabetes mellitus,,2020,Q1,2,F,201906.0,20200122.0,20200129,20200131,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-004251",BOEHRINGER INGELHEIM,,65.0,YR,,F,Y,,,20200131.0,,MD,CO,CO,2020,Q1,Elderly
173377802,17337780,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2020,Q1,Drug ineffective,,2020,Q1,2,F,201906.0,20200122.0,20200129,20200131,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-004251",BOEHRINGER INGELHEIM,,65.0,YR,,F,Y,,,20200131.0,,MD,CO,CO,2020,Q1,Elderly
173377802,17337780,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,2,F,201906.0,20200122.0,20200129,20200131,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-004251",BOEHRINGER INGELHEIM,,65.0,YR,,F,Y,,,20200131.0,,MD,CO,CO,2020,Q1,Elderly
173377802,17337780,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2020,Q1,Toe amputation,,2020,Q1,2,F,201906.0,20200122.0,20200129,20200131,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-004251",BOEHRINGER INGELHEIM,,65.0,YR,,F,Y,,,20200131.0,,MD,CO,CO,2020,Q1,Elderly
173431041,17343104,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Drug ineffective,,2020,Q1,1,I,20181107.0,20190218.0,20200129,20200129,PER,,US-ALLERGAN-1906919US,ALLERGAN,,60.0,YR,,M,Y,,,20200129.0,,MD,COUNTRY NOT SPECIFIED,US,2020,Q1,Adult
173431041,17343104,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Off label use,,2020,Q1,1,I,20181107.0,20190218.0,20200129,20200129,PER,,US-ALLERGAN-1906919US,ALLERGAN,,60.0,YR,,M,Y,,,20200129.0,,MD,COUNTRY NOT SPECIFIED,US,2020,Q1,Adult
173458341,17345834,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, QW",,,U,U, UNK,,,0.75,MG,,/wk,2020,Q1,Abscess,,2020,Q1,1,I,,20200120.0,20200129,20200129,EXP,,CA-NOVOPROD-709237,NOVO NORDISK,,50.0,YR,,F,Y,75.0,KG,20200129.0,,CN,CA,CA,2020,Q1,Adult
173458341,17345834,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, QW",,,U,U, UNK,,,0.75,MG,,/wk,2020,Q1,Blood glucose fluctuation,,2020,Q1,1,I,,20200120.0,20200129,20200129,EXP,,CA-NOVOPROD-709237,NOVO NORDISK,,50.0,YR,,F,Y,75.0,KG,20200129.0,,CN,CA,CA,2020,Q1,Adult
173458341,17345834,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, QW",,,U,U, UNK,,,0.75,MG,,/wk,2020,Q1,Cardiac disorder,,2020,Q1,1,I,,20200120.0,20200129,20200129,EXP,,CA-NOVOPROD-709237,NOVO NORDISK,,50.0,YR,,F,Y,75.0,KG,20200129.0,,CN,CA,CA,2020,Q1,Adult
173458341,17345834,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, QW",,,U,U, UNK,,,0.75,MG,,/wk,2020,Q1,Constipation,,2020,Q1,1,I,,20200120.0,20200129,20200129,EXP,,CA-NOVOPROD-709237,NOVO NORDISK,,50.0,YR,,F,Y,75.0,KG,20200129.0,,CN,CA,CA,2020,Q1,Adult
173458341,17345834,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, QW",,,U,U, UNK,,,0.75,MG,,/wk,2020,Q1,Headache,,2020,Q1,1,I,,20200120.0,20200129,20200129,EXP,,CA-NOVOPROD-709237,NOVO NORDISK,,50.0,YR,,F,Y,75.0,KG,20200129.0,,CN,CA,CA,2020,Q1,Adult
173458341,17345834,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, QW",,,U,U, UNK,,,0.75,MG,,/wk,2020,Q1,Hypoaesthesia,,2020,Q1,1,I,,20200120.0,20200129,20200129,EXP,,CA-NOVOPROD-709237,NOVO NORDISK,,50.0,YR,,F,Y,75.0,KG,20200129.0,,CN,CA,CA,2020,Q1,Adult
173458341,17345834,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, QW",,,U,U, UNK,,,0.75,MG,,/wk,2020,Q1,Night sweats,,2020,Q1,1,I,,20200120.0,20200129,20200129,EXP,,CA-NOVOPROD-709237,NOVO NORDISK,,50.0,YR,,F,Y,75.0,KG,20200129.0,,CN,CA,CA,2020,Q1,Adult
173458341,17345834,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, QW",,,U,U, UNK,,,0.75,MG,,/wk,2020,Q1,Swelling,,2020,Q1,1,I,,20200120.0,20200129,20200129,EXP,,CA-NOVOPROD-709237,NOVO NORDISK,,50.0,YR,,F,Y,75.0,KG,20200129.0,,CN,CA,CA,2020,Q1,Adult
173458341,17345834,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, QW",,,U,U, UNK,,,0.75,MG,,/wk,2020,Q1,Swelling face,,2020,Q1,1,I,,20200120.0,20200129,20200129,EXP,,CA-NOVOPROD-709237,NOVO NORDISK,,50.0,YR,,F,Y,75.0,KG,20200129.0,,CN,CA,CA,2020,Q1,Adult
173458341,17345834,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, QW",,,U,U, UNK,,,0.75,MG,,/wk,2020,Q1,Taste disorder,,2020,Q1,1,I,,20200120.0,20200129,20200129,EXP,,CA-NOVOPROD-709237,NOVO NORDISK,,50.0,YR,,F,Y,75.0,KG,20200129.0,,CN,CA,CA,2020,Q1,Adult
173458341,17345834,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, QW",,,U,U, UNK,,,0.75,MG,,/wk,2020,Q1,Thirst decreased,,2020,Q1,1,I,,20200120.0,20200129,20200129,EXP,,CA-NOVOPROD-709237,NOVO NORDISK,,50.0,YR,,F,Y,75.0,KG,20200129.0,,CN,CA,CA,2020,Q1,Adult
173458341,17345834,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, QW",,,U,U, UNK,,,0.75,MG,,/wk,2020,Q1,Weight increased,,2020,Q1,1,I,,20200120.0,20200129,20200129,EXP,,CA-NOVOPROD-709237,NOVO NORDISK,,50.0,YR,,F,Y,75.0,KG,20200129.0,,CN,CA,CA,2020,Q1,Adult
173465892,17346589,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U,,,,1.5,MG,INJECTION,,2020,Q1,Incorrect dose administered,,2020,Q1,2,F,,20200127.0,20200130,20200220,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013096,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20200220.0,,CN,US,US,2020,Q1,Elderly
173465892,17346589,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U,,,,1.5,MG,INJECTION,,2020,Q1,Injection site pain,,2020,Q1,2,F,,20200127.0,20200130,20200220,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013096,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20200220.0,,CN,US,US,2020,Q1,Elderly
173465892,17346589,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U, D157682D,,,1.5,MG,INJECTION,,2020,Q1,Incorrect dose administered,,2020,Q1,2,F,,20200127.0,20200130,20200220,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013096,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20200220.0,,CN,US,US,2020,Q1,Elderly
173465892,17346589,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U, D157682D,,,1.5,MG,INJECTION,,2020,Q1,Injection site pain,,2020,Q1,2,F,,20200127.0,20200130,20200220,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013096,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20200220.0,,CN,US,US,2020,Q1,Elderly
173605831,17360583,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20170101.0,20181009.0,20200203,20200203,EXP,FR-EMA-DD-20190828-PAWAR_P-085615,FR-MYLANLABS-2019M1071649,MYLAN,,69.0,YR,,F,Y,85.0,KG,20200203.0,,MD,FR,FR,2020,Q1,Elderly
173605831,17360583,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,20170101.0,20181009.0,20200203,20200203,EXP,FR-EMA-DD-20190828-PAWAR_P-085615,FR-MYLANLABS-2019M1071649,MYLAN,,69.0,YR,,F,Y,85.0,KG,20200203.0,,MD,FR,FR,2020,Q1,Elderly
173690184,17369018,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Acute myocardial infarction,,2020,Q1,4,F,20200130.0,20200302.0,20200204,20200306,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-008408,BRISTOL MYERS SQUIBB,,80.0,YR,,M,Y,56.5,KG,20200306.0,,HP,JP,JP,2020,Q1,Elderly
173694271,17369427,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QD,2020,Q1,Pancreatitis,,2020,Q1,1,I,20191202.0,,20200121,20200121,DIR,,,FDA-CTU,,45.0,YR,,M,N,,,20200117.0,N,PH,US,US,2020,Q1,Adult
173723832,17372383,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, WEEKLY (1/W)",,,U,U,,,125469.0,0.75,MG,SOLUTION FOR INJECTION,/wk,2020,Q1,Cholecystitis,,2020,Q1,2,F,20181120.0,20200307.0,20200205,20200318,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202001014240,ELI LILLY AND CO,,59.0,YR,,M,Y,86.0,KG,20200318.0,,MD,JP,JP,2020,Q1,Adult
173867201,17386720,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",1.5,MG,Y,U,,,125469.0,1.5,MG,,/wk,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200104.0,20200129.0,20200206,20200206,EXP,IT-MINISAL02-601501,IT-ELI_LILLY_AND_COMPANY-IT202001013774,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20200206.0,,MD,IT,IT,2020,Q1,Elderly
173867201,17386720,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",1.5,MG,Y,U,,,125469.0,1.5,MG,,/wk,2020,Q1,Dehydration,,2020,Q1,1,I,20200104.0,20200129.0,20200206,20200206,EXP,IT-MINISAL02-601501,IT-ELI_LILLY_AND_COMPANY-IT202001013774,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20200206.0,,MD,IT,IT,2020,Q1,Elderly
173867201,17386720,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",1.5,MG,Y,U,,,125469.0,1.5,MG,,/wk,2020,Q1,Vomiting,,2020,Q1,1,I,20200104.0,20200129.0,20200206,20200206,EXP,IT-MINISAL02-601501,IT-ELI_LILLY_AND_COMPANY-IT202001013774,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20200206.0,,MD,IT,IT,2020,Q1,Elderly
174076481,17407648,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200210.0,20200212,20200212,EXP,,NVSC2020CZ037024,NOVARTIS,,54.0,YR,,M,Y,,,20200212.0,,HP,CZ,CZ,2020,Q1,Adult
174076481,17407648,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200210.0,20200212,20200212,EXP,,NVSC2020CZ037024,NOVARTIS,,54.0,YR,,M,Y,,,20200212.0,,HP,CZ,CZ,2020,Q1,Adult
174076481,17407648,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Weight increased,,2020,Q1,1,I,,20200210.0,20200212,20200212,EXP,,NVSC2020CZ037024,NOVARTIS,,54.0,YR,,M,Y,,,20200212.0,,HP,CZ,CZ,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Acute kidney injury,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Acute respiratory distress syndrome,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Altered state of consciousness,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Anaemia,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Brain oedema,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Cardiovascular insufficiency,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Cerebral infarction,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Hypoxia,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Lactic acidosis,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Multiple organ dysfunction syndrome,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Pneumonia aspiration,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Septic shock,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Thrombocytopenia,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174096364,17409636,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,/wk,2020,Q1,Urinary tract infection,,2020,Q1,4,F,20191202.0,20200316.0,20200212,20200319,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008205",BOEHRINGER INGELHEIM,,35.0,YR,,M,Y,160.0,KG,20200320.0,,MD,DE,DE,2020,Q1,Adult
174123731,17412373,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,,,,,,0.75,MG,,,2020,Q1,Cholelithiasis,,2020,Q1,1,I,20200210.0,,20200212,20200212,DIR,,,FDA-CTU,,37.0,YR,,F,N,,,20200212.0,N,PH,US,US,2020,Q1,Adult
174123731,17412373,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,,,,,,0.75,MG,,,2020,Q1,Hepatic steatosis,,2020,Q1,1,I,20200210.0,,20200212,20200212,DIR,,,FDA-CTU,,37.0,YR,,F,N,,,20200212.0,N,PH,US,US,2020,Q1,Adult
174131511,17413151,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,125469.0,,,INJECTION,,2020,Q1,Blood glucose decreased,,2020,Q1,1,I,,20200107.0,20200213,20200213,EXP,,US-ELI_LILLY_AND_COMPANY-US202001002796,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200213.0,,CN,US,US,2020,Q1,Adult
174131511,17413151,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,125469.0,,,INJECTION,,2020,Q1,Loss of consciousness,,2020,Q1,1,I,,20200107.0,20200213,20200213,EXP,,US-ELI_LILLY_AND_COMPANY-US202001002796,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200213.0,,CN,US,US,2020,Q1,Adult
174131511,17413151,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,125469.0,,,INJECTION,,2020,Q1,Weight decreased,,2020,Q1,1,I,,20200107.0,20200213,20200213,EXP,,US-ELI_LILLY_AND_COMPANY-US202001002796,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200213.0,,CN,US,US,2020,Q1,Adult
174134311,17413431,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q1,Depressed level of consciousness,,2020,Q1,1,I,20190127.0,20190212.0,20200213,20200213,EXP,,GB-ASTRAZENECA-2019SE25140,ASTRAZENECA,,64.0,YR,,F,Y,98.4,KG,20200213.0,,,GB,GB,2020,Q1,Adult
174134311,17413431,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,20190127.0,20190212.0,20200213,20200213,EXP,,GB-ASTRAZENECA-2019SE25140,ASTRAZENECA,,64.0,YR,,F,Y,98.4,KG,20200213.0,,,GB,GB,2020,Q1,Adult
174138471,17413847,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,20191105.0,20191203.0,20200213,20200213,EXP,,GB-ASTRAZENECA-2019SF74017,ASTRAZENECA,,53.0,YR,,F,Y,,,20200213.0,,,GB,GB,2020,Q1,Adult
174176063,17417606,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q1,Immune-mediated hepatitis,,2020,Q1,3,F,20200130.0,20200318.0,20200213,20200327,EXP,,US-EXELIXIS-XL18420027272,EXELIXIS,,67.0,YR,,M,Y,96.2,KG,20200327.0,,MD,US,US,2020,Q1,Elderly
174255091,17425509,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20200202.0,20200217.0,20200218,20200218,EXP,GB-MHRA-EYC 00217783,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-009245",BOEHRINGER INGELHEIM,,44.0,YR,,F,Y,,,20200218.0,,HP,GB,GB,2020,Q1,Adult
174272291,17427229,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q1,Transaminases increased,,2020,Q1,1,I,20200130.0,20200205.0,20200218,20200218,EXP,,US-ROCHE-2551809,ROCHE,,67.0,YR,,M,Y,96.2,KG,20200218.0,,MD,US,US,2020,Q1,Elderly
174314902,17431490,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,,,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,/wk,2020,Q1,Blood creatinine increased,,2020,Q1,2,F,,20200218.0,20200218,20200302,EXP,,FI-ELI_LILLY_AND_COMPANY-FI202002002746,ELI LILLY AND CO,,63.0,YR,,,Y,,,20200302.0,,MD,FI,FI,2020,Q1,Adult
174314902,17431490,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,,,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,/wk,2020,Q1,Hepatic fibrosis,,2020,Q1,2,F,,20200218.0,20200218,20200302,EXP,,FI-ELI_LILLY_AND_COMPANY-FI202002002746,ELI LILLY AND CO,,63.0,YR,,,Y,,,20200302.0,,MD,FI,FI,2020,Q1,Adult
174318401,17431840,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, 1/WEEK",6.0,MG,Y,,,,,0.75,MG,SOLUTION FOR INJECTION,/wk,2020,Q1,Dermatitis exfoliative generalised,,2020,Q1,1,I,20191001.0,20200213.0,20200218,20200218,EXP,IT-MINISAL02-604753,IT-TAKEDA-2020TEU001782,TAKEDA,,55.0,YR,,M,Y,76.0,KG,20200218.0,,HP,IT,IT,2020,Q1,Adult
174472101,17447210,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,6.0,MG,Y,U,,,125469.0,0.75,MG,,/wk,2020,Q1,Dermatitis exfoliative generalised,,2020,Q1,1,I,20191001.0,20200210.0,20200221,20200221,EXP,IT-MINISAL02-604753,IT-ELI_LILLY_AND_COMPANY-IT202002004576,ELI LILLY AND CO,,55.0,YR,,M,Y,76.0,KG,20200221.0,,CN,IT,IT,2020,Q1,Adult
174542251,17454225,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,1,I,20200202.0,20200218.0,20200224,20200224,EXP,GB-MHRA-EYC 00218162,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-009536",BOEHRINGER INGELHEIM,,65.0,YR,,M,Y,92.0,KG,20200225.0,,MD,GB,GB,2020,Q1,Elderly
174542251,17454225,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,20200202.0,20200218.0,20200224,20200224,EXP,GB-MHRA-EYC 00218162,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-009536",BOEHRINGER INGELHEIM,,65.0,YR,,M,Y,92.0,KG,20200225.0,,MD,GB,GB,2020,Q1,Elderly
174542251,17454225,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q1,Nausea,,2020,Q1,1,I,20200202.0,20200218.0,20200224,20200224,EXP,GB-MHRA-EYC 00218162,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-009536",BOEHRINGER INGELHEIM,,65.0,YR,,M,Y,92.0,KG,20200225.0,,MD,GB,GB,2020,Q1,Elderly
174542251,17454225,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q1,Tachycardia,,2020,Q1,1,I,20200202.0,20200218.0,20200224,20200224,EXP,GB-MHRA-EYC 00218162,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-009536",BOEHRINGER INGELHEIM,,65.0,YR,,M,Y,92.0,KG,20200225.0,,MD,GB,GB,2020,Q1,Elderly
174542251,17454225,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,20200202.0,20200218.0,20200224,20200224,EXP,GB-MHRA-EYC 00218162,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-009536",BOEHRINGER INGELHEIM,,65.0,YR,,M,Y,92.0,KG,20200225.0,,MD,GB,GB,2020,Q1,Elderly
174544261,17454426,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Kaposi's sarcoma,,2020,Q1,1,I,,20200213.0,20200225,20200225,EXP,,US-APOTEX-2020AP007976,APOTEX,"AHMED M, DENICOLA R. GASTRIC KAPOSI^S SARCOMA IN A PATIENT WITH APLASTIC ANEMIA. DOI: 10.14309/01.AJG.0000597548.92525.7B. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2019;114:S1121-S1122",70.0,YR,,M,Y,,,20200225.0,,HP,US,US,2020,Q1,Elderly
174579241,17457924,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,, UNKNWON,,,1.5,MG,,,2020,Q1,Pancreatitis acute,Pancreatitis acute,2020,Q1,1,I,20191224.0,20200210.0,20200225,20200225,EXP,FR-AFSSAPS-RE20200062,FR-ZYDUS-047620,ZYDUS PHARM,,55.0,YR,,M,Y,99.0,KG,20200225.0,,MD,FR,FR,2020,Q1,Adult
174662821,17466282,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Colitis ulcerative,,2020,Q1,1,I,,20200218.0,20200227,20200227,EXP,,CA-TEVA-2020-CA-1189917,TEVA,,73.0,YR,,F,Y,,,20200227.0,,CN,CA,CA,2020,Q1,Elderly
174717411,17471741,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20191201.0,20200227.0,20200228,20200228,EXP,GB-MHRA-EYC 00215705,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-011634",BOEHRINGER INGELHEIM,,55.0,YR,,M,Y,82.9,KG,20200228.0,,PH,GB,GB,2020,Q1,Adult
174717411,17471741,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,20191201.0,20200227.0,20200228,20200228,EXP,GB-MHRA-EYC 00215705,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-011634",BOEHRINGER INGELHEIM,,55.0,YR,,M,Y,82.9,KG,20200228.0,,PH,GB,GB,2020,Q1,Adult
174838381,17483838,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Kaposi's sarcoma,,2020,Q1,1,I,,20200219.0,20200302,20200302,EXP,,US-MYLANLABS-2020M1021204,MYLAN,"AHMED M, DENICOLA R. GASTRIC KAPOSI^S SARCOMA IN A PATIENT WITH APLASTIC ANEMIA. AM-J-GASTROENTEROL 2019;114 (SUPPL.):S1121-S1122 ABSTR. 2004.",70.0,YR,,M,Y,,,20200302.0,,MD,US,US,2020,Q1,Elderly
174863871,17486387,1,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,, UNKNWON,,,1.5,MG,,,2020,Q1,Cholelithiasis,Cholelithiasis,2020,Q1,1,I,2019.0,20200217.0,20200303,20200303,EXP,FR-AFSSAPS-PS20200154,FR-ZYDUS-047959,ZYDUS PHARM,,78.0,YR,,F,Y,78.0,KG,20200303.0,,MD,FR,FR,2020,Q1,Elderly
174863871,17486387,1,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,, UNKNWON,,,1.5,MG,,,2020,Q1,Pancreatitis acute,Pancreatitis acute,2020,Q1,1,I,2019.0,20200217.0,20200303,20200303,EXP,FR-AFSSAPS-PS20200154,FR-ZYDUS-047959,ZYDUS PHARM,,78.0,YR,,F,Y,78.0,KG,20200303.0,,MD,FR,FR,2020,Q1,Elderly
174889211,17488921,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN,PEN)",DULAGLUTIDE,1,Subcutaneous,?          OTHER STRENGTH:0.75MG/0.5ML;?,,,,,,,,0.75,MG,,QW,2020,Q1,Accidental exposure to product,,2020,Q1,1,I,20190104.0,,20200220,20200220,DIR,,,FDA-CTU,,64.0,YR,,F,N,121.0,KG,20190115.0,N,PH,US,US,2020,Q1,Adult
175022631,17502263,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20200109.0,20200302.0,20200305,20200305,EXP,,GB-ASTRAZENECA-2020SE30646,ASTRAZENECA,,65.0,YR,,F,Y,,,20200305.0,,,GB,GB,2020,Q1,Elderly
175024751,17502475,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q1,Fournier's gangrene,,2020,Q1,1,I,20200213.0,20200303.0,20200305,20200305,EXP,GB-MHRA-EYC 00219002,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-012526",BOEHRINGER INGELHEIM,,60.0,YR,,F,Y,120.0,KG,20200305.0,,PH,GB,GB,2020,Q1,Adult
175024931,17502493,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Kaposi's sarcoma,,2020,Q1,1,I,,20200224.0,20200305,20200305,EXP,,US-TEVA-2020-US-1193459,TEVA,"AHMED M, DENICOLA R. GASTRIC KAPOSI^S SARCOMA IN A PATIENT WITH APLASTIC ANEMIA. AM-J-GASTROENTEROL 2019;114 (SUPPL.):S1121-S1122 ABSTR. 2004.",70.0,YR,,M,Y,,,20200305.0,,MD,US,US,2020,Q1,Elderly
175055191,17505519,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q1,Abdominal pain,,2020,Q1,1,I,20191227.0,,20200225,20200225,DIR,,,FDA-CTU,,60.0,YR,,M,N,,,20200217.0,N,PH,US,US,2020,Q1,Adult
175055191,17505519,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,1,I,20191227.0,,20200225,20200225,DIR,,,FDA-CTU,,60.0,YR,,M,N,,,20200217.0,N,PH,US,US,2020,Q1,Adult
175055191,17505519,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q1,Nausea,,2020,Q1,1,I,20191227.0,,20200225,20200225,DIR,,,FDA-CTU,,60.0,YR,,M,N,,,20200217.0,N,PH,US,US,2020,Q1,Adult
175092481,17509248,2,SS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20200101.0,,20200225,20200225,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175092481,17509248,2,SS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,1,I,20200101.0,,20200225,20200225,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175092481,17509248,2,SS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,1,I,20200101.0,,20200225,20200225,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175092481,17509248,2,SS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q1,Nausea,,2020,Q1,1,I,20200101.0,,20200225,20200225,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175092481,17509248,2,SS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,20200101.0,,20200225,20200225,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175095831,17509583,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,Y,,,,,,,,2020,Q1,Nausea,,2020,Q1,1,I,20191206.0,,20200225,20200225,DIR,,,FDA-CTU,,60.0,YR,,M,N,,,20200217.0,N,PH,US,US,2020,Q1,Adult
175095831,17509583,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,Y,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,20191206.0,,20200225,20200225,DIR,,,FDA-CTU,,60.0,YR,,M,N,,,20200217.0,N,PH,US,US,2020,Q1,Adult
175116282,17511628,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q1,Ketoacidosis,,2020,Q1,2,F,,20200306.0,20200307,20200309,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-013243",BOEHRINGER INGELHEIM,,23.0,YR,,M,Y,117.0,KG,20200309.0,,MD,DE,DE,2020,Q1,Youth
175144011,17514401,2,SS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20200101.0,,20200226,20200226,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175144011,17514401,2,SS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,1,I,20200101.0,,20200226,20200226,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175144011,17514401,2,SS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q1,Nausea,,2020,Q1,1,I,20200101.0,,20200226,20200226,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175144011,17514401,2,SS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,20200101.0,,20200226,20200226,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200225.0,N,PH,US,US,2020,Q1,Elderly
175691991,17569199,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Oral,,,,Y,D,,,,0.75,MG,,QW,2020,Q1,Pancreatitis,,2020,Q1,1,I,20191112.0,,20200316,20200316,DIR,,,FDA-CTU,,53.0,YR,,M,N,91.63,KG,20200217.0,N,PH,US,US,2020,Q1,Adult
175699911,17569991,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q1,Nausea,,2020,Q1,1,I,,,20200316,20200316,DIR,,,FDA-CTU,,55.0,YR,,F,N,,,20190715.0,N,PH,US,US,2020,Q1,Adult
175699911,17569991,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,,,20200316,20200316,DIR,,,FDA-CTU,,55.0,YR,,F,N,,,20190715.0,N,PH,US,US,2020,Q1,Adult
175717651,17571765,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,U, D144007,,,,,,,2020,Q1,Gait disturbance,,2020,Q1,1,I,20191225.0,20200312.0,20200323,20200323,EXP,,GR-ASTRAZENECA-2020SE37566,ASTRAZENECA,,75.0,YR,,F,Y,,,20200323.0,,CN,GR,GR,2020,Q1,Elderly
175717651,17571765,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,U, D144007,,,,,,,2020,Q1,Ketoacidosis,,2020,Q1,1,I,20191225.0,20200312.0,20200323,20200323,EXP,,GR-ASTRAZENECA-2020SE37566,ASTRAZENECA,,75.0,YR,,F,Y,,,20200323.0,,CN,GR,GR,2020,Q1,Elderly
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Asthenia,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Atrioventricular block,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Blood creatinine increased,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Cardiac murmur,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Hyperkalaemia,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Nodal rhythm,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Rales,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Renal cyst,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Renal failure,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Renal impairment,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175753701,17575370,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q1,Shock,,2020,Q1,1,I,,20200309.0,20200324,20200324,EXP,,US-GLAXOSMITHKLINE-US2020GSK044705,GLAXOSMITHKLINE,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR. BRASH SYNDROME. BMJ CASE REPORTS. 2020;13 (2):DOI:10.1136/BCR-2019-233825",62.0,YR,,F,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
175842711,17584271,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q1,Colitis ulcerative,,2020,Q1,1,I,,20200317.0,20200326,20200326,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-09716,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,,,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175930791,17593079,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,,20181112.0,20200327,20200327,EXP,,GR-JNJFOC-20181116173,JOHNSON AND JOHNSON,"PRODROMIADOU E, KONTRAFOURI P, KOURTI E, TSAKANIKAS A, KARAOLIA M, NTZIORA F, ET AL. EUGLYCEMIC DIABETIC KETOACIDOSIS IN PATIENT WITH DIABETES MELLITUS DURING ADMINISTRATION OF SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT2) INHIBITORS. 2018.",65.0,YR,,F,Y,,,20200327.0,,MD,GR,GR,2020,Q1,Elderly
175998481,17599848,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q1,Gangrene,,2020,Q1,1,I,20200302.0,20200323.0,20200330,20200330,EXP,GB-MHRA-EYC 00220232,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-016136",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,,,20200330.0,,MD,GB,GB,2020,Q1,Adult
176058671,17605867,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.5 MG, WEEKLY (1/W)",,,Y,U,,,125469.0,0.5,MG,,/wk,2020,Q1,Aphasia,,2020,Q1,1,I,,20200320.0,20200331,20200331,EXP,GB-MHRA-EYC 00220100,GB-ELI_LILLY_AND_COMPANY-GB202003010245,ELI LILLY AND CO,,66.0,YR,,M,Y,160.0,KG,20200331.0,,MD,GB,GB,2020,Q1,Elderly
176058671,17605867,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.5 MG, WEEKLY (1/W)",,,Y,U,,,125469.0,0.5,MG,,/wk,2020,Q1,Underdose,,2020,Q1,1,I,,20200320.0,20200331,20200331,EXP,GB-MHRA-EYC 00220100,GB-ELI_LILLY_AND_COMPANY-GB202003010245,ELI LILLY AND CO,,66.0,YR,,M,Y,160.0,KG,20200331.0,,MD,GB,GB,2020,Q1,Elderly
176118431,17611843,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,, D137501D,20210731.0,,0.75,MG,,QW,2020,Q1,Diarrhoea,,2020,Q1,1,I,20200301.0,,20200330,20200330,DIR,,,FDA-CTU,,65.0,YR,,M,N,72.0,KG,20200330.0,N,PH,US,US,2020,Q1,Elderly
176118431,17611843,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,, D137501D,20210731.0,,0.75,MG,,QW,2020,Q1,Nausea,,2020,Q1,1,I,20200301.0,,20200330,20200330,DIR,,,FDA-CTU,,65.0,YR,,M,N,72.0,KG,20200330.0,N,PH,US,US,2020,Q1,Elderly
176118431,17611843,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,, D137501D,20210731.0,,0.75,MG,,QW,2020,Q1,Vomiting,,2020,Q1,1,I,20200301.0,,20200330,20200330,DIR,,,FDA-CTU,,65.0,YR,,M,N,72.0,KG,20200330.0,N,PH,US,US,2020,Q1,Elderly
142003062,14200306,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, WEEKLY (1/W)",,,,,,,,0.75,MG,INJECTION,/wk,2020,Q2,Injection site erythema,,2020,Q2,2,F,201710.0,20200326.0,20171117,20200403,PER,,US-ELI_LILLY_AND_COMPANY-US201711002548,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200403.0,,PH,US,US,2020,Q2,Elderly
142003062,14200306,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, WEEKLY (1/W)",,,,,,,,0.75,MG,INJECTION,/wk,2020,Q2,Injection site pain,,2020,Q2,2,F,201710.0,20200326.0,20171117,20200403,PER,,US-ELI_LILLY_AND_COMPANY-US201711002548,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200403.0,,PH,US,US,2020,Q2,Elderly
142003062,14200306,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, WEEKLY (1/W)",,,,,,,,0.75,MG,INJECTION,/wk,2020,Q2,Injection site urticaria,,2020,Q2,2,F,201710.0,20200326.0,20171117,20200403,PER,,US-ELI_LILLY_AND_COMPANY-US201711002548,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200403.0,,PH,US,US,2020,Q2,Elderly
146512753,14651275,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,, C805223E,,,0.75,MG,INJECTION,,2020,Q2,Decreased appetite,,2020,Q2,3,F,20180309.0,20200414.0,20180316,20200512,PER,,US-ELI_LILLY_AND_COMPANY-US201803004732,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Adult
146512753,14651275,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,, C805223E,,,0.75,MG,INJECTION,,2020,Q2,Eating disorder,,2020,Q2,3,F,20180309.0,20200414.0,20180316,20200512,PER,,US-ELI_LILLY_AND_COMPANY-US201803004732,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Adult
146512753,14651275,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,, C805223E,,,0.75,MG,INJECTION,,2020,Q2,Eructation,,2020,Q2,3,F,20180309.0,20200414.0,20180316,20200512,PER,,US-ELI_LILLY_AND_COMPANY-US201803004732,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Adult
146512753,14651275,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,, C805223E,,,0.75,MG,INJECTION,,2020,Q2,Injection site erythema,,2020,Q2,3,F,20180309.0,20200414.0,20180316,20200512,PER,,US-ELI_LILLY_AND_COMPANY-US201803004732,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Adult
146512753,14651275,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,, C805223E,,,0.75,MG,INJECTION,,2020,Q2,Mobility decreased,,2020,Q2,3,F,20180309.0,20200414.0,20180316,20200512,PER,,US-ELI_LILLY_AND_COMPANY-US201803004732,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Adult
146512753,14651275,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,, C805223E,,,0.75,MG,INJECTION,,2020,Q2,Weight decreased,,2020,Q2,3,F,20180309.0,20200414.0,20180316,20200512,PER,,US-ELI_LILLY_AND_COMPANY-US201803004732,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Adult
146512753,14651275,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,, C805223E,,,0.75,MG,INJECTION,,2020,Q2,Weight increased,,2020,Q2,3,F,20180309.0,20200414.0,20180316,20200512,PER,,US-ELI_LILLY_AND_COMPANY-US201803004732,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Adult
150510442,15051044,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2020,Q2,Drug ineffective,,2020,Q2,2,F,201804.0,20180531.0,20180622,20200616,PER,,US-ASTELLAS-2018US020916,ASTELLAS,,71.0,YR,,M,Y,,,20200616.0,,CN,US,US,2020,Q2,Elderly
150510442,15051044,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2020,Q2,Fatigue,,2020,Q2,2,F,201804.0,20180531.0,20180622,20200616,PER,,US-ASTELLAS-2018US020916,ASTELLAS,,71.0,YR,,M,Y,,,20200616.0,,CN,US,US,2020,Q2,Elderly
167040323,16704032,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1 DOSAGE FORM, WEEKLY (1/W)",5.0,DF,,,,,125469.0,1.0,DF,,/wk,2020,Q2,Jaundice cholestatic,,2020,Q2,3,F,20190709.0,20200507.0,20190814,20200519,EXP,IT-MINISAL02-566728,IT-ELI_LILLY_AND_COMPANY-IT201908002531,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200519.0,,HP,IT,IT,2020,Q2,Elderly
167286413,16728641,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, EVERY WEEK",,,U,,,,,7.5,MG,,/wk,2020,Q2,Colitis,,2020,Q2,3,F,,20200417.0,20190822,20200427,EXP,,CA-AUROBINDO-AUR-APL-2019-054419,AUROBINDO,,73.0,YR,,F,Y,,,20200427.0,,CN,CA,CA,2020,Q2,Elderly
167286413,16728641,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, EVERY WEEK",,,U,,,,,7.5,MG,,/wk,2020,Q2,Colitis ulcerative,,2020,Q2,3,F,,20200417.0,20190822,20200427,EXP,,CA-AUROBINDO-AUR-APL-2019-054419,AUROBINDO,,73.0,YR,,F,Y,,,20200427.0,,CN,CA,CA,2020,Q2,Elderly
167286413,16728641,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, EVERY WEEK",,,U,,,,,7.5,MG,,/wk,2020,Q2,Decreased activity,,2020,Q2,3,F,,20200417.0,20190822,20200427,EXP,,CA-AUROBINDO-AUR-APL-2019-054419,AUROBINDO,,73.0,YR,,F,Y,,,20200427.0,,CN,CA,CA,2020,Q2,Elderly
167286413,16728641,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, EVERY WEEK",,,U,,,,,7.5,MG,,/wk,2020,Q2,Frequent bowel movements,,2020,Q2,3,F,,20200417.0,20190822,20200427,EXP,,CA-AUROBINDO-AUR-APL-2019-054419,AUROBINDO,,73.0,YR,,F,Y,,,20200427.0,,CN,CA,CA,2020,Q2,Elderly
167286413,16728641,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, EVERY WEEK",,,U,,,,,7.5,MG,,/wk,2020,Q2,Rectal haemorrhage,,2020,Q2,3,F,,20200417.0,20190822,20200427,EXP,,CA-AUROBINDO-AUR-APL-2019-054419,AUROBINDO,,73.0,YR,,F,Y,,,20200427.0,,CN,CA,CA,2020,Q2,Elderly
170382582,17038258,37,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Abscess limb,,2020,Q2,2,F,20180112.0,20200519.0,20191115,20200528,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20200528.0,,,US,US,2020,Q2,Elderly
170382582,17038258,37,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,2,F,20180112.0,20200519.0,20191115,20200528,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20200528.0,,,US,US,2020,Q2,Elderly
170382582,17038258,37,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Clostridial sepsis,,2020,Q2,2,F,20180112.0,20200519.0,20191115,20200528,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20200528.0,,,US,US,2020,Q2,Elderly
170382582,17038258,37,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Fournier's gangrene,,2020,Q2,2,F,20180112.0,20200519.0,20191115,20200528,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20200528.0,,,US,US,2020,Q2,Elderly
170382582,17038258,37,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Perineal abscess,,2020,Q2,2,F,20180112.0,20200519.0,20191115,20200528,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20200528.0,,,US,US,2020,Q2,Elderly
170382582,17038258,37,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Perirectal abscess,,2020,Q2,2,F,20180112.0,20200519.0,20191115,20200528,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20200528.0,,,US,US,2020,Q2,Elderly
170382582,17038258,37,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,2,F,20180112.0,20200519.0,20191115,20200528,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20200528.0,,,US,US,2020,Q2,Elderly
170382582,17038258,37,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Renal tubular necrosis,,2020,Q2,2,F,20180112.0,20200519.0,20191115,20200528,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20200528.0,,,US,US,2020,Q2,Elderly
170876722,17087672,27,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,U,,,,,,,,2020,Q2,Rheumatoid arthritis,,2020,Q2,2,F,201806.0,20180725.0,20191128,20200527,PER,,US-UCBSA-2018033678,UCB,,75.0,YR,,M,Y,,,20200527.0,,PH,US,US,2020,Q2,Elderly
171042232,17104223,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Injection site erythema,,2020,Q2,2,F,2017.0,20171127.0,20191203,20200528,PER,,US-UCBSA-2017048530,UCB,,47.0,YR,,M,Y,,,20200528.0,,PH,US,US,2020,Q2,Adult
171042232,17104223,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Injection site reaction,,2020,Q2,2,F,2017.0,20171127.0,20191203,20200528,PER,,US-UCBSA-2017048530,UCB,,47.0,YR,,M,Y,,,20200528.0,,PH,US,US,2020,Q2,Adult
171042232,17104223,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Off label use,,2020,Q2,2,F,2017.0,20171127.0,20191203,20200528,PER,,US-UCBSA-2017048530,UCB,,47.0,YR,,M,Y,,,20200528.0,,PH,US,US,2020,Q2,Adult
171042232,17104223,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Pain,,2020,Q2,2,F,2017.0,20171127.0,20191203,20200528,PER,,US-UCBSA-2017048530,UCB,,47.0,YR,,M,Y,,,20200528.0,,PH,US,US,2020,Q2,Adult
171042232,17104223,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Psoriasis,,2020,Q2,2,F,2017.0,20171127.0,20191203,20200528,PER,,US-UCBSA-2017048530,UCB,,47.0,YR,,M,Y,,,20200528.0,,PH,US,US,2020,Q2,Adult
172571322,17257132,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Colitis,,2020,Q2,2,F,,20200527.0,20200110,20200604,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-40855,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,,,20200604.0,,CN,CA,CA,2020,Q2,Elderly
172571322,17257132,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Colitis ulcerative,,2020,Q2,2,F,,20200527.0,20200110,20200604,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-40855,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,,,20200604.0,,CN,CA,CA,2020,Q2,Elderly
172571322,17257132,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Decreased activity,,2020,Q2,2,F,,20200527.0,20200110,20200604,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-40855,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,,,20200604.0,,CN,CA,CA,2020,Q2,Elderly
172571322,17257132,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Frequent bowel movements,,2020,Q2,2,F,,20200527.0,20200110,20200604,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-40855,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,,,20200604.0,,CN,CA,CA,2020,Q2,Elderly
172571322,17257132,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Rectal haemorrhage,,2020,Q2,2,F,,20200527.0,20200110,20200604,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-40855,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,,,20200604.0,,CN,CA,CA,2020,Q2,Elderly
172757552,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q2,Anxiety,,2020,Q2,2,F,20190623.0,20200514.0,20200116,20200521,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,E,F,Y,63.0,KG,20200521.0,,HP,GB,GB,2020,Q2,Elderly
172757552,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q2,Arthralgia,,2020,Q2,2,F,20190623.0,20200514.0,20200116,20200521,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,E,F,Y,63.0,KG,20200521.0,,HP,GB,GB,2020,Q2,Elderly
172757552,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q2,Depression,,2020,Q2,2,F,20190623.0,20200514.0,20200116,20200521,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,E,F,Y,63.0,KG,20200521.0,,HP,GB,GB,2020,Q2,Elderly
172757552,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q2,Fatigue,,2020,Q2,2,F,20190623.0,20200514.0,20200116,20200521,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,E,F,Y,63.0,KG,20200521.0,,HP,GB,GB,2020,Q2,Elderly
172757552,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q2,Feeling of body temperature change,,2020,Q2,2,F,20190623.0,20200514.0,20200116,20200521,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,E,F,Y,63.0,KG,20200521.0,,HP,GB,GB,2020,Q2,Elderly
172757552,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q2,Lacrimation increased,,2020,Q2,2,F,20190623.0,20200514.0,20200116,20200521,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,E,F,Y,63.0,KG,20200521.0,,HP,GB,GB,2020,Q2,Elderly
172757552,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q2,Night sweats,,2020,Q2,2,F,20190623.0,20200514.0,20200116,20200521,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,E,F,Y,63.0,KG,20200521.0,,HP,GB,GB,2020,Q2,Elderly
172757552,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q2,Pain,,2020,Q2,2,F,20190623.0,20200514.0,20200116,20200521,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,E,F,Y,63.0,KG,20200521.0,,HP,GB,GB,2020,Q2,Elderly
172757552,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q2,Palpitations,,2020,Q2,2,F,20190623.0,20200514.0,20200116,20200521,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,E,F,Y,63.0,KG,20200521.0,,HP,GB,GB,2020,Q2,Elderly
172757552,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q2,Skin burning sensation,,2020,Q2,2,F,20190623.0,20200514.0,20200116,20200521,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,E,F,Y,63.0,KG,20200521.0,,HP,GB,GB,2020,Q2,Elderly
172757552,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q2,Suicide attempt,,2020,Q2,2,F,20190623.0,20200514.0,20200116,20200521,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,E,F,Y,63.0,KG,20200521.0,,HP,GB,GB,2020,Q2,Elderly
172757552,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q2,Vision blurred,,2020,Q2,2,F,20190623.0,20200514.0,20200116,20200521,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,E,F,Y,63.0,KG,20200521.0,,HP,GB,GB,2020,Q2,Elderly
172757552,17275755,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,2,F,20190623.0,20200514.0,20200116,20200521,EXP,GB-MHRA-EYC 00208979,GB-SAMSUNG BIOEPIS-SB-2020-00167,SAMSUNG BIOEPIS,,69.0,YR,E,F,Y,63.0,KG,20200521.0,,HP,GB,GB,2020,Q2,Elderly
172884832,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q2,Abscess,,2020,Q2,2,F,,20200610.0,20200120,20200617,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200617.0,,HP,CA,CA,2020,Q2,Adult
172884832,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q2,Blood glucose fluctuation,,2020,Q2,2,F,,20200610.0,20200120,20200617,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200617.0,,HP,CA,CA,2020,Q2,Adult
172884832,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q2,Cardiac disorder,,2020,Q2,2,F,,20200610.0,20200120,20200617,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200617.0,,HP,CA,CA,2020,Q2,Adult
172884832,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q2,Constipation,,2020,Q2,2,F,,20200610.0,20200120,20200617,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200617.0,,HP,CA,CA,2020,Q2,Adult
172884832,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q2,Headache,,2020,Q2,2,F,,20200610.0,20200120,20200617,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200617.0,,HP,CA,CA,2020,Q2,Adult
172884832,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q2,Hypoaesthesia,,2020,Q2,2,F,,20200610.0,20200120,20200617,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200617.0,,HP,CA,CA,2020,Q2,Adult
172884832,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q2,Night sweats,,2020,Q2,2,F,,20200610.0,20200120,20200617,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200617.0,,HP,CA,CA,2020,Q2,Adult
172884832,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q2,Swelling,,2020,Q2,2,F,,20200610.0,20200120,20200617,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200617.0,,HP,CA,CA,2020,Q2,Adult
172884832,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q2,Swelling face,,2020,Q2,2,F,,20200610.0,20200120,20200617,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200617.0,,HP,CA,CA,2020,Q2,Adult
172884832,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q2,Taste disorder,,2020,Q2,2,F,,20200610.0,20200120,20200617,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200617.0,,HP,CA,CA,2020,Q2,Adult
172884832,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q2,Thirst decreased,,2020,Q2,2,F,,20200610.0,20200120,20200617,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200617.0,,HP,CA,CA,2020,Q2,Adult
172884832,17288483,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q2,Weight increased,,2020,Q2,2,F,,20200610.0,20200120,20200617,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002918,BRISTOL MYERS SQUIBB,,50.0,YR,,F,Y,75.0,KG,20200617.0,,HP,CA,CA,2020,Q2,Adult
173242092,17324209,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,, UNKNOWN,,,0.75,MG,,,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,2017.0,20200404.0,20200127,20200409,PER,,US-DRREDDYS-USA/USA/20/0119012,DR REDDYS,"FANTASIA KL, STEENKAMP DW. OPTIMAL GLYCEMIC CONTROL IN A PATIENT WITH HNF1A MODY WITH GLP-1 RA MONOTHERAPY: IMPLICATIONS FOR FUTURE THERAPY. JOURNAL OF THE ENDOCRINE SOCIETY. 2019;3(12):2286-2289. DOI: 10.1210/JS.2019-00278.",27.0,YR,A,F,Y,,,20200409.0,,MD,US,US,2020,Q2,Young Adult
174176066,17417606,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Transaminases increased,,2020,Q2,6,F,20200130.0,20200605.0,20200213,20200612,EXP,,US-EXELIXIS-XL18420027272,EXELIXIS,,67.0,YR,,M,Y,96.2,KG,20200612.0,,MD,US,US,2020,Q2,Elderly
174272293,17427229,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Transaminases increased,,2020,Q2,3,F,20200130.0,20200605.0,20200218,20200616,EXP,,US-ROCHE-2551809,ROCHE,,67.0,YR,,M,Y,96.2,KG,20200616.0,,MD,US,US,2020,Q2,Elderly
175579922,17557992,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200316.0,20200316.0,20200319,20200413,PER,,US-ELI_LILLY_AND_COMPANY-US202003007317,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Adult
175579922,17557992,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q2,Insomnia,,2020,Q2,2,F,20200316.0,20200316.0,20200319,20200413,PER,,US-ELI_LILLY_AND_COMPANY-US202003007317,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Adult
175608633,17560863,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,3,F,,20200424.0,20200319,20200427,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20200427.0,,HP,PT,PT,2020,Q2,Adult
175608633,17560863,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Gastrointestinal disorder,,2020,Q2,3,F,,20200424.0,20200319,20200427,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20200427.0,,HP,PT,PT,2020,Q2,Adult
175608633,17560863,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Product administration error,,2020,Q2,3,F,,20200424.0,20200319,20200427,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20200427.0,,HP,PT,PT,2020,Q2,Adult
175608633,17560863,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,3,F,,20200424.0,20200319,20200427,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20200427.0,,HP,PT,PT,2020,Q2,Adult
175608633,17560863,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Urinary tract disorder,,2020,Q2,3,F,,20200424.0,20200319,20200427,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20200427.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Drug ineffective,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Gastrointestinal disorder,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Genitourinary symptom,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Product administration error,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Treatment noncompliance,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Urinary tract disorder,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
176178912,17617891,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,U,,,125469.0,0.75,MG,INJECTION,,2020,Q2,Anxiety,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,U,,,125469.0,0.75,MG,INJECTION,,2020,Q2,Asthenia,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,U,,,125469.0,0.75,MG,INJECTION,,2020,Q2,Blood glucose decreased,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,U,,,125469.0,0.75,MG,INJECTION,,2020,Q2,Blood pressure abnormal,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,U,,,125469.0,0.75,MG,INJECTION,,2020,Q2,Diarrhoea,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,U,,,125469.0,0.75,MG,INJECTION,,2020,Q2,Feeling abnormal,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,U,,,125469.0,0.75,MG,INJECTION,,2020,Q2,Head discomfort,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,U,,,125469.0,0.75,MG,INJECTION,,2020,Q2,Headache,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,U,,,125469.0,0.75,MG,INJECTION,,2020,Q2,Malaise,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,U,,,125469.0,0.75,MG,INJECTION,,2020,Q2,Nausea,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,U,,,125469.0,0.75,MG,INJECTION,,2020,Q2,Off label use,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,U,,,125469.0,0.75,MG,INJECTION,,2020,Q2,Tremor,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,,U,,,125469.0,1.5,MG,INJECTION,,2020,Q2,Anxiety,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,,U,,,125469.0,1.5,MG,INJECTION,,2020,Q2,Asthenia,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,,U,,,125469.0,1.5,MG,INJECTION,,2020,Q2,Blood glucose decreased,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,,U,,,125469.0,1.5,MG,INJECTION,,2020,Q2,Blood pressure abnormal,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,,U,,,125469.0,1.5,MG,INJECTION,,2020,Q2,Diarrhoea,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,,U,,,125469.0,1.5,MG,INJECTION,,2020,Q2,Feeling abnormal,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,,U,,,125469.0,1.5,MG,INJECTION,,2020,Q2,Head discomfort,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,,U,,,125469.0,1.5,MG,INJECTION,,2020,Q2,Headache,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,,U,,,125469.0,1.5,MG,INJECTION,,2020,Q2,Malaise,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,,U,,,125469.0,1.5,MG,INJECTION,,2020,Q2,Nausea,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,,U,,,125469.0,1.5,MG,INJECTION,,2020,Q2,Off label use,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176178912,17617891,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,,U,,,125469.0,1.5,MG,INJECTION,,2020,Q2,Tremor,,2020,Q2,2,F,20200327.0,20200401.0,20200402,20200413,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013754,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200413.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Asthenia,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Asthma,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Balance disorder,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Bronchitis,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Cystitis,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Energy increased,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Fatigue,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Feeling abnormal,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Hypersensitivity,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Intervertebral disc degeneration,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Macular degeneration,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Mobility decreased,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Pain,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Peripheral swelling,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Spinal stenosis,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Stress,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Thrombosis,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Asthenia,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Asthma,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Balance disorder,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Bronchitis,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Cystitis,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Energy increased,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Fatigue,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Feeling abnormal,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Hypersensitivity,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Intervertebral disc degeneration,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Macular degeneration,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Mobility decreased,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Pain,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Peripheral swelling,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Spinal stenosis,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Stress,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,,,,,,1.5,MG,INJECTION,,2020,Q2,Thrombosis,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Asthenia,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Asthma,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Balance disorder,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Bronchitis,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Cystitis,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Energy increased,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Fatigue,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Feeling abnormal,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Hypersensitivity,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Intervertebral disc degeneration,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Macular degeneration,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Mobility decreased,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Pain,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Peripheral swelling,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Spinal stenosis,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Stress,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206412,17620641,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2020,Q2,Thrombosis,,2020,Q2,2,F,202002.0,20200323.0,20200403,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003011010,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
176206632,17620663,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,Y,, D162176C,,125469.0,0.75,MG,INJECTION,,2020,Q2,Abdominal discomfort,,2020,Q2,2,F,202003.0,20200330.0,20200403,20200408,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013232,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200408.0,,CN,US,US,2020,Q2,Elderly
176206632,17620663,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,Y,, D162176C,,125469.0,0.75,MG,INJECTION,,2020,Q2,Asthenia,,2020,Q2,2,F,202003.0,20200330.0,20200403,20200408,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013232,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200408.0,,CN,US,US,2020,Q2,Elderly
176206632,17620663,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,Y,, D162176C,,125469.0,0.75,MG,INJECTION,,2020,Q2,Body temperature decreased,,2020,Q2,2,F,202003.0,20200330.0,20200403,20200408,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013232,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200408.0,,CN,US,US,2020,Q2,Elderly
176206632,17620663,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,Y,, D162176C,,125469.0,0.75,MG,INJECTION,,2020,Q2,Dehydration,,2020,Q2,2,F,202003.0,20200330.0,20200403,20200408,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013232,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200408.0,,CN,US,US,2020,Q2,Elderly
176206632,17620663,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,Y,, D162176C,,125469.0,0.75,MG,INJECTION,,2020,Q2,Diarrhoea,,2020,Q2,2,F,202003.0,20200330.0,20200403,20200408,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013232,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200408.0,,CN,US,US,2020,Q2,Elderly
176206632,17620663,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,Y,, D162176C,,125469.0,0.75,MG,INJECTION,,2020,Q2,Dyspnoea,,2020,Q2,2,F,202003.0,20200330.0,20200403,20200408,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013232,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200408.0,,CN,US,US,2020,Q2,Elderly
176206632,17620663,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,Y,, D162176C,,125469.0,0.75,MG,INJECTION,,2020,Q2,Gastroenteritis viral,,2020,Q2,2,F,202003.0,20200330.0,20200403,20200408,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013232,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200408.0,,CN,US,US,2020,Q2,Elderly
176206632,17620663,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,Y,, D162176C,,125469.0,0.75,MG,INJECTION,,2020,Q2,Malaise,,2020,Q2,2,F,202003.0,20200330.0,20200403,20200408,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013232,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200408.0,,CN,US,US,2020,Q2,Elderly
176206632,17620663,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,Y,, D162176C,,125469.0,0.75,MG,INJECTION,,2020,Q2,Nausea,,2020,Q2,2,F,202003.0,20200330.0,20200403,20200408,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013232,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200408.0,,CN,US,US,2020,Q2,Elderly
176206632,17620663,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,Y,, D162176C,,125469.0,0.75,MG,INJECTION,,2020,Q2,Renal failure,,2020,Q2,2,F,202003.0,20200330.0,20200403,20200408,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013232,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200408.0,,CN,US,US,2020,Q2,Elderly
176206632,17620663,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,Y,, D162176C,,125469.0,0.75,MG,INJECTION,,2020,Q2,Weight decreased,,2020,Q2,2,F,202003.0,20200330.0,20200403,20200408,EXP,,US-ELI_LILLY_AND_COMPANY-US202003013232,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200408.0,,CN,US,US,2020,Q2,Elderly
176207901,17620790,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q2,Chest discomfort,,2020,Q2,1,I,20200107.0,,20200401,20200401,DIR,,,FDA-CTU,,77.0,YR,,M,N,,,20200319.0,N,PH,US,US,2020,Q2,Elderly
176207901,17620790,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q2,Chest pain,,2020,Q2,1,I,20200107.0,,20200401,20200401,DIR,,,FDA-CTU,,77.0,YR,,M,N,,,20200319.0,N,PH,US,US,2020,Q2,Elderly
176207901,17620790,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q2,Diarrhoea,,2020,Q2,1,I,20200107.0,,20200401,20200401,DIR,,,FDA-CTU,,77.0,YR,,M,N,,,20200319.0,N,PH,US,US,2020,Q2,Elderly
176207901,17620790,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q2,Tachycardia,,2020,Q2,1,I,20200107.0,,20200401,20200401,DIR,,,FDA-CTU,,77.0,YR,,M,N,,,20200319.0,N,PH,US,US,2020,Q2,Elderly
176207901,17620790,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q2,Throat tightness,,2020,Q2,1,I,20200107.0,,20200401,20200401,DIR,,,FDA-CTU,,77.0,YR,,M,N,,,20200319.0,N,PH,US,US,2020,Q2,Elderly
176307081,17630708,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,1.0,MG,,QW,2020,Q2,Diarrhoea,,2020,Q2,1,I,20190731.0,,20200403,20200403,DIR,,,FDA-CTU,,72.0,YR,,M,N,86.0,KG,20200217.0,N,PH,US,US,2020,Q2,Elderly
176307081,17630708,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,1.0,MG,,QW,2020,Q2,Therapy interrupted,,2020,Q2,1,I,20190731.0,,20200403,20200403,DIR,,,FDA-CTU,,72.0,YR,,M,N,86.0,KG,20200217.0,N,PH,US,US,2020,Q2,Elderly
176440561,17644056,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"EVERY MONDAY, 1.5MG/0.5ML.",,,,,,,,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,/wk,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,20200330.0,20200407.0,20200408,20200408,EXP,GB-MHRA-MIDB-66022039-D6EE-4BD1-9408-5BA263D9FAF9,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-018521",BOEHRINGER INGELHEIM,,62.0,YR,,M,Y,,,20200408.0,,PH,GB,GB,2020,Q2,Adult
176481982,17648198,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176481982,17648198,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Drug ineffective,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176481982,17648198,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Gastrointestinal disorder,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176481982,17648198,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Genitourinary symptom,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176481982,17648198,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Product administration error,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176481982,17648198,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176481982,17648198,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Treatment noncompliance,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176481982,17648198,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Urinary tract disorder,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176520801,17652080,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,UNK,,,U,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20181212.0,20200407.0,20200409,20200409,EXP,FR-AFSSAPS-DJ20200377,FR-SA-2020SA089232,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20200409.0,,MD,FR,FR,2020,Q2,Elderly
176520801,17652080,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,UNK,,,U,,,,,,,,,2020,Q2,Hypothyroidism,,2020,Q2,1,I,20181212.0,20200407.0,20200409,20200409,EXP,FR-AFSSAPS-DJ20200377,FR-SA-2020SA089232,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20200409.0,,MD,FR,FR,2020,Q2,Elderly
176538821,17653882,11,C,dulaglutide ((MAMMIFERE/HAMSTER/CELLULES CHO)),,2,Oral,,,,,, UNKNOWN,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20181212.0,20200406.0,20200410,20200410,EXP,FR-AFSSAPS-DJ20200377,FR-TEVA-2020-FR-1221568,TEVA,,73.0,YR,,F,Y,,,20200410.0,,MD,FR,FR,2020,Q2,Elderly
176538821,17653882,11,C,dulaglutide ((MAMMIFERE/HAMSTER/CELLULES CHO)),,2,Oral,,,,,, UNKNOWN,,,,,,,2020,Q2,Hypothyroidism,,2020,Q2,1,I,20181212.0,20200406.0,20200410,20200410,EXP,FR-AFSSAPS-DJ20200377,FR-TEVA-2020-FR-1221568,TEVA,,73.0,YR,,F,Y,,,20200410.0,,MD,FR,FR,2020,Q2,Elderly
176578802,17657880,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, BIW",,,U,,,,,1.5,MG,,QOW,2020,Q2,Blood glucose increased,,2020,Q2,2,F,201901.0,20200407.0,20200411,20200430,EXP,,NVSC2020CZ097042,NOVARTIS,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200430.0,,HP,CZ,CZ,2020,Q2,Elderly
176578802,17657880,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, BIW",,,U,,,,,1.5,MG,,QOW,2020,Q2,Condition aggravated,,2020,Q2,2,F,201901.0,20200407.0,20200411,20200430,EXP,,NVSC2020CZ097042,NOVARTIS,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200430.0,,HP,CZ,CZ,2020,Q2,Elderly
176578802,17657880,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, BIW",,,U,,,,,1.5,MG,,QOW,2020,Q2,Drug intolerance,,2020,Q2,2,F,201901.0,20200407.0,20200411,20200430,EXP,,NVSC2020CZ097042,NOVARTIS,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200430.0,,HP,CZ,CZ,2020,Q2,Elderly
176613871,17661387,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,UNK,,,U,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20181212.0,20200406.0,20200413,20200413,EXP,FR-AFSSAPS-DJ20200377,FR-GLAXOSMITHKLINE-FR2020059531,GLAXOSMITHKLINE,,73.0,YR,,F,Y,,,20200413.0,,MD,FR,FR,2020,Q2,Elderly
176613871,17661387,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,UNK,,,U,,,,,,,,,2020,Q2,Hypothyroidism,,2020,Q2,1,I,20181212.0,20200406.0,20200413,20200413,EXP,FR-AFSSAPS-DJ20200377,FR-GLAXOSMITHKLINE-FR2020059531,GLAXOSMITHKLINE,,73.0,YR,,F,Y,,,20200413.0,,MD,FR,FR,2020,Q2,Elderly
176687081,17668708,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,UNK,,,U,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20181212.0,20200406.0,20200415,20200415,EXP,,FR-AUROBINDO-AUR-APL-2020-017704,AUROBINDO,,73.0,YR,,F,Y,,,20200415.0,,MD,FR,FR,2020,Q2,Elderly
176687081,17668708,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,UNK,,,U,,,,,,,,,2020,Q2,Hypothyroidism,,2020,Q2,1,I,20181212.0,20200406.0,20200415,20200415,EXP,,FR-AUROBINDO-AUR-APL-2020-017704,AUROBINDO,,73.0,YR,,F,Y,,,20200415.0,,MD,FR,FR,2020,Q2,Elderly
176802711,17680271,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,Y,,,,0.75,MG,,QW,2020,Q2,Rash,,2020,Q2,1,I,,,20200417,20200417,DIR,,,FDA-CTU,,67.0,YR,,M,N,175.54,KG,20200416.0,N,PH,US,US,2020,Q2,Elderly
176972061,17697206,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Atrioventricular block,,2020,Q2,1,I,,20200420.0,20200423,20200423,EXP,,US-HETERO-HET2020US00436,HETERO,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR.. BRASH SYNDROME.. BMJ-CASE-REP. 2020;13:E233825",62.0,YR,,F,Y,,,20200423.0,,MD,US,US,2020,Q2,Adult
176972061,17697206,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Bradycardia,,2020,Q2,1,I,,20200420.0,20200423,20200423,EXP,,US-HETERO-HET2020US00436,HETERO,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR.. BRASH SYNDROME.. BMJ-CASE-REP. 2020;13:E233825",62.0,YR,,F,Y,,,20200423.0,,MD,US,US,2020,Q2,Adult
176972061,17697206,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Hyperkalaemia,,2020,Q2,1,I,,20200420.0,20200423,20200423,EXP,,US-HETERO-HET2020US00436,HETERO,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR.. BRASH SYNDROME.. BMJ-CASE-REP. 2020;13:E233825",62.0,YR,,F,Y,,,20200423.0,,MD,US,US,2020,Q2,Adult
176972061,17697206,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,1,I,,20200420.0,20200423,20200423,EXP,,US-HETERO-HET2020US00436,HETERO,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR.. BRASH SYNDROME.. BMJ-CASE-REP. 2020;13:E233825",62.0,YR,,F,Y,,,20200423.0,,MD,US,US,2020,Q2,Adult
176972061,17697206,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Shock,,2020,Q2,1,I,,20200420.0,20200423,20200423,EXP,,US-HETERO-HET2020US00436,HETERO,"SRIVASTAVA S, KEMNIC T, HILDEBRANDT KR.. BRASH SYNDROME.. BMJ-CASE-REP. 2020;13:E233825",62.0,YR,,F,Y,,,20200423.0,,MD,US,US,2020,Q2,Adult
176987251,17698725,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q2,Constipation,,2020,Q2,1,I,20200224.0,,20200422,20200422,DIR,,,FDA-CTU,,56.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Adult
176987251,17698725,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q2,Nausea,,2020,Q2,1,I,20200224.0,,20200422,20200422,DIR,,,FDA-CTU,,56.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Adult
176987251,17698725,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q2,Vomiting,,2020,Q2,1,I,20200224.0,,20200422,20200422,DIR,,,FDA-CTU,,56.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Adult
177033843,17703384,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, 2 WEEK",,,U,,,,,1.5,MG,,,2020,Q2,Blood glucose increased,,2020,Q2,3,F,201901.0,20200511.0,20200423,20200522,EXP,,CZ-AUROBINDO-AUR-APL-2020-019965,AUROBINDO,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200522.0,,MD,CZ,CZ,2020,Q2,Elderly
177033843,17703384,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, 2 WEEK",,,U,,,,,1.5,MG,,,2020,Q2,Condition aggravated,,2020,Q2,3,F,201901.0,20200511.0,20200423,20200522,EXP,,CZ-AUROBINDO-AUR-APL-2020-019965,AUROBINDO,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200522.0,,MD,CZ,CZ,2020,Q2,Elderly
177033843,17703384,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, 2 WEEK",,,U,,,,,1.5,MG,,,2020,Q2,Drug intolerance,,2020,Q2,3,F,201901.0,20200511.0,20200423,20200522,EXP,,CZ-AUROBINDO-AUR-APL-2020-019965,AUROBINDO,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200522.0,,MD,CZ,CZ,2020,Q2,Elderly
177033843,17703384,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, 2 WEEK",,,U,,,,,1.5,MG,,,2020,Q2,Mass,,2020,Q2,3,F,201901.0,20200511.0,20200423,20200522,EXP,,CZ-AUROBINDO-AUR-APL-2020-019965,AUROBINDO,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200522.0,,MD,CZ,CZ,2020,Q2,Elderly
177033843,17703384,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, 2 WEEK",,,U,,,,,1.5,MG,,,2020,Q2,Necrosis,,2020,Q2,3,F,201901.0,20200511.0,20200423,20200522,EXP,,CZ-AUROBINDO-AUR-APL-2020-019965,AUROBINDO,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200522.0,,MD,CZ,CZ,2020,Q2,Elderly
177040711,17704071,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"750 UG, WEEKLY (1/W)",,,Y,U,,,125469.0,750.0,UG,,/wk,2020,Q2,Decreased appetite,,2020,Q2,1,I,20191114.0,20200414.0,20200424,20200424,EXP,GB-MHRA-EYC 00221203,GB-ELI_LILLY_AND_COMPANY-GB202004005249,ELI LILLY AND CO,,69.0,YR,,M,Y,80.0,KG,20200424.0,,MD,GB,GB,2020,Q2,Elderly
177040711,17704071,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"750 UG, WEEKLY (1/W)",,,Y,U,,,125469.0,750.0,UG,,/wk,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20191114.0,20200414.0,20200424,20200424,EXP,GB-MHRA-EYC 00221203,GB-ELI_LILLY_AND_COMPANY-GB202004005249,ELI LILLY AND CO,,69.0,YR,,M,Y,80.0,KG,20200424.0,,MD,GB,GB,2020,Q2,Elderly
177040711,17704071,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"750 UG, WEEKLY (1/W)",,,Y,U,,,125469.0,750.0,UG,,/wk,2020,Q2,Syncope,,2020,Q2,1,I,20191114.0,20200414.0,20200424,20200424,EXP,GB-MHRA-EYC 00221203,GB-ELI_LILLY_AND_COMPANY-GB202004005249,ELI LILLY AND CO,,69.0,YR,,M,Y,80.0,KG,20200424.0,,MD,GB,GB,2020,Q2,Elderly
177166831,17716683,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,DULAGLUTIDE: MAMMAL / HAMSTER / CHO CELLS,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20181212.0,20200417.0,20200428,20200428,EXP,FR-AFSSAPS-DJ20200377,FR-ACCORD-179732,ACCORD,,73.0,YR,,F,Y,,,20200428.0,,MD,FR,FR,2020,Q2,Elderly
177166831,17716683,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,DULAGLUTIDE: MAMMAL / HAMSTER / CHO CELLS,,,,,,,,,,,,2020,Q2,Hypothyroidism,,2020,Q2,1,I,20181212.0,20200417.0,20200428,20200428,EXP,FR-AFSSAPS-DJ20200377,FR-ACCORD-179732,ACCORD,,73.0,YR,,F,Y,,,20200428.0,,MD,FR,FR,2020,Q2,Elderly
177181021,17718102,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.75,MG,,QW,2020,Q2,Abdominal pain,,2020,Q2,1,I,20190807.0,,20200428,20200428,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191017.0,N,PH,US,US,2020,Q2,Elderly
177181021,17718102,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.75,MG,,QW,2020,Q2,Diarrhoea,,2020,Q2,1,I,20190807.0,,20200428,20200428,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191017.0,N,PH,US,US,2020,Q2,Elderly
177181021,17718102,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.75,MG,,QW,2020,Q2,Nausea,,2020,Q2,1,I,20190807.0,,20200428,20200428,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191017.0,N,PH,US,US,2020,Q2,Elderly
177181021,17718102,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.75,MG,,QW,2020,Q2,Therapy interrupted,,2020,Q2,1,I,20190807.0,,20200428,20200428,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191017.0,N,PH,US,US,2020,Q2,Elderly
177181021,17718102,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.75,MG,,QW,2020,Q2,Vomiting,,2020,Q2,1,I,20190807.0,,20200428,20200428,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191017.0,N,PH,US,US,2020,Q2,Elderly
177182151,17718215,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,,,,,,0.75,MG,,QW,2020,Q2,Anger,,2020,Q2,1,I,20200226.0,,20200428,20200428,DIR,,,FDA-CTU,,60.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Adult
177182151,17718215,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,,,,,,0.75,MG,,QW,2020,Q2,Depression,,2020,Q2,1,I,20200226.0,,20200428,20200428,DIR,,,FDA-CTU,,60.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Adult
177182151,17718215,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,,,,,,0.75,MG,,QW,2020,Q2,Suicidal ideation,,2020,Q2,1,I,20200226.0,,20200428,20200428,DIR,,,FDA-CTU,,60.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Adult
177229682,17722968,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,2,F,,20200424.0,20200429,20200504,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP005096,STRIDES,,62.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Adult
177229682,17722968,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Asthenia,,2020,Q2,2,F,,20200424.0,20200429,20200504,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP005096,STRIDES,,62.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Adult
177229682,17722968,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Atrioventricular block,,2020,Q2,2,F,,20200424.0,20200429,20200504,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP005096,STRIDES,,62.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Adult
177229682,17722968,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Bradycardia,,2020,Q2,2,F,,20200424.0,20200429,20200504,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP005096,STRIDES,,62.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Adult
177229682,17722968,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Cardiac murmur,,2020,Q2,2,F,,20200424.0,20200429,20200504,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP005096,STRIDES,,62.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Adult
177229682,17722968,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,2,F,,20200424.0,20200429,20200504,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP005096,STRIDES,,62.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Adult
177229682,17722968,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Hyperkalaemia,,2020,Q2,2,F,,20200424.0,20200429,20200504,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP005096,STRIDES,,62.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Adult
177229682,17722968,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,2,F,,20200424.0,20200429,20200504,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP005096,STRIDES,,62.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Adult
177229682,17722968,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Lactic acidosis,,2020,Q2,2,F,,20200424.0,20200429,20200504,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP005096,STRIDES,,62.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Adult
177229682,17722968,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Oedema,,2020,Q2,2,F,,20200424.0,20200429,20200504,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP005096,STRIDES,,62.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Adult
177229682,17722968,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Rales,,2020,Q2,2,F,,20200424.0,20200429,20200504,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP005096,STRIDES,,62.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Adult
177229682,17722968,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Shock,,2020,Q2,2,F,,20200424.0,20200429,20200504,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP005096,STRIDES,,62.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Adult
177255553,17725555,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Diabetes mellitus,,2020,Q2,3,F,20180326.0,20200515.0,20200429,20200519,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033579,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20200519.0,,MD,ES,ES,2020,Q2,Elderly
177255553,17725555,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Hypothyroidism,,2020,Q2,3,F,20180326.0,20200515.0,20200429,20200519,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033579,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20200519.0,,MD,ES,ES,2020,Q2,Elderly
177255553,17725555,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Off label use,,2020,Q2,3,F,20180326.0,20200515.0,20200429,20200519,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033579,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20200519.0,,MD,ES,ES,2020,Q2,Elderly
177255553,17725555,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Pemphigoid,,2020,Q2,3,F,20180326.0,20200515.0,20200429,20200519,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033579,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20200519.0,,MD,ES,ES,2020,Q2,Elderly
177255553,17725555,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Rash,,2020,Q2,3,F,20180326.0,20200515.0,20200429,20200519,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033579,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20200519.0,,MD,ES,ES,2020,Q2,Elderly
177255553,17725555,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Staphylococcal bacteraemia,,2020,Q2,3,F,20180326.0,20200515.0,20200429,20200519,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033579,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20200519.0,,MD,ES,ES,2020,Q2,Elderly
177327101,17732710,3,C,SUBDERMALLY TRULICITY (DULAGLUTIDE),,2,,,,,,,,,,,,,,2020,Q2,Body mass index increased,,2020,Q2,1,I,201906.0,20200424.0,20200501,20200501,EXP,,RU-ASTRAZENECA-2020SE55736,ASTRAZENECA,,40.0,YR,,F,Y,66.0,KG,20200501.0,,CN,RU,RU,2020,Q2,Adult
177327101,17732710,3,C,SUBDERMALLY TRULICITY (DULAGLUTIDE),,2,,,,,,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,201906.0,20200424.0,20200501,20200501,EXP,,RU-ASTRAZENECA-2020SE55736,ASTRAZENECA,,40.0,YR,,F,Y,66.0,KG,20200501.0,,CN,RU,RU,2020,Q2,Adult
177327101,17732710,3,C,SUBDERMALLY TRULICITY (DULAGLUTIDE),,2,,,,,,,,,,,,,,2020,Q2,Pruritus,,2020,Q2,1,I,201906.0,20200424.0,20200501,20200501,EXP,,RU-ASTRAZENECA-2020SE55736,ASTRAZENECA,,40.0,YR,,F,Y,66.0,KG,20200501.0,,CN,RU,RU,2020,Q2,Adult
177338101,17733810,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200429.0,,20200430,20200430,DIR,,,FDA-CTU,,48.0,YR,,M,N,,,20200429.0,N,PH,US,US,2020,Q2,Adult
177338101,17733810,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q2,Blood urea increased,,2020,Q2,1,I,20200429.0,,20200430,20200430,DIR,,,FDA-CTU,,48.0,YR,,M,N,,,20200429.0,N,PH,US,US,2020,Q2,Adult
177338101,17733810,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q2,Cholelithiasis,,2020,Q2,1,I,20200429.0,,20200430,20200430,DIR,,,FDA-CTU,,48.0,YR,,M,N,,,20200429.0,N,PH,US,US,2020,Q2,Adult
177343071,17734307,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2020,Q2,Insulin resistance,,2020,Q2,1,I,,20200428.0,20200501,20200501,EXP,,HK-PFIZER INC-2020172928,PFIZER,"CHAN, N.. OPTIMIZING LIPID MANAGEMENT IN A HIGH-RISK DIABETES PATIENT. MIMS DOCTOR. 2020;16-17",76.0,YR,,M,Y,,,20200501.0,,MD,HK,HK,2020,Q2,Elderly
177343071,17734307,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2020,Q2,Muscle atrophy,,2020,Q2,1,I,,20200428.0,20200501,20200501,EXP,,HK-PFIZER INC-2020172928,PFIZER,"CHAN, N.. OPTIMIZING LIPID MANAGEMENT IN A HIGH-RISK DIABETES PATIENT. MIMS DOCTOR. 2020;16-17",76.0,YR,,M,Y,,,20200501.0,,MD,HK,HK,2020,Q2,Elderly
177444901,17744490,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,,,,125469.0,1.5,MG,INJECTION,/wk,2020,Q2,Decreased appetite,,2020,Q2,1,I,201902.0,20200423.0,20200505,20200505,EXP,,US-ELI_LILLY_AND_COMPANY-US202004009693,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Elderly
177444901,17744490,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,,,,125469.0,1.5,MG,INJECTION,/wk,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,201902.0,20200423.0,20200505,20200505,EXP,,US-ELI_LILLY_AND_COMPANY-US202004009693,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Elderly
177444901,17744490,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,,,,125469.0,1.5,MG,INJECTION,/wk,2020,Q2,Malaise,,2020,Q2,1,I,201902.0,20200423.0,20200505,20200505,EXP,,US-ELI_LILLY_AND_COMPANY-US202004009693,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Elderly
177444901,17744490,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,,,,125469.0,1.5,MG,INJECTION,/wk,2020,Q2,Nausea,,2020,Q2,1,I,201902.0,20200423.0,20200505,20200505,EXP,,US-ELI_LILLY_AND_COMPANY-US202004009693,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Elderly
177444901,17744490,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,,,,125469.0,1.5,MG,INJECTION,/wk,2020,Q2,Renal disorder,,2020,Q2,1,I,201902.0,20200423.0,20200505,20200505,EXP,,US-ELI_LILLY_AND_COMPANY-US202004009693,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Elderly
177444901,17744490,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,,,,125469.0,1.5,MG,INJECTION,/wk,2020,Q2,Weight decreased,,2020,Q2,1,I,201902.0,20200423.0,20200505,20200505,EXP,,US-ELI_LILLY_AND_COMPANY-US202004009693,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Elderly
177444901,17744490,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,, D190812,,125469.0,1.5,MG,INJECTION,/wk,2020,Q2,Decreased appetite,,2020,Q2,1,I,201902.0,20200423.0,20200505,20200505,EXP,,US-ELI_LILLY_AND_COMPANY-US202004009693,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Elderly
177444901,17744490,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,, D190812,,125469.0,1.5,MG,INJECTION,/wk,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,201902.0,20200423.0,20200505,20200505,EXP,,US-ELI_LILLY_AND_COMPANY-US202004009693,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Elderly
177444901,17744490,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,, D190812,,125469.0,1.5,MG,INJECTION,/wk,2020,Q2,Malaise,,2020,Q2,1,I,201902.0,20200423.0,20200505,20200505,EXP,,US-ELI_LILLY_AND_COMPANY-US202004009693,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Elderly
177444901,17744490,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,, D190812,,125469.0,1.5,MG,INJECTION,/wk,2020,Q2,Nausea,,2020,Q2,1,I,201902.0,20200423.0,20200505,20200505,EXP,,US-ELI_LILLY_AND_COMPANY-US202004009693,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Elderly
177444901,17744490,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,, D190812,,125469.0,1.5,MG,INJECTION,/wk,2020,Q2,Renal disorder,,2020,Q2,1,I,201902.0,20200423.0,20200505,20200505,EXP,,US-ELI_LILLY_AND_COMPANY-US202004009693,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Elderly
177444901,17744490,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,, D190812,,125469.0,1.5,MG,INJECTION,/wk,2020,Q2,Weight decreased,,2020,Q2,1,I,201902.0,20200423.0,20200505,20200505,EXP,,US-ELI_LILLY_AND_COMPANY-US202004009693,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Elderly
177472171,17747217,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177472171,17747217,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Drug ineffective,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177472171,17747217,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Gastrointestinal disorder,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177472171,17747217,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Product administration error,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177472171,17747217,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Urinary tract disorder,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177475321,17747532,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Colitis,,2020,Q2,1,I,,20200425.0,20200505,20200505,EXP,,CA-BAUSCH-BL-2020-012898,BAUSCH AND LOMB,,73.0,YR,,F,Y,,,20200505.0,,CN,CA,CA,2020,Q2,Elderly
177475321,17747532,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Colitis ulcerative,,2020,Q2,1,I,,20200425.0,20200505,20200505,EXP,,CA-BAUSCH-BL-2020-012898,BAUSCH AND LOMB,,73.0,YR,,F,Y,,,20200505.0,,CN,CA,CA,2020,Q2,Elderly
177475321,17747532,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Decreased activity,,2020,Q2,1,I,,20200425.0,20200505,20200505,EXP,,CA-BAUSCH-BL-2020-012898,BAUSCH AND LOMB,,73.0,YR,,F,Y,,,20200505.0,,CN,CA,CA,2020,Q2,Elderly
177475321,17747532,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Frequent bowel movements,,2020,Q2,1,I,,20200425.0,20200505,20200505,EXP,,CA-BAUSCH-BL-2020-012898,BAUSCH AND LOMB,,73.0,YR,,F,Y,,,20200505.0,,CN,CA,CA,2020,Q2,Elderly
177475321,17747532,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Rectal haemorrhage,,2020,Q2,1,I,,20200425.0,20200505,20200505,EXP,,CA-BAUSCH-BL-2020-012898,BAUSCH AND LOMB,,73.0,YR,,F,Y,,,20200505.0,,CN,CA,CA,2020,Q2,Elderly
177613481,17761348,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Colitis,,2020,Q2,1,I,,20200429.0,20200508,20200508,EXP,,CA-TEVA-2020-CA-1232428,TEVA,,73.0,YR,,F,Y,,,20200508.0,,CN,CA,CA,2020,Q2,Elderly
177613481,17761348,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Colitis ulcerative,,2020,Q2,1,I,,20200429.0,20200508,20200508,EXP,,CA-TEVA-2020-CA-1232428,TEVA,,73.0,YR,,F,Y,,,20200508.0,,CN,CA,CA,2020,Q2,Elderly
177613481,17761348,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Decreased activity,,2020,Q2,1,I,,20200429.0,20200508,20200508,EXP,,CA-TEVA-2020-CA-1232428,TEVA,,73.0,YR,,F,Y,,,20200508.0,,CN,CA,CA,2020,Q2,Elderly
177613481,17761348,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Frequent bowel movements,,2020,Q2,1,I,,20200429.0,20200508,20200508,EXP,,CA-TEVA-2020-CA-1232428,TEVA,,73.0,YR,,F,Y,,,20200508.0,,CN,CA,CA,2020,Q2,Elderly
177613481,17761348,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q2,Rectal haemorrhage,,2020,Q2,1,I,,20200429.0,20200508,20200508,EXP,,CA-TEVA-2020-CA-1232428,TEVA,,73.0,YR,,F,Y,,,20200508.0,,CN,CA,CA,2020,Q2,Elderly
177614821,17761482,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, BIW",,,U,U,,,,1.5,MG,,QOW,2020,Q2,Blood glucose increased,,2020,Q2,1,I,201901.0,20200504.0,20200508,20200508,EXP,,CZ-MYLANLABS-2020M1045101,MYLAN,HALCIAKOVA K.. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE.. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200508.0,,HP,CZ,CZ,2020,Q2,Elderly
177614821,17761482,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, BIW",,,U,U,,,,1.5,MG,,QOW,2020,Q2,Condition aggravated,,2020,Q2,1,I,201901.0,20200504.0,20200508,20200508,EXP,,CZ-MYLANLABS-2020M1045101,MYLAN,HALCIAKOVA K.. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE.. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200508.0,,HP,CZ,CZ,2020,Q2,Elderly
177614821,17761482,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, BIW",,,U,U,,,,1.5,MG,,QOW,2020,Q2,Drug intolerance,,2020,Q2,1,I,201901.0,20200504.0,20200508,20200508,EXP,,CZ-MYLANLABS-2020M1045101,MYLAN,HALCIAKOVA K.. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE.. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200508.0,,HP,CZ,CZ,2020,Q2,Elderly
177614821,17761482,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, BIW",,,U,U,,,,1.5,MG,,QOW,2020,Q2,Mass,,2020,Q2,1,I,201901.0,20200504.0,20200508,20200508,EXP,,CZ-MYLANLABS-2020M1045101,MYLAN,HALCIAKOVA K.. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE.. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200508.0,,HP,CZ,CZ,2020,Q2,Elderly
177614821,17761482,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, BIW",,,U,U,,,,1.5,MG,,QOW,2020,Q2,Necrosis,,2020,Q2,1,I,201901.0,20200504.0,20200508,20200508,EXP,,CZ-MYLANLABS-2020M1045101,MYLAN,HALCIAKOVA K.. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE.. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200508.0,,HP,CZ,CZ,2020,Q2,Elderly
177627231,17762723,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"UNK, WEEKLY (1/W)",,,,,,,125469.0,,,SOLUTION FOR INJECTION IN PRE-FILLED PEN,/wk,2020,Q2,Colorectal cancer,,2020,Q2,1,I,,20200429.0,20200508,20200508,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202004011897,ELI LILLY AND CO,,45.0,YR,,M,Y,,,20200508.0,,MD,GR,GR,2020,Q2,Adult
177627231,17762723,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"UNK, WEEKLY (1/W)",,,,,,,125469.0,,,SOLUTION FOR INJECTION IN PRE-FILLED PEN,/wk,2020,Q2,Ileus,,2020,Q2,1,I,,20200429.0,20200508,20200508,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202004011897,ELI LILLY AND CO,,45.0,YR,,M,Y,,,20200508.0,,MD,GR,GR,2020,Q2,Adult
177627231,17762723,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"UNK, WEEKLY (1/W)",,,,,,,125469.0,,,SOLUTION FOR INJECTION IN PRE-FILLED PEN,/wk,2020,Q2,Metastases to spleen,,2020,Q2,1,I,,20200429.0,20200508,20200508,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202004011897,ELI LILLY AND CO,,45.0,YR,,M,Y,,,20200508.0,,MD,GR,GR,2020,Q2,Adult
177709582,17770958,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,,,,,0.75,MG,INJECTION,,2020,Q2,Feeling abnormal,,2020,Q2,2,F,20200507.0,20200508.0,20200512,20200519,PER,,US-ELI_LILLY_AND_COMPANY-US202005003139,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
177709582,17770958,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,,,,,0.75,MG,INJECTION,,2020,Q2,Malaise,,2020,Q2,2,F,20200507.0,20200508.0,20200512,20200519,PER,,US-ELI_LILLY_AND_COMPANY-US202005003139,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
177709582,17770958,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,,,,,0.75,MG,INJECTION,,2020,Q2,Nausea,,2020,Q2,2,F,20200507.0,20200508.0,20200512,20200519,PER,,US-ELI_LILLY_AND_COMPANY-US202005003139,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
177709582,17770958,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,,,,,0.75,MG,INJECTION,,2020,Q2,Off label use,,2020,Q2,2,F,20200507.0,20200508.0,20200512,20200519,PER,,US-ELI_LILLY_AND_COMPANY-US202005003139,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
177709582,17770958,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,,,,,1.5,MG,INJECTION,,2020,Q2,Feeling abnormal,,2020,Q2,2,F,20200507.0,20200508.0,20200512,20200519,PER,,US-ELI_LILLY_AND_COMPANY-US202005003139,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
177709582,17770958,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,,,,,1.5,MG,INJECTION,,2020,Q2,Malaise,,2020,Q2,2,F,20200507.0,20200508.0,20200512,20200519,PER,,US-ELI_LILLY_AND_COMPANY-US202005003139,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
177709582,17770958,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,,,,,1.5,MG,INJECTION,,2020,Q2,Nausea,,2020,Q2,2,F,20200507.0,20200508.0,20200512,20200519,PER,,US-ELI_LILLY_AND_COMPANY-US202005003139,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
177709582,17770958,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,,,,,1.5,MG,INJECTION,,2020,Q2,Off label use,,2020,Q2,2,F,20200507.0,20200508.0,20200512,20200519,PER,,US-ELI_LILLY_AND_COMPANY-US202005003139,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
177811661,17781166,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.5,MG,,,2020,Q2,Oedematous pancreatitis,,2020,Q2,1,I,20200330.0,20200507.0,20200514,20200514,EXP,DE-BFARM-20004993,DE-ACCORD-181724,ACCORD,,56.0,YR,A,F,Y,,,20200514.0,,MD,DE,DE,2020,Q2,Adult
178057011,17805701,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q2,Coronary artery disease,,2020,Q2,1,I,,20200513.0,20200520,20200520,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-024412",BOEHRINGER INGELHEIM,"BROWN F, WESTCOTT G, SEGAL A, MITRI J. PROLONGED GLUCOSURIA AND RELAPSE OF DIABETIC KETOACIDOSIS RELATED TO SGLT2-INHIBITOR THERAPY. ENDOCRINOLOGY, DIABETES + METABOLISM. 2020;3:2:.",56.0,YR,,M,Y,,,20200520.0,,HP,US,US,2020,Q2,Adult
178057011,17805701,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,,20200513.0,20200520,20200520,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-024412",BOEHRINGER INGELHEIM,"BROWN F, WESTCOTT G, SEGAL A, MITRI J. PROLONGED GLUCOSURIA AND RELAPSE OF DIABETIC KETOACIDOSIS RELATED TO SGLT2-INHIBITOR THERAPY. ENDOCRINOLOGY, DIABETES + METABOLISM. 2020;3:2:.",56.0,YR,,M,Y,,,20200520.0,,HP,US,US,2020,Q2,Adult
178073271,17807327,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,,20200513.0,20200520,20200520,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-024417",BOEHRINGER INGELHEIM,"BROWN F, WESTCOTT G, SEGAL A, MITRI J. PROLONGED GLUCOSURIA AND RELAPSE OF DIABETIC KETOACIDOSIS RELATED TO SGLT2-INHIBITOR THERAPY. ENDOCRINOLOGY, DIABETES + METABOLISM. 2020;3:2:.",56.0,YR,,F,Y,,,20200520.0,,HP,US,US,2020,Q2,Adult
178073271,17807327,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q2,Staphylococcal infection,,2020,Q2,1,I,,20200513.0,20200520,20200520,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-024417",BOEHRINGER INGELHEIM,"BROWN F, WESTCOTT G, SEGAL A, MITRI J. PROLONGED GLUCOSURIA AND RELAPSE OF DIABETIC KETOACIDOSIS RELATED TO SGLT2-INHIBITOR THERAPY. ENDOCRINOLOGY, DIABETES + METABOLISM. 2020;3:2:.",56.0,YR,,F,Y,,,20200520.0,,HP,US,US,2020,Q2,Adult
178111881,17811188,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?,,,D,D,,,,1.5,MG,,QW,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200415.0,,20200520,20200520,DIR,,,FDA-CTU,,54.0,YR,,F,N,108.6,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178111881,17811188,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?,,,D,D,,,,1.5,MG,,QW,2020,Q2,Dehydration,,2020,Q2,1,I,20200415.0,,20200520,20200520,DIR,,,FDA-CTU,,54.0,YR,,F,N,108.6,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178111881,17811188,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?,,,D,D,,,,1.5,MG,,QW,2020,Q2,Dialysis,,2020,Q2,1,I,20200415.0,,20200520,20200520,DIR,,,FDA-CTU,,54.0,YR,,F,N,108.6,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178111881,17811188,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?,,,D,D,,,,1.5,MG,,QW,2020,Q2,Diarrhoea,,2020,Q2,1,I,20200415.0,,20200520,20200520,DIR,,,FDA-CTU,,54.0,YR,,F,N,108.6,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178111881,17811188,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?,,,D,D,,,,1.5,MG,,QW,2020,Q2,Electrocardiogram abnormal,,2020,Q2,1,I,20200415.0,,20200520,20200520,DIR,,,FDA-CTU,,54.0,YR,,F,N,108.6,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178111881,17811188,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?,,,D,D,,,,1.5,MG,,QW,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,1,I,20200415.0,,20200520,20200520,DIR,,,FDA-CTU,,54.0,YR,,F,N,108.6,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178111881,17811188,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?,,,D,D,,,,1.5,MG,,QW,2020,Q2,Hyperkalaemia,,2020,Q2,1,I,20200415.0,,20200520,20200520,DIR,,,FDA-CTU,,54.0,YR,,F,N,108.6,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178111881,17811188,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?,,,D,D,,,,1.5,MG,,QW,2020,Q2,Lactic acidosis,,2020,Q2,1,I,20200415.0,,20200520,20200520,DIR,,,FDA-CTU,,54.0,YR,,F,N,108.6,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178111881,17811188,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?,,,D,D,,,,1.5,MG,,QW,2020,Q2,Nausea,,2020,Q2,1,I,20200415.0,,20200520,20200520,DIR,,,FDA-CTU,,54.0,YR,,F,N,108.6,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178111881,17811188,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?,,,D,D,,,,1.5,MG,,QW,2020,Q2,Shock,,2020,Q2,1,I,20200415.0,,20200520,20200520,DIR,,,FDA-CTU,,54.0,YR,,F,N,108.6,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178111881,17811188,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?,,,D,D,,,,1.5,MG,,QW,2020,Q2,Vomiting,,2020,Q2,1,I,20200415.0,,20200520,20200520,DIR,,,FDA-CTU,,54.0,YR,,F,N,108.6,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178114611,17811461,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN,PEN)",DULAGLUTIDE,1,,,,,,,,,,,,INJECTION,,2020,Q2,Dyspnoea,,2020,Q2,1,I,20200224.0,,20200520,20200520,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200417.0,N,PH,US,US,2020,Q2,Elderly
178115581,17811558,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN,PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q2,Nausea,,2020,Q2,1,I,20200302.0,,20200520,20200520,DIR,,,FDA-CTU,,59.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Adult
178115581,17811558,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN,PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q2,Vomiting,,2020,Q2,1,I,20200302.0,,20200520,20200520,DIR,,,FDA-CTU,,59.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Adult
178340741,17834074,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,20200219.0,,20200528,20200528,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Elderly
178340741,17834074,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,20200219.0,,20200528,20200528,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Elderly
178340791,17834079,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN,PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q2,Constipation,,2020,Q2,1,I,20200317.0,,20200528,20200528,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Adult
178340791,17834079,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN,PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,20200317.0,,20200528,20200528,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Adult
178340791,17834079,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN,PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,20200317.0,,20200528,20200528,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Adult
178341111,17834111,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,20200311.0,,20200528,20200528,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Elderly
178341111,17834111,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,20200311.0,,20200528,20200528,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20200518.0,N,PH,US,US,2020,Q2,Elderly
178424181,17842418,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,125469.0,1.5,MG,,/wk,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200508.0,20200520.0,20200529,20200529,EXP,GB-MHRA-WEBRADR-20200508180145,GB-ELI_LILLY_AND_COMPANY-GB202005008125,ELI LILLY AND CO,,66.0,YR,,M,Y,81.0,KG,20200529.0,,PH,GB,GB,2020,Q2,Elderly
178424181,17842418,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,125469.0,1.5,MG,,/wk,2020,Q2,Blood calcium decreased,,2020,Q2,1,I,20200508.0,20200520.0,20200529,20200529,EXP,GB-MHRA-WEBRADR-20200508180145,GB-ELI_LILLY_AND_COMPANY-GB202005008125,ELI LILLY AND CO,,66.0,YR,,M,Y,81.0,KG,20200529.0,,PH,GB,GB,2020,Q2,Elderly
178424181,17842418,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,125469.0,1.5,MG,,/wk,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200508.0,20200520.0,20200529,20200529,EXP,GB-MHRA-WEBRADR-20200508180145,GB-ELI_LILLY_AND_COMPANY-GB202005008125,ELI LILLY AND CO,,66.0,YR,,M,Y,81.0,KG,20200529.0,,PH,GB,GB,2020,Q2,Elderly
178424181,17842418,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,125469.0,1.5,MG,,/wk,2020,Q2,Blood magnesium decreased,,2020,Q2,1,I,20200508.0,20200520.0,20200529,20200529,EXP,GB-MHRA-WEBRADR-20200508180145,GB-ELI_LILLY_AND_COMPANY-GB202005008125,ELI LILLY AND CO,,66.0,YR,,M,Y,81.0,KG,20200529.0,,PH,GB,GB,2020,Q2,Elderly
178424181,17842418,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,125469.0,1.5,MG,,/wk,2020,Q2,Gastrointestinal disorder,,2020,Q2,1,I,20200508.0,20200520.0,20200529,20200529,EXP,GB-MHRA-WEBRADR-20200508180145,GB-ELI_LILLY_AND_COMPANY-GB202005008125,ELI LILLY AND CO,,66.0,YR,,M,Y,81.0,KG,20200529.0,,PH,GB,GB,2020,Q2,Elderly
178471074,17847107,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,4,F,,20200622.0,20200601,20200626,EXP,,NVSC2020PT074359,NOVARTIS,,61.0,YR,,M,Y,,,20200626.0,,HP,PT,PT,2020,Q2,Adult
178471074,17847107,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,4,F,,20200622.0,20200601,20200626,EXP,,NVSC2020PT074359,NOVARTIS,,61.0,YR,,M,Y,,,20200626.0,,HP,PT,PT,2020,Q2,Adult
178471074,17847107,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Gastrointestinal disorder,,2020,Q2,4,F,,20200622.0,20200601,20200626,EXP,,NVSC2020PT074359,NOVARTIS,,61.0,YR,,M,Y,,,20200626.0,,HP,PT,PT,2020,Q2,Adult
178471074,17847107,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Genitourinary symptom,,2020,Q2,4,F,,20200622.0,20200601,20200626,EXP,,NVSC2020PT074359,NOVARTIS,,61.0,YR,,M,Y,,,20200626.0,,HP,PT,PT,2020,Q2,Adult
178471074,17847107,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Product administration error,,2020,Q2,4,F,,20200622.0,20200601,20200626,EXP,,NVSC2020PT074359,NOVARTIS,,61.0,YR,,M,Y,,,20200626.0,,HP,PT,PT,2020,Q2,Adult
178471074,17847107,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,4,F,,20200622.0,20200601,20200626,EXP,,NVSC2020PT074359,NOVARTIS,,61.0,YR,,M,Y,,,20200626.0,,HP,PT,PT,2020,Q2,Adult
178471074,17847107,4,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Urinary tract disorder,,2020,Q2,4,F,,20200622.0,20200601,20200626,EXP,,NVSC2020PT074359,NOVARTIS,,61.0,YR,,M,Y,,,20200626.0,,HP,PT,PT,2020,Q2,Adult
178521732,17852173,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2020,Q2,Respiratory failure,,2020,Q2,2,F,20200508.0,20200602.0,20200602,20200605,EXP,,US-ROCHE-2611175,ROCHE,,67.0,YR,,M,Y,95.7,KG,20200605.0,,MD,US,US,2020,Q2,Elderly
178648521,17864852,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,,,,,,,,INJECTION,,2020,Q2,Enteritis,,2020,Q2,1,I,20200227.0,,20200604,20200604,DIR,,,FDA-CTU,,42.0,YR,,M,N,101.0,KG,20200518.0,N,PH,US,US,2020,Q2,Adult
178707641,17870764,1,PS,DULAGLUTIDE 0.75MG/0.5ML,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,QW,2020,Q2,Dehydration,,2020,Q2,1,I,20200604.0,,20200605,20200605,DIR,,,FDA-CTU,,54.0,YR,,F,N,82.1,KG,20200605.0,N,HP,US,US,2020,Q2,Adult
178707641,17870764,1,PS,DULAGLUTIDE 0.75MG/0.5ML,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,QW,2020,Q2,Diarrhoea,,2020,Q2,1,I,20200604.0,,20200605,20200605,DIR,,,FDA-CTU,,54.0,YR,,F,N,82.1,KG,20200605.0,N,HP,US,US,2020,Q2,Adult
178707641,17870764,1,PS,DULAGLUTIDE 0.75MG/0.5ML,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,QW,2020,Q2,Pancreatitis,,2020,Q2,1,I,20200604.0,,20200605,20200605,DIR,,,FDA-CTU,,54.0,YR,,F,N,82.1,KG,20200605.0,N,HP,US,US,2020,Q2,Adult
178707641,17870764,1,PS,DULAGLUTIDE 0.75MG/0.5ML,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,QW,2020,Q2,Vomiting,,2020,Q2,1,I,20200604.0,,20200605,20200605,DIR,,,FDA-CTU,,54.0,YR,,F,N,82.1,KG,20200605.0,N,HP,US,US,2020,Q2,Adult
178757531,17875753,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,N,,,,,0.75,MG,,QW,2020,Q2,Pancreatic mass,,2020,Q2,1,I,20190429.0,,20200608,20200608,DIR,,,FDA-CTU,,68.0,YR,,M,N,97.07,KG,20190718.0,N,PH,US,US,2020,Q2,Elderly
178757531,17875753,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,N,,,,,0.75,MG,,QW,2020,Q2,Pancreatitis,,2020,Q2,1,I,20190429.0,,20200608,20200608,DIR,,,FDA-CTU,,68.0,YR,,M,N,97.07,KG,20190718.0,N,PH,US,US,2020,Q2,Elderly
178770511,17877051,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,U,,,,125469.0,,,INJECTION,,2020,Q2,COVID-19,,2020,Q2,1,I,,20200603.0,20200609,20200609,EXP,,MX-ELI_LILLY_AND_COMPANY-MX202006001906,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20200609.0,,MD,MX,MX,2020,Q2,Adult
178794942,17879494,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,,20200605.0,20200610,20200617,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-02613,LUPIN,,59.0,YR,,F,Y,,,20200617.0,,PH,US,US,2020,Q2,Adult
178794942,17879494,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK (INTENSIFIED),,,,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,,20200605.0,20200610,20200617,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-02613,LUPIN,,59.0,YR,,F,Y,,,20200617.0,,PH,US,US,2020,Q2,Adult
178866031,17886603,4,C,Trulicity (Dulaglutide) .75 mg,,2,Unknown,,,,,,,,,0.75,MG,UNKNOWN,/wk,2020,Q2,Diarrhoea,,2020,Q2,1,I,20190918.0,20190920.0,20200611,20200611,PER,,US-GALDERMA-US19060344,GALDERMA,,55.0,YR,,F,Y,,,20200611.0,,CN,US,US,2020,Q2,Adult
178866031,17886603,4,C,Trulicity (Dulaglutide) .75 mg,,2,Unknown,,,,,,,,,0.75,MG,UNKNOWN,/wk,2020,Q2,Drug ineffective for unapproved indication,,2020,Q2,1,I,20190918.0,20190920.0,20200611,20200611,PER,,US-GALDERMA-US19060344,GALDERMA,,55.0,YR,,F,Y,,,20200611.0,,CN,US,US,2020,Q2,Adult
178866031,17886603,4,C,Trulicity (Dulaglutide) .75 mg,,2,Unknown,,,,,,,,,0.75,MG,UNKNOWN,/wk,2020,Q2,Headache,,2020,Q2,1,I,20190918.0,20190920.0,20200611,20200611,PER,,US-GALDERMA-US19060344,GALDERMA,,55.0,YR,,F,Y,,,20200611.0,,CN,US,US,2020,Q2,Adult
178866031,17886603,4,C,Trulicity (Dulaglutide) .75 mg,,2,Unknown,,,,,,,,,0.75,MG,UNKNOWN,/wk,2020,Q2,Intentional product use issue,,2020,Q2,1,I,20190918.0,20190920.0,20200611,20200611,PER,,US-GALDERMA-US19060344,GALDERMA,,55.0,YR,,F,Y,,,20200611.0,,CN,US,US,2020,Q2,Adult
178886231,17888623,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,1,I,20200608.0,,20200611,20200611,DIR,,,FDA-CTU,,38.0,YR,,F,N,69.0,KG,20200611.0,N,PH,US,US,2020,Q2,Adult
178886231,17888623,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Lactic acidosis,,2020,Q2,1,I,20200608.0,,20200611,20200611,DIR,,,FDA-CTU,,38.0,YR,,F,N,69.0,KG,20200611.0,N,PH,US,US,2020,Q2,Adult
179206181,17920618,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,0.75,MG,,/wk,2020,Q2,Alcoholic ketoacidosis,,2020,Q2,1,I,,20200612.0,20200621,20200621,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029872",BOEHRINGER INGELHEIM,"REDDY J, LATIF A, GASTELUM A, SOOD A. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A 43- YEAR- OLD WOMAN WITH TYPE 2 DIABETES MELLITUS ON SGLT-2 INHIBITOR (EMPAGLIFLOZIN). BMJ CASE REPORTS. 2020;13:.",43.0,YR,,F,Y,,,20200621.0,,MD,US,US,2020,Q2,Adult
179206181,17920618,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,0.75,MG,,/wk,2020,Q2,Bacteraemia,,2020,Q2,1,I,,20200612.0,20200621,20200621,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029872",BOEHRINGER INGELHEIM,"REDDY J, LATIF A, GASTELUM A, SOOD A. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A 43- YEAR- OLD WOMAN WITH TYPE 2 DIABETES MELLITUS ON SGLT-2 INHIBITOR (EMPAGLIFLOZIN). BMJ CASE REPORTS. 2020;13:.",43.0,YR,,F,Y,,,20200621.0,,MD,US,US,2020,Q2,Adult
179206181,17920618,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,0.75,MG,,/wk,2020,Q2,Blood ketone body increased,,2020,Q2,1,I,,20200612.0,20200621,20200621,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029872",BOEHRINGER INGELHEIM,"REDDY J, LATIF A, GASTELUM A, SOOD A. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A 43- YEAR- OLD WOMAN WITH TYPE 2 DIABETES MELLITUS ON SGLT-2 INHIBITOR (EMPAGLIFLOZIN). BMJ CASE REPORTS. 2020;13:.",43.0,YR,,F,Y,,,20200621.0,,MD,US,US,2020,Q2,Adult
179206181,17920618,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,0.75,MG,,/wk,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,1,I,,20200612.0,20200621,20200621,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029872",BOEHRINGER INGELHEIM,"REDDY J, LATIF A, GASTELUM A, SOOD A. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A 43- YEAR- OLD WOMAN WITH TYPE 2 DIABETES MELLITUS ON SGLT-2 INHIBITOR (EMPAGLIFLOZIN). BMJ CASE REPORTS. 2020;13:.",43.0,YR,,F,Y,,,20200621.0,,MD,US,US,2020,Q2,Adult
179206181,17920618,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,0.75,MG,,/wk,2020,Q2,Gastroenteritis,,2020,Q2,1,I,,20200612.0,20200621,20200621,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029872",BOEHRINGER INGELHEIM,"REDDY J, LATIF A, GASTELUM A, SOOD A. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A 43- YEAR- OLD WOMAN WITH TYPE 2 DIABETES MELLITUS ON SGLT-2 INHIBITOR (EMPAGLIFLOZIN). BMJ CASE REPORTS. 2020;13:.",43.0,YR,,F,Y,,,20200621.0,,MD,US,US,2020,Q2,Adult
179206181,17920618,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,0.75,MG,,/wk,2020,Q2,Ketonuria,,2020,Q2,1,I,,20200612.0,20200621,20200621,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029872",BOEHRINGER INGELHEIM,"REDDY J, LATIF A, GASTELUM A, SOOD A. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A 43- YEAR- OLD WOMAN WITH TYPE 2 DIABETES MELLITUS ON SGLT-2 INHIBITOR (EMPAGLIFLOZIN). BMJ CASE REPORTS. 2020;13:.",43.0,YR,,F,Y,,,20200621.0,,MD,US,US,2020,Q2,Adult
179206181,17920618,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,0.75,MG,,/wk,2020,Q2,Lactic acidosis,,2020,Q2,1,I,,20200612.0,20200621,20200621,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029872",BOEHRINGER INGELHEIM,"REDDY J, LATIF A, GASTELUM A, SOOD A. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A 43- YEAR- OLD WOMAN WITH TYPE 2 DIABETES MELLITUS ON SGLT-2 INHIBITOR (EMPAGLIFLOZIN). BMJ CASE REPORTS. 2020;13:.",43.0,YR,,F,Y,,,20200621.0,,MD,US,US,2020,Q2,Adult
179206181,17920618,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,0.75,MG,,/wk,2020,Q2,Metabolic acidosis,,2020,Q2,1,I,,20200612.0,20200621,20200621,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029872",BOEHRINGER INGELHEIM,"REDDY J, LATIF A, GASTELUM A, SOOD A. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A 43- YEAR- OLD WOMAN WITH TYPE 2 DIABETES MELLITUS ON SGLT-2 INHIBITOR (EMPAGLIFLOZIN). BMJ CASE REPORTS. 2020;13:.",43.0,YR,,F,Y,,,20200621.0,,MD,US,US,2020,Q2,Adult
179206181,17920618,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,0.75,MG,,/wk,2020,Q2,Pancreatitis,,2020,Q2,1,I,,20200612.0,20200621,20200621,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029872",BOEHRINGER INGELHEIM,"REDDY J, LATIF A, GASTELUM A, SOOD A. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A 43- YEAR- OLD WOMAN WITH TYPE 2 DIABETES MELLITUS ON SGLT-2 INHIBITOR (EMPAGLIFLOZIN). BMJ CASE REPORTS. 2020;13:.",43.0,YR,,F,Y,,,20200621.0,,MD,US,US,2020,Q2,Adult
179206181,17920618,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,0.75,MG,,/wk,2020,Q2,Tachycardia,,2020,Q2,1,I,,20200612.0,20200621,20200621,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029872",BOEHRINGER INGELHEIM,"REDDY J, LATIF A, GASTELUM A, SOOD A. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A 43- YEAR- OLD WOMAN WITH TYPE 2 DIABETES MELLITUS ON SGLT-2 INHIBITOR (EMPAGLIFLOZIN). BMJ CASE REPORTS. 2020;13:.",43.0,YR,,F,Y,,,20200621.0,,MD,US,US,2020,Q2,Adult
179206181,17920618,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,0.75,MG,,/wk,2020,Q2,Tachypnoea,,2020,Q2,1,I,,20200612.0,20200621,20200621,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029872",BOEHRINGER INGELHEIM,"REDDY J, LATIF A, GASTELUM A, SOOD A. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A 43- YEAR- OLD WOMAN WITH TYPE 2 DIABETES MELLITUS ON SGLT-2 INHIBITOR (EMPAGLIFLOZIN). BMJ CASE REPORTS. 2020;13:.",43.0,YR,,F,Y,,,20200621.0,,MD,US,US,2020,Q2,Adult
179206181,17920618,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,0.75,MG,,/wk,2020,Q2,Viral upper respiratory tract infection,,2020,Q2,1,I,,20200612.0,20200621,20200621,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-029872",BOEHRINGER INGELHEIM,"REDDY J, LATIF A, GASTELUM A, SOOD A. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A 43- YEAR- OLD WOMAN WITH TYPE 2 DIABETES MELLITUS ON SGLT-2 INHIBITOR (EMPAGLIFLOZIN). BMJ CASE REPORTS. 2020;13:.",43.0,YR,,F,Y,,,20200621.0,,MD,US,US,2020,Q2,Adult
179628681,17962868,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Anaemia,,2020,Q2,1,I,,20200618.0,20200630,20200630,EXP,,US-BAYER-2020-124506,BAYER,"SISE ME, BAGGETT MV, SHEPARD J-AO, STEVENS JS, RHEE EP. CASE 17-2020: A 68-YEAR-OLD MAN WITH COVID-19 AND ACUTE KIDNEY INJURY. NEW ENGLAND JOURNAL OF MEDICINE. 2020;382:22:2147-2156",68.0,YR,E,M,Y,,,20200630.0,,MD,US,US,2020,Q2,Elderly
179628681,17962868,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Haematuria,,2020,Q2,1,I,,20200618.0,20200630,20200630,EXP,,US-BAYER-2020-124506,BAYER,"SISE ME, BAGGETT MV, SHEPARD J-AO, STEVENS JS, RHEE EP. CASE 17-2020: A 68-YEAR-OLD MAN WITH COVID-19 AND ACUTE KIDNEY INJURY. NEW ENGLAND JOURNAL OF MEDICINE. 2020;382:22:2147-2156",68.0,YR,E,M,Y,,,20200630.0,,MD,US,US,2020,Q2,Elderly
179628681,17962868,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Haemorrhage,,2020,Q2,1,I,,20200618.0,20200630,20200630,EXP,,US-BAYER-2020-124506,BAYER,"SISE ME, BAGGETT MV, SHEPARD J-AO, STEVENS JS, RHEE EP. CASE 17-2020: A 68-YEAR-OLD MAN WITH COVID-19 AND ACUTE KIDNEY INJURY. NEW ENGLAND JOURNAL OF MEDICINE. 2020;382:22:2147-2156",68.0,YR,E,M,Y,,,20200630.0,,MD,US,US,2020,Q2,Elderly
179628681,17962868,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Labelled drug-drug interaction medication error,,2020,Q2,1,I,,20200618.0,20200630,20200630,EXP,,US-BAYER-2020-124506,BAYER,"SISE ME, BAGGETT MV, SHEPARD J-AO, STEVENS JS, RHEE EP. CASE 17-2020: A 68-YEAR-OLD MAN WITH COVID-19 AND ACUTE KIDNEY INJURY. NEW ENGLAND JOURNAL OF MEDICINE. 2020;382:22:2147-2156",68.0,YR,E,M,Y,,,20200630.0,,MD,US,US,2020,Q2,Elderly
179628681,17962868,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q2,Product administration error,,2020,Q2,1,I,,20200618.0,20200630,20200630,EXP,,US-BAYER-2020-124506,BAYER,"SISE ME, BAGGETT MV, SHEPARD J-AO, STEVENS JS, RHEE EP. CASE 17-2020: A 68-YEAR-OLD MAN WITH COVID-19 AND ACUTE KIDNEY INJURY. NEW ENGLAND JOURNAL OF MEDICINE. 2020;382:22:2147-2156",68.0,YR,E,M,Y,,,20200630.0,,MD,US,US,2020,Q2,Elderly
122911005,12291100,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"0.75 MG/0.5 ML, Q WEEKLY",,,,,,,,,,,,2020,Q3,Cough,,2020,Q3,5,F,20160412.0,20160615.0,20160421,20160627,EXP,,US-JNJFOC-20160418100,PHARMACYCLICS,,31.0,YR,A,M,Y,128.2,KG,20160627.0,,MD,US,US,2020,Q3,Young Adult
122911005,12291100,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"0.75 MG/0.5 ML, Q WEEKLY",,,,,,,,,,,,2020,Q3,Influenza,,2020,Q3,5,F,20160412.0,20160615.0,20160421,20160627,EXP,,US-JNJFOC-20160418100,PHARMACYCLICS,,31.0,YR,A,M,Y,128.2,KG,20160627.0,,MD,US,US,2020,Q3,Young Adult
122911005,12291100,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"0.75 MG/0.5 ML, Q WEEKLY",,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,5,F,20160412.0,20160615.0,20160421,20160627,EXP,,US-JNJFOC-20160418100,PHARMACYCLICS,,31.0,YR,A,M,Y,128.2,KG,20160627.0,,MD,US,US,2020,Q3,Young Adult
122911005,12291100,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"0.75 MG/0.5 ML, Q WEEKLY",,,,,,,,,,,,2020,Q3,Rectal haemorrhage,,2020,Q3,5,F,20160412.0,20160615.0,20160421,20160627,EXP,,US-JNJFOC-20160418100,PHARMACYCLICS,,31.0,YR,A,M,Y,128.2,KG,20160627.0,,MD,US,US,2020,Q3,Young Adult
162443542,16244354,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,D,,,,,1.5,MG,,/wk,2020,Q3,Febrile neutropenia,,2020,Q3,2,F,20190412.0,20190504.0,20190426,20190510,EXP,,US-JNJFOC-20190438183,PHARMACYCLICS,,34.0,YR,A,M,Y,123.4,KG,20190510.0,,MD,US,US,2020,Q3,Young Adult
168551673,16855167,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Anhedonia,,2020,Q3,3,F,20120710.0,20200713.0,20190926,20200825,EXP,,US-GILEAD-2019-0429566,GILEAD,,56.0,YR,A,M,Y,78.91,KG,20200825.0,,CN,US,US,2020,Q3,Adult
168551673,16855167,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Anxiety,,2020,Q3,3,F,20120710.0,20200713.0,20190926,20200825,EXP,,US-GILEAD-2019-0429566,GILEAD,,56.0,YR,A,M,Y,78.91,KG,20200825.0,,CN,US,US,2020,Q3,Adult
168551673,16855167,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Chronic kidney disease,,2020,Q3,3,F,20120710.0,20200713.0,20190926,20200825,EXP,,US-GILEAD-2019-0429566,GILEAD,,56.0,YR,A,M,Y,78.91,KG,20200825.0,,CN,US,US,2020,Q3,Adult
168551673,16855167,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Decreased activity,,2020,Q3,3,F,20120710.0,20200713.0,20190926,20200825,EXP,,US-GILEAD-2019-0429566,GILEAD,,56.0,YR,A,M,Y,78.91,KG,20200825.0,,CN,US,US,2020,Q3,Adult
168551673,16855167,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Economic problem,,2020,Q3,3,F,20120710.0,20200713.0,20190926,20200825,EXP,,US-GILEAD-2019-0429566,GILEAD,,56.0,YR,A,M,Y,78.91,KG,20200825.0,,CN,US,US,2020,Q3,Adult
168551673,16855167,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Emotional distress,,2020,Q3,3,F,20120710.0,20200713.0,20190926,20200825,EXP,,US-GILEAD-2019-0429566,GILEAD,,56.0,YR,A,M,Y,78.91,KG,20200825.0,,CN,US,US,2020,Q3,Adult
168551673,16855167,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,End stage renal disease,,2020,Q3,3,F,20120710.0,20200713.0,20190926,20200825,EXP,,US-GILEAD-2019-0429566,GILEAD,,56.0,YR,A,M,Y,78.91,KG,20200825.0,,CN,US,US,2020,Q3,Adult
168551673,16855167,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Fatigue,,2020,Q3,3,F,20120710.0,20200713.0,20190926,20200825,EXP,,US-GILEAD-2019-0429566,GILEAD,,56.0,YR,A,M,Y,78.91,KG,20200825.0,,CN,US,US,2020,Q3,Adult
168551673,16855167,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Fear,,2020,Q3,3,F,20120710.0,20200713.0,20190926,20200825,EXP,,US-GILEAD-2019-0429566,GILEAD,,56.0,YR,A,M,Y,78.91,KG,20200825.0,,CN,US,US,2020,Q3,Adult
168551673,16855167,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Loss of personal independence in daily activities,,2020,Q3,3,F,20120710.0,20200713.0,20190926,20200825,EXP,,US-GILEAD-2019-0429566,GILEAD,,56.0,YR,A,M,Y,78.91,KG,20200825.0,,CN,US,US,2020,Q3,Adult
168551673,16855167,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Pain,,2020,Q3,3,F,20120710.0,20200713.0,20190926,20200825,EXP,,US-GILEAD-2019-0429566,GILEAD,,56.0,YR,A,M,Y,78.91,KG,20200825.0,,CN,US,US,2020,Q3,Adult
168551673,16855167,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Quality of life decreased,,2020,Q3,3,F,20120710.0,20200713.0,20190926,20200825,EXP,,US-GILEAD-2019-0429566,GILEAD,,56.0,YR,A,M,Y,78.91,KG,20200825.0,,CN,US,US,2020,Q3,Adult
168551673,16855167,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Renal failure,,2020,Q3,3,F,20120710.0,20200713.0,20190926,20200825,EXP,,US-GILEAD-2019-0429566,GILEAD,,56.0,YR,A,M,Y,78.91,KG,20200825.0,,CN,US,US,2020,Q3,Adult
168745595,16874559,72,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Abscess limb,,2020,Q3,5,F,20180611.0,20200813.0,20191001,20200819,EXP,,US-ASTRAZENECA-2019SF36586,ASTRAZENECA,,21738.0,DY,,F,Y,132.9,KG,20200819.0,,,US,US,2020,Q3,Elderly
168745595,16874559,72,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Cellulitis,,2020,Q3,5,F,20180611.0,20200813.0,20191001,20200819,EXP,,US-ASTRAZENECA-2019SF36586,ASTRAZENECA,,21738.0,DY,,F,Y,132.9,KG,20200819.0,,,US,US,2020,Q3,Elderly
168745595,16874559,72,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Fournier's gangrene,,2020,Q3,5,F,20180611.0,20200813.0,20191001,20200819,EXP,,US-ASTRAZENECA-2019SF36586,ASTRAZENECA,,21738.0,DY,,F,Y,132.9,KG,20200819.0,,,US,US,2020,Q3,Elderly
168745595,16874559,72,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Perirectal abscess,,2020,Q3,5,F,20180611.0,20200813.0,20191001,20200819,EXP,,US-ASTRAZENECA-2019SF36586,ASTRAZENECA,,21738.0,DY,,F,Y,132.9,KG,20200819.0,,,US,US,2020,Q3,Elderly
168745595,16874559,72,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Subcutaneous abscess,,2020,Q3,5,F,20180611.0,20200813.0,20191001,20200819,EXP,,US-ASTRAZENECA-2019SF36586,ASTRAZENECA,,21738.0,DY,,F,Y,132.9,KG,20200819.0,,,US,US,2020,Q3,Elderly
169403944,16940394,6,C,Dulaglutide ((MAMMIFERE/HAMSTER/CELLULES CHO)),DULAGLUTIDE,1,Unknown,(),,,U,,,,,,,,,2020,Q3,Parkinsonism,,2020,Q3,4,F,201812.0,20200826.0,20191021,20200909,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-224321,RANBAXY,,65.0,YR,,M,Y,88.0,KG,20200909.0,,HP,NL,FR,2020,Q3,Elderly
172030277,17203027,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML SUBQ SUNDAYS,,,,,,,,1.0,DF,,,2020,Q3,Acute respiratory failure,,2020,Q3,7,F,20191104.0,20200721.0,20191226,20200723,EXP,,NVSC2019US079162,NOVARTIS,,58.0,YR,,F,Y,99.34,KG,20200723.0,,HP,US,US,2020,Q3,Adult
172030277,17203027,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML SUBQ SUNDAYS,,,,,,,,1.0,DF,,,2020,Q3,Cardiac failure congestive,,2020,Q3,7,F,20191104.0,20200721.0,20191226,20200723,EXP,,NVSC2019US079162,NOVARTIS,,58.0,YR,,F,Y,99.34,KG,20200723.0,,HP,US,US,2020,Q3,Adult
172030277,17203027,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML SUBQ SUNDAYS,,,,,,,,1.0,DF,,,2020,Q3,Hypoxia,,2020,Q3,7,F,20191104.0,20200721.0,20191226,20200723,EXP,,NVSC2019US079162,NOVARTIS,,58.0,YR,,F,Y,99.34,KG,20200723.0,,HP,US,US,2020,Q3,Adult
172030277,17203027,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML SUBQ SUNDAYS,,,,,,,,1.0,DF,,,2020,Q3,Pneumonia,,2020,Q3,7,F,20191104.0,20200721.0,20191226,20200723,EXP,,NVSC2019US079162,NOVARTIS,,58.0,YR,,F,Y,99.34,KG,20200723.0,,HP,US,US,2020,Q3,Adult
172030277,17203027,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML SUBQ SUNDAYS,,,,,,,,1.0,DF,,,2020,Q3,Streptococcus test positive,,2020,Q3,7,F,20191104.0,20200721.0,20191226,20200723,EXP,,NVSC2019US079162,NOVARTIS,,58.0,YR,,F,Y,99.34,KG,20200723.0,,HP,US,US,2020,Q3,Adult
173047993,17304799,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Abscess,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Blood glucose fluctuation,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Cardiac disorder,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Constipation,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Headache,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Hypoaesthesia,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Night sweats,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Swelling,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Swelling face,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Taste disorder,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Thirst decreased,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Weight increased,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Abscess,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Blood glucose fluctuation,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Cardiac disorder,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Constipation,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Headache,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Hypoaesthesia,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Night sweats,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Swelling,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Swelling face,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Taste disorder,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Thirst decreased,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173047993,17304799,6,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MILLIGRAM, QWK",,,U,,,,,0.75,MG,,/wk,2020,Q3,Weight increased,,2020,Q3,3,F,,20200704.0,20200123,20200707,EXP,,CA-PFIZER INC-2020027179,PFIZER,,50.0,YR,,F,Y,75.0,KG,20200707.0,,HP,CA,CA,2020,Q3,Adult
173169633,17316963,57,C,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,2.0MG UNKNOWN,,,,,,,,2.0,MG,TABLET,,2020,Q3,Fournier's gangrene,,2020,Q3,3,F,20180120.0,20200715.0,20200124,20200720,EXP,,US-ASTRAZENECA-2020SE09104,ASTRAZENECA,,20667.0,DY,,M,Y,93.0,KG,20200720.0,,,US,US,2020,Q3,Elderly
173169633,17316963,57,C,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,2.0MG UNKNOWN,,,,,,,,2.0,MG,TABLET,,2020,Q3,Necrotising fasciitis,,2020,Q3,3,F,20180120.0,20200715.0,20200124,20200720,EXP,,US-ASTRAZENECA-2020SE09104,ASTRAZENECA,,20667.0,DY,,M,Y,93.0,KG,20200720.0,,,US,US,2020,Q3,Elderly
173169633,17316963,57,C,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,2.0MG UNKNOWN,,,,,,,,2.0,MG,TABLET,,2020,Q3,Sepsis,,2020,Q3,3,F,20180120.0,20200715.0,20200124,20200720,EXP,,US-ASTRAZENECA-2020SE09104,ASTRAZENECA,,20667.0,DY,,M,Y,93.0,KG,20200720.0,,,US,US,2020,Q3,Elderly
173169633,17316963,57,C,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,2.0MG UNKNOWN,,,,,,,,2.0,MG,TABLET,,2020,Q3,Subcutaneous abscess,,2020,Q3,3,F,20180120.0,20200715.0,20200124,20200720,EXP,,US-ASTRAZENECA-2020SE09104,ASTRAZENECA,,20667.0,DY,,M,Y,93.0,KG,20200720.0,,,US,US,2020,Q3,Elderly
174176067,17417606,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Transaminases increased,,2020,Q3,7,F,20200130.0,20200728.0,20200213,20200804,EXP,,US-EXELIXIS-XL18420027272,EXELIXIS,,67.0,YR,,M,Y,96.2,KG,20200804.0,,MD,US,US,2020,Q3,Elderly
174272294,17427229,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Transaminases increased,,2020,Q3,4,F,20200130.0,20200728.0,20200218,20200806,EXP,,US-ROCHE-2551809,ROCHE,,67.0,YR,,M,Y,96.2,KG,20200807.0,,MD,US,US,2020,Q3,Elderly
175842712,17584271,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q3,Colitis,,2020,Q3,2,F,,20200806.0,20200326,20200813,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-09716,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,,,20200813.0,,CN,CA,CA,2020,Q3,Elderly
175842712,17584271,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q3,Colitis ulcerative,,2020,Q3,2,F,,20200806.0,20200326,20200813,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-09716,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,,,20200813.0,,CN,CA,CA,2020,Q3,Elderly
175842712,17584271,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q3,Decreased activity,,2020,Q3,2,F,,20200806.0,20200326,20200813,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-09716,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,,,20200813.0,,CN,CA,CA,2020,Q3,Elderly
175842712,17584271,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q3,Frequent bowel movements,,2020,Q3,2,F,,20200806.0,20200326,20200813,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-09716,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,,,20200813.0,,CN,CA,CA,2020,Q3,Elderly
175842712,17584271,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q3,Rectal haemorrhage,,2020,Q3,2,F,,20200806.0,20200326,20200813,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-09716,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,,,20200813.0,,CN,CA,CA,2020,Q3,Elderly
179010652,17901065,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"UNK, UNKNOWN",,,,, D179330C,,,0.75,MG,INJECTION,,2020,Q3,Skin odour abnormal,,2020,Q3,2,F,20200607.0,20200615.0,20200616,20200714,PER,,US-ELI_LILLY_AND_COMPANY-US202006006640,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20200714.0,,CN,US,US,2020,Q3,Elderly
179703891,17970389,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,U,,,,,,,,,2020,Q3,Fibrosis,,2020,Q3,1,I,,20200626.0,20200701,20200701,EXP,GB-MHRA-EYC 00224762,GB-ELI_LILLY_AND_COMPANY-GB202006012286,ELI LILLY AND CO,,69.0,YR,,F,Y,94.0,KG,20200701.0,,PH,GB,GB,2020,Q3,Elderly
179815811,17981581,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Fibrosis,,2020,Q3,1,I,,20200626.0,20200706,20200706,EXP,,GB-AUROBINDO-AUR-APL-2020-031917,AUROBINDO,,69.0,YR,,F,Y,94.0,KG,20200706.0,,PH,GB,GB,2020,Q3,Elderly
179885021,17988502,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Abdominal discomfort,,2020,Q3,1,I,20200705.0,,20200706,20200706,DIR,,,FDA-CTU,,51.0,YR,,F,N,92.25,KG,20200706.0,N,CN,US,US,2020,Q3,Adult
179885021,17988502,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Chills,,2020,Q3,1,I,20200705.0,,20200706,20200706,DIR,,,FDA-CTU,,51.0,YR,,F,N,92.25,KG,20200706.0,N,CN,US,US,2020,Q3,Adult
179885021,17988502,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,20200705.0,,20200706,20200706,DIR,,,FDA-CTU,,51.0,YR,,F,N,92.25,KG,20200706.0,N,CN,US,US,2020,Q3,Adult
179885021,17988502,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Dystonia,,2020,Q3,1,I,20200705.0,,20200706,20200706,DIR,,,FDA-CTU,,51.0,YR,,F,N,92.25,KG,20200706.0,N,CN,US,US,2020,Q3,Adult
179885021,17988502,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Hyperhidrosis,,2020,Q3,1,I,20200705.0,,20200706,20200706,DIR,,,FDA-CTU,,51.0,YR,,F,N,92.25,KG,20200706.0,N,CN,US,US,2020,Q3,Adult
179885021,17988502,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Hyperreflexia,,2020,Q3,1,I,20200705.0,,20200706,20200706,DIR,,,FDA-CTU,,51.0,YR,,F,N,92.25,KG,20200706.0,N,CN,US,US,2020,Q3,Adult
179885021,17988502,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Hypertension,,2020,Q3,1,I,20200705.0,,20200706,20200706,DIR,,,FDA-CTU,,51.0,YR,,F,N,92.25,KG,20200706.0,N,CN,US,US,2020,Q3,Adult
179885021,17988502,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Serotonin syndrome,,2020,Q3,1,I,20200705.0,,20200706,20200706,DIR,,,FDA-CTU,,51.0,YR,,F,N,92.25,KG,20200706.0,N,CN,US,US,2020,Q3,Adult
179885021,17988502,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Tachycardia,,2020,Q3,1,I,20200705.0,,20200706,20200706,DIR,,,FDA-CTU,,51.0,YR,,F,N,92.25,KG,20200706.0,N,CN,US,US,2020,Q3,Adult
179885021,17988502,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Tremor,,2020,Q3,1,I,20200705.0,,20200706,20200706,DIR,,,FDA-CTU,,51.0,YR,,F,N,92.25,KG,20200706.0,N,CN,US,US,2020,Q3,Adult
179918212,17991821,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,Y,, D188748C,,,0.75,MG,INJECTION,,2020,Q3,Abdominal discomfort,,2020,Q3,2,F,20200627.0,20200706.0,20200707,20200717,EXP,,US-ELI_LILLY_AND_COMPANY-US202006012821,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200717.0,,CN,US,US,2020,Q3,Adult
179918212,17991821,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,Y,, D188748C,,,0.75,MG,INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,2,F,20200627.0,20200706.0,20200707,20200717,EXP,,US-ELI_LILLY_AND_COMPANY-US202006012821,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200717.0,,CN,US,US,2020,Q3,Adult
179918212,17991821,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,Y,, D188748C,,,0.75,MG,INJECTION,,2020,Q3,Headache,,2020,Q3,2,F,20200627.0,20200706.0,20200707,20200717,EXP,,US-ELI_LILLY_AND_COMPANY-US202006012821,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200717.0,,CN,US,US,2020,Q3,Adult
179918212,17991821,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,Y,, D188748C,,,0.75,MG,INJECTION,,2020,Q3,Malaise,,2020,Q3,2,F,20200627.0,20200706.0,20200707,20200717,EXP,,US-ELI_LILLY_AND_COMPANY-US202006012821,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200717.0,,CN,US,US,2020,Q3,Adult
179918212,17991821,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,Y,, D188748C,,,0.75,MG,INJECTION,,2020,Q3,Nausea,,2020,Q3,2,F,20200627.0,20200706.0,20200707,20200717,EXP,,US-ELI_LILLY_AND_COMPANY-US202006012821,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200717.0,,CN,US,US,2020,Q3,Adult
179918212,17991821,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,Y,, D188748C,,,0.75,MG,INJECTION,,2020,Q3,Pallor,,2020,Q3,2,F,20200627.0,20200706.0,20200707,20200717,EXP,,US-ELI_LILLY_AND_COMPANY-US202006012821,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200717.0,,CN,US,US,2020,Q3,Adult
179918212,17991821,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,Y,, D188748C,,,0.75,MG,INJECTION,,2020,Q3,Presyncope,,2020,Q3,2,F,20200627.0,20200706.0,20200707,20200717,EXP,,US-ELI_LILLY_AND_COMPANY-US202006012821,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200717.0,,CN,US,US,2020,Q3,Adult
179918212,17991821,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,Y,, D188748C,,,0.75,MG,INJECTION,,2020,Q3,Syncope,,2020,Q3,2,F,20200627.0,20200706.0,20200707,20200717,EXP,,US-ELI_LILLY_AND_COMPANY-US202006012821,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200717.0,,CN,US,US,2020,Q3,Adult
180001301,18000130,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,, UNKNOWN,,,,,,,2020,Q3,Fibrosis,,2020,Q3,1,I,,20200702.0,20200709,20200709,EXP,GB-MHRA-EYC 00224762,GB-TEVA-2020-GB-1798267,TEVA,,69.0,YR,,F,Y,94.0,KG,20200709.0,,PH,GB,GB,2020,Q3,Elderly
180076401,18007640,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2020,Q3,Fibrosis,,2020,Q3,1,I,,20200701.0,20200710,20200710,EXP,GB-MHRA-EYC 00224762,GB-MYLANLABS-2020M1061753,MYLAN,,69.0,YR,,F,Y,94.0,KG,20200710.0,,PH,GB,GB,2020,Q3,Elderly
180231921,18023192,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,(),,,U,,,,,,,,,2020,Q3,Fibrosis,,2020,Q3,1,I,,20200702.0,20200715,20200715,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-253600,RANBAXY,,69.0,YR,,F,Y,94.0,KG,20200715.0,,HP,NL,GB,2020,Q3,Elderly
180572551,18057255,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/wk,2020,Q3,Abscess,,2020,Q3,1,I,,20200714.0,20200722,20200722,EXP,,CA-TEVA-2020-CA-1802449,TEVA,,50.0,YR,,F,Y,75.0,KG,20200723.0,,HP,CA,CA,2020,Q3,Adult
180572551,18057255,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/wk,2020,Q3,Blood glucose fluctuation,,2020,Q3,1,I,,20200714.0,20200722,20200722,EXP,,CA-TEVA-2020-CA-1802449,TEVA,,50.0,YR,,F,Y,75.0,KG,20200723.0,,HP,CA,CA,2020,Q3,Adult
180572551,18057255,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/wk,2020,Q3,Cardiac disorder,,2020,Q3,1,I,,20200714.0,20200722,20200722,EXP,,CA-TEVA-2020-CA-1802449,TEVA,,50.0,YR,,F,Y,75.0,KG,20200723.0,,HP,CA,CA,2020,Q3,Adult
180572551,18057255,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/wk,2020,Q3,Constipation,,2020,Q3,1,I,,20200714.0,20200722,20200722,EXP,,CA-TEVA-2020-CA-1802449,TEVA,,50.0,YR,,F,Y,75.0,KG,20200723.0,,HP,CA,CA,2020,Q3,Adult
180572551,18057255,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/wk,2020,Q3,Headache,,2020,Q3,1,I,,20200714.0,20200722,20200722,EXP,,CA-TEVA-2020-CA-1802449,TEVA,,50.0,YR,,F,Y,75.0,KG,20200723.0,,HP,CA,CA,2020,Q3,Adult
180572551,18057255,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/wk,2020,Q3,Hypoaesthesia,,2020,Q3,1,I,,20200714.0,20200722,20200722,EXP,,CA-TEVA-2020-CA-1802449,TEVA,,50.0,YR,,F,Y,75.0,KG,20200723.0,,HP,CA,CA,2020,Q3,Adult
180572551,18057255,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/wk,2020,Q3,Night sweats,,2020,Q3,1,I,,20200714.0,20200722,20200722,EXP,,CA-TEVA-2020-CA-1802449,TEVA,,50.0,YR,,F,Y,75.0,KG,20200723.0,,HP,CA,CA,2020,Q3,Adult
180572551,18057255,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/wk,2020,Q3,Swelling,,2020,Q3,1,I,,20200714.0,20200722,20200722,EXP,,CA-TEVA-2020-CA-1802449,TEVA,,50.0,YR,,F,Y,75.0,KG,20200723.0,,HP,CA,CA,2020,Q3,Adult
180572551,18057255,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/wk,2020,Q3,Swelling face,,2020,Q3,1,I,,20200714.0,20200722,20200722,EXP,,CA-TEVA-2020-CA-1802449,TEVA,,50.0,YR,,F,Y,75.0,KG,20200723.0,,HP,CA,CA,2020,Q3,Adult
180572551,18057255,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/wk,2020,Q3,Taste disorder,,2020,Q3,1,I,,20200714.0,20200722,20200722,EXP,,CA-TEVA-2020-CA-1802449,TEVA,,50.0,YR,,F,Y,75.0,KG,20200723.0,,HP,CA,CA,2020,Q3,Adult
180572551,18057255,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/wk,2020,Q3,Thirst decreased,,2020,Q3,1,I,,20200714.0,20200722,20200722,EXP,,CA-TEVA-2020-CA-1802449,TEVA,,50.0,YR,,F,Y,75.0,KG,20200723.0,,HP,CA,CA,2020,Q3,Adult
180572551,18057255,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/wk,2020,Q3,Weight increased,,2020,Q3,1,I,,20200714.0,20200722,20200722,EXP,,CA-TEVA-2020-CA-1802449,TEVA,,50.0,YR,,F,Y,75.0,KG,20200723.0,,HP,CA,CA,2020,Q3,Adult
180801861,18080186,14,SS,DULAGLUTIDE.,DULAGLUTIDE,1,,THERAPY START DATE: JUL 2019,,,,,,,,0.75,MG,,/wk,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,14,SS,DULAGLUTIDE.,DULAGLUTIDE,1,,THERAPY START DATE: JUL 2019,,,,,,,,0.75,MG,,/wk,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,14,SS,DULAGLUTIDE.,DULAGLUTIDE,1,,THERAPY START DATE: JUL 2019,,,,,,,,0.75,MG,,/wk,2020,Q3,Weight increased,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,15,SS,DULAGLUTIDE.,DULAGLUTIDE,1,,THERAPY START DATE: JUL 2019,,,,,,,,1.5,MG,,/wk,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,15,SS,DULAGLUTIDE.,DULAGLUTIDE,1,,THERAPY START DATE: JUL 2019,,,,,,,,1.5,MG,,/wk,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,15,SS,DULAGLUTIDE.,DULAGLUTIDE,1,,THERAPY START DATE: JUL 2019,,,,,,,,1.5,MG,,/wk,2020,Q3,Weight increased,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
181046321,18104632,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Bacteraemia,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,54.0,YR,,M,N,179.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181046321,18104632,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Necrotising fasciitis,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,54.0,YR,,M,N,179.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181046321,18104632,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,54.0,YR,,M,N,179.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181070461,18107046,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,44.0,YR,,F,N,111.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181070461,18107046,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,44.0,YR,,F,N,111.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181070461,18107046,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Delirium,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,44.0,YR,,F,N,111.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181070461,18107046,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,44.0,YR,,F,N,111.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181070461,18107046,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Euglycaemic diabetic ketoacidosis,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,44.0,YR,,F,N,111.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181070461,18107046,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Tachypnoea,,2020,Q3,1,I,20200728.0,,20200803,20200803,DIR,,,FDA-CTU,,44.0,YR,,F,N,111.0,KG,20200803.0,N,PH,US,US,2020,Q3,Adult
181333601,18133360,7,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, WEEKLY",,,,,,,,1.5,MG,,,2020,Q3,Electrocardiogram QT prolonged,,2020,Q3,1,I,,20200729.0,20200811,20200811,EXP,,BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-257089,RANBAXY,,60.0,YR,,F,Y,,,20200811.0,,HP,BE,BE,2020,Q3,Adult
181374781,18137478,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, PER WEEK",,,,, UNKNOWN,,,1.5,MG,,,2020,Q3,Atrioventricular block second degree,,2020,Q3,1,I,,20200729.0,20200812,20200812,EXP,,BE-LUPIN PHARMACEUTICALS INC.-2020-04375,LUPIN,,60.0,YR,,F,Y,,,20200812.0,,HP,BE,BE,2020,Q3,Adult
181374781,18137478,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, PER WEEK",,,,, UNKNOWN,,,1.5,MG,,,2020,Q3,Electrocardiogram QT prolonged,,2020,Q3,1,I,,20200729.0,20200812,20200812,EXP,,BE-LUPIN PHARMACEUTICALS INC.-2020-04375,LUPIN,,60.0,YR,,F,Y,,,20200812.0,,HP,BE,BE,2020,Q3,Adult
181400261,18140026,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q3,Abdominal pain,,2020,Q3,1,I,20191212.0,,20200812,20200812,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200217.0,N,PH,US,US,2020,Q3,Elderly
181400261,18140026,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q3,Anxiety,,2020,Q3,1,I,20191212.0,,20200812,20200812,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200217.0,N,PH,US,US,2020,Q3,Elderly
181400261,18140026,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q3,Diarrhoea,,2020,Q3,1,I,20191212.0,,20200812,20200812,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200217.0,N,PH,US,US,2020,Q3,Elderly
181400261,18140026,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q3,Dyspnoea,,2020,Q3,1,I,20191212.0,,20200812,20200812,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200217.0,N,PH,US,US,2020,Q3,Elderly
181400261,18140026,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q3,Panic attack,,2020,Q3,1,I,20191212.0,,20200812,20200812,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200217.0,N,PH,US,US,2020,Q3,Elderly
181400261,18140026,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q3,Tremor,,2020,Q3,1,I,20191212.0,,20200812,20200812,DIR,,,FDA-CTU,,71.0,YR,,M,N,,,20200217.0,N,PH,US,US,2020,Q3,Elderly
181603951,18160395,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,THURSDAYS,,,U,,,,125469.0,,,,,2020,Q3,Haematuria,,2020,Q3,1,I,,20200806.0,20200817,20200817,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008002904,ELI LILLY AND CO,,36.0,YR,,M,Y,98.0,KG,20200817.0,,PH,DE,DE,2020,Q3,Adult
181603951,18160395,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,THURSDAYS,,,U,,,,125469.0,,,,,2020,Q3,Pollakiuria,,2020,Q3,1,I,,20200806.0,20200817,20200817,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008002904,ELI LILLY AND CO,,36.0,YR,,M,Y,98.0,KG,20200817.0,,PH,DE,DE,2020,Q3,Adult
181603951,18160395,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,THURSDAYS,,,U,,,,125469.0,,,,,2020,Q3,Urinary retention,,2020,Q3,1,I,,20200806.0,20200817,20200817,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008002904,ELI LILLY AND CO,,36.0,YR,,M,Y,98.0,KG,20200817.0,,PH,DE,DE,2020,Q3,Adult
181637581,18163758,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, Q24H",,,U,,,,,1.5,MG,,,2020,Q3,Blood pressure decreased,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,NVSC2020DE225077,NOVARTIS,,70.0,YR,,M,Y,,,20200818.0,,CN,FR,DE,2020,Q3,Elderly
181637581,18163758,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, Q24H",,,U,,,,,1.5,MG,,,2020,Q3,Constipation,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,NVSC2020DE225077,NOVARTIS,,70.0,YR,,M,Y,,,20200818.0,,CN,FR,DE,2020,Q3,Elderly
181637581,18163758,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, Q24H",,,U,,,,,1.5,MG,,,2020,Q3,Dysuria,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,NVSC2020DE225077,NOVARTIS,,70.0,YR,,M,Y,,,20200818.0,,CN,FR,DE,2020,Q3,Elderly
181637581,18163758,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, Q24H",,,U,,,,,1.5,MG,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,NVSC2020DE225077,NOVARTIS,,70.0,YR,,M,Y,,,20200818.0,,CN,FR,DE,2020,Q3,Elderly
181637581,18163758,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, Q24H",,,U,,,,,1.5,MG,,,2020,Q3,Nocturia,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,NVSC2020DE225077,NOVARTIS,,70.0,YR,,M,Y,,,20200818.0,,CN,FR,DE,2020,Q3,Elderly
181637581,18163758,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, Q24H",,,U,,,,,1.5,MG,,,2020,Q3,Polyuria,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,NVSC2020DE225077,NOVARTIS,,70.0,YR,,M,Y,,,20200818.0,,CN,FR,DE,2020,Q3,Elderly
181637581,18163758,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, Q24H",,,U,,,,,1.5,MG,,,2020,Q3,Product monitoring error,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,NVSC2020DE225077,NOVARTIS,,70.0,YR,,M,Y,,,20200818.0,,CN,FR,DE,2020,Q3,Elderly
181637581,18163758,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, Q24H",,,U,,,,,1.5,MG,,,2020,Q3,Product prescribing error,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,NVSC2020DE225077,NOVARTIS,,70.0,YR,,M,Y,,,20200818.0,,CN,FR,DE,2020,Q3,Elderly
181637581,18163758,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, Q24H",,,U,,,,,1.5,MG,,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,NVSC2020DE225077,NOVARTIS,,70.0,YR,,M,Y,,,20200818.0,,CN,FR,DE,2020,Q3,Elderly
181664001,18166400,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK, (1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN)",,,U,U,,,,1.5,MG,,/wk,2020,Q3,Chest pain,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181664001,18166400,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK, (1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN)",,,U,U,,,,1.5,MG,,/wk,2020,Q3,Dyspepsia,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181664001,18166400,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK, (1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN)",,,U,U,,,,1.5,MG,,/wk,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181664001,18166400,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK, (1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN)",,,U,U,,,,1.5,MG,,/wk,2020,Q3,Haematuria,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181664001,18166400,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK, (1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN)",,,U,U,,,,1.5,MG,,/wk,2020,Q3,Inflammation,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181664001,18166400,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK, (1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN)",,,U,U,,,,1.5,MG,,/wk,2020,Q3,Localised infection,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181664001,18166400,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK, (1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN)",,,U,U,,,,1.5,MG,,/wk,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181664001,18166400,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK, (1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN)",,,U,U,,,,1.5,MG,,/wk,2020,Q3,Pain,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181693911,18169391,7,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,D,,,,,1.5,MG,,/wk,2020,Q3,Atrioventricular block second degree,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,BE-TEVA-2020-BE-1814960,TEVA,"GHAFARI C, VANDERGHEYNST F, PARENT E, TANAKA K, CARLIER S. EXERCISE?INDUCED TORSADES DE POINTES AS AN UNUSUAL PRESENTATION OF CARDIAC SARCOIDOSIS: A CASE REPORT AND REVIEW OF LITERATURE. WORLD?J?CARDIOL 2020?12(6):291?302.",60.0,YR,A,F,Y,,,20200819.0,,MD,BE,BE,2020,Q3,Adult
181693911,18169391,7,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,D,,,,,1.5,MG,,/wk,2020,Q3,Electrocardiogram QT prolonged,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,BE-TEVA-2020-BE-1814960,TEVA,"GHAFARI C, VANDERGHEYNST F, PARENT E, TANAKA K, CARLIER S. EXERCISE?INDUCED TORSADES DE POINTES AS AN UNUSUAL PRESENTATION OF CARDIAC SARCOIDOSIS: A CASE REPORT AND REVIEW OF LITERATURE. WORLD?J?CARDIOL 2020?12(6):291?302.",60.0,YR,A,F,Y,,,20200819.0,,MD,BE,BE,2020,Q3,Adult
181720841,18172084,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN (1.5 MG / WEEK, SCHEME, PREFILLED SYRINGES)",,,U,U, UNKNOWN,,,1.5,MG,,,2020,Q3,Chest pain,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181720841,18172084,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN (1.5 MG / WEEK, SCHEME, PREFILLED SYRINGES)",,,U,U, UNKNOWN,,,1.5,MG,,,2020,Q3,Dyspepsia,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181720841,18172084,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN (1.5 MG / WEEK, SCHEME, PREFILLED SYRINGES)",,,U,U, UNKNOWN,,,1.5,MG,,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181720841,18172084,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN (1.5 MG / WEEK, SCHEME, PREFILLED SYRINGES)",,,U,U, UNKNOWN,,,1.5,MG,,,2020,Q3,Haematuria,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181720841,18172084,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN (1.5 MG / WEEK, SCHEME, PREFILLED SYRINGES)",,,U,U, UNKNOWN,,,1.5,MG,,,2020,Q3,Inflammation,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181720841,18172084,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN (1.5 MG / WEEK, SCHEME, PREFILLED SYRINGES)",,,U,U, UNKNOWN,,,1.5,MG,,,2020,Q3,Localised infection,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181720841,18172084,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN (1.5 MG / WEEK, SCHEME, PREFILLED SYRINGES)",,,U,U, UNKNOWN,,,1.5,MG,,,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181720841,18172084,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN (1.5 MG / WEEK, SCHEME, PREFILLED SYRINGES)",,,U,U, UNKNOWN,,,1.5,MG,,,2020,Q3,Pain,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181731921,18173192,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM (1?0?0?0),,,,,,,,1.5,MG,,,2020,Q3,Blood pressure decreased,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,,DE-AUROBINDO-AUR-APL-2020-039409,AUROBINDO,,70.0,YR,,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181731921,18173192,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM (1?0?0?0),,,,,,,,1.5,MG,,,2020,Q3,Constipation,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,,DE-AUROBINDO-AUR-APL-2020-039409,AUROBINDO,,70.0,YR,,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181731921,18173192,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM (1?0?0?0),,,,,,,,1.5,MG,,,2020,Q3,Dysuria,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,,DE-AUROBINDO-AUR-APL-2020-039409,AUROBINDO,,70.0,YR,,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181731921,18173192,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM (1?0?0?0),,,,,,,,1.5,MG,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,,DE-AUROBINDO-AUR-APL-2020-039409,AUROBINDO,,70.0,YR,,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181731921,18173192,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM (1?0?0?0),,,,,,,,1.5,MG,,,2020,Q3,Nocturia,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,,DE-AUROBINDO-AUR-APL-2020-039409,AUROBINDO,,70.0,YR,,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181731921,18173192,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM (1?0?0?0),,,,,,,,1.5,MG,,,2020,Q3,Polyuria,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,,DE-AUROBINDO-AUR-APL-2020-039409,AUROBINDO,,70.0,YR,,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181731921,18173192,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM (1?0?0?0),,,,,,,,1.5,MG,,,2020,Q3,Product monitoring error,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,,DE-AUROBINDO-AUR-APL-2020-039409,AUROBINDO,,70.0,YR,,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181731921,18173192,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM (1?0?0?0),,,,,,,,1.5,MG,,,2020,Q3,Product prescribing error,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,,DE-AUROBINDO-AUR-APL-2020-039409,AUROBINDO,,70.0,YR,,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181731921,18173192,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM (1?0?0?0),,,,,,,,1.5,MG,,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,,DE-AUROBINDO-AUR-APL-2020-039409,AUROBINDO,,70.0,YR,,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181735921,18173592,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Blood pressure decreased,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,DE-BFARM-20008806,DE-ACCORD-196173,ACCORD,,70.0,YR,E,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181735921,18173592,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Constipation,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,DE-BFARM-20008806,DE-ACCORD-196173,ACCORD,,70.0,YR,E,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181735921,18173592,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Dysuria,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,DE-BFARM-20008806,DE-ACCORD-196173,ACCORD,,70.0,YR,E,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181735921,18173592,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,DE-BFARM-20008806,DE-ACCORD-196173,ACCORD,,70.0,YR,E,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181735921,18173592,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Nocturia,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,DE-BFARM-20008806,DE-ACCORD-196173,ACCORD,,70.0,YR,E,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181735921,18173592,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Polyuria,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,DE-BFARM-20008806,DE-ACCORD-196173,ACCORD,,70.0,YR,E,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181735921,18173592,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Product monitoring error,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,DE-BFARM-20008806,DE-ACCORD-196173,ACCORD,,70.0,YR,E,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181735921,18173592,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Product prescribing error,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,DE-BFARM-20008806,DE-ACCORD-196173,ACCORD,,70.0,YR,E,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181735921,18173592,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,DE-BFARM-20008806,DE-ACCORD-196173,ACCORD,,70.0,YR,E,M,Y,101.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Elderly
181743041,18174304,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, QD (1?0?0?0)",,,U,,,,,1.5,MG,,QD,2020,Q3,Blood pressure decreased,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,NVSC2020DE225329,NOVARTIS,,70.0,YR,,M,Y,101.0,KG,20200820.0,,HP,DE,DE,2020,Q3,Elderly
181743041,18174304,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, QD (1?0?0?0)",,,U,,,,,1.5,MG,,QD,2020,Q3,Constipation,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,NVSC2020DE225329,NOVARTIS,,70.0,YR,,M,Y,101.0,KG,20200820.0,,HP,DE,DE,2020,Q3,Elderly
181743041,18174304,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, QD (1?0?0?0)",,,U,,,,,1.5,MG,,QD,2020,Q3,Dysuria,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,NVSC2020DE225329,NOVARTIS,,70.0,YR,,M,Y,101.0,KG,20200820.0,,HP,DE,DE,2020,Q3,Elderly
181743041,18174304,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, QD (1?0?0?0)",,,U,,,,,1.5,MG,,QD,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,NVSC2020DE225329,NOVARTIS,,70.0,YR,,M,Y,101.0,KG,20200820.0,,HP,DE,DE,2020,Q3,Elderly
181743041,18174304,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, QD (1?0?0?0)",,,U,,,,,1.5,MG,,QD,2020,Q3,Nocturia,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,NVSC2020DE225329,NOVARTIS,,70.0,YR,,M,Y,101.0,KG,20200820.0,,HP,DE,DE,2020,Q3,Elderly
181743041,18174304,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, QD (1?0?0?0)",,,U,,,,,1.5,MG,,QD,2020,Q3,Polyuria,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,NVSC2020DE225329,NOVARTIS,,70.0,YR,,M,Y,101.0,KG,20200820.0,,HP,DE,DE,2020,Q3,Elderly
181743041,18174304,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, QD (1?0?0?0)",,,U,,,,,1.5,MG,,QD,2020,Q3,Product monitoring error,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,NVSC2020DE225329,NOVARTIS,,70.0,YR,,M,Y,101.0,KG,20200820.0,,HP,DE,DE,2020,Q3,Elderly
181743041,18174304,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, QD (1?0?0?0)",,,U,,,,,1.5,MG,,QD,2020,Q3,Product prescribing error,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,NVSC2020DE225329,NOVARTIS,,70.0,YR,,M,Y,101.0,KG,20200820.0,,HP,DE,DE,2020,Q3,Elderly
181743041,18174304,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, QD (1?0?0?0)",,,U,,,,,1.5,MG,,QD,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,NVSC2020DE225329,NOVARTIS,,70.0,YR,,M,Y,101.0,KG,20200820.0,,HP,DE,DE,2020,Q3,Elderly
181762631,18176263,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY",,,U,, UNKNOWN,,,1.5,MG,,/wk,2020,Q3,Chest pain,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181762631,18176263,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY",,,U,, UNKNOWN,,,1.5,MG,,/wk,2020,Q3,Dyspepsia,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181762631,18176263,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY",,,U,, UNKNOWN,,,1.5,MG,,/wk,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181762631,18176263,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY",,,U,, UNKNOWN,,,1.5,MG,,/wk,2020,Q3,Haematuria,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181762631,18176263,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY",,,U,, UNKNOWN,,,1.5,MG,,/wk,2020,Q3,Inflammation,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181762631,18176263,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY",,,U,, UNKNOWN,,,1.5,MG,,/wk,2020,Q3,Localised infection,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181762631,18176263,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY",,,U,, UNKNOWN,,,1.5,MG,,/wk,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181762631,18176263,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY",,,U,, UNKNOWN,,,1.5,MG,,/wk,2020,Q3,Pain in extremity,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181766671,18176667,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,USE AS DIRECTED,,,,,,,,,,,,2020,Q3,Abnormal weight gain,,2020,Q3,1,I,20200723.0,20200810.0,20200820,20200820,EXP,GB-MHRA-ADR 24511437,GB-JNJFOC-20200813526,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,150.0,KG,20200820.0,,MD,GB,GB,2020,Q3,Elderly
181766671,18176667,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,USE AS DIRECTED,,,,,,,,,,,,2020,Q3,Cardiac failure,,2020,Q3,1,I,20200723.0,20200810.0,20200820,20200820,EXP,GB-MHRA-ADR 24511437,GB-JNJFOC-20200813526,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,150.0,KG,20200820.0,,MD,GB,GB,2020,Q3,Elderly
181766671,18176667,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,USE AS DIRECTED,,,,,,,,,,,,2020,Q3,Fluid retention,,2020,Q3,1,I,20200723.0,20200810.0,20200820,20200820,EXP,GB-MHRA-ADR 24511437,GB-JNJFOC-20200813526,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,150.0,KG,20200820.0,,MD,GB,GB,2020,Q3,Elderly
181780481,18178048,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,U,,,,1.5,MG,INJECTION,/wk,2020,Q3,Chest pain,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,U,,,,1.5,MG,INJECTION,/wk,2020,Q3,Dyspepsia,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,U,,,,1.5,MG,INJECTION,/wk,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,U,,,,1.5,MG,INJECTION,/wk,2020,Q3,Haematuria,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,U,,,,1.5,MG,INJECTION,/wk,2020,Q3,Inflammation,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,U,,,,1.5,MG,INJECTION,/wk,2020,Q3,Localised infection,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,U,,,,1.5,MG,INJECTION,/wk,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,U,,,,1.5,MG,INJECTION,/wk,2020,Q3,Pain,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181789971,18178997,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK",,,Y,,,,,1.5,MG,,/wk,2020,Q3,Atrioventricular block second degree,,2020,Q3,1,I,,20200810.0,20200821,20200821,EXP,,BE-AUROBINDO-AUR-APL-2020-040476,AUROBINDO,,60.0,YR,,F,Y,,,20200821.0,,HP,BE,BE,2020,Q3,Adult
181789971,18178997,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK",,,Y,,,,,1.5,MG,,/wk,2020,Q3,Cardiac sarcoidosis,,2020,Q3,1,I,,20200810.0,20200821,20200821,EXP,,BE-AUROBINDO-AUR-APL-2020-040476,AUROBINDO,,60.0,YR,,F,Y,,,20200821.0,,HP,BE,BE,2020,Q3,Adult
181789971,18178997,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK",,,Y,,,,,1.5,MG,,/wk,2020,Q3,Electrocardiogram QT prolonged,,2020,Q3,1,I,,20200810.0,20200821,20200821,EXP,,BE-AUROBINDO-AUR-APL-2020-040476,AUROBINDO,,60.0,YR,,F,Y,,,20200821.0,,HP,BE,BE,2020,Q3,Adult
181789971,18178997,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK",,,Y,,,,,1.5,MG,,/wk,2020,Q3,Supraventricular extrasystoles,,2020,Q3,1,I,,20200810.0,20200821,20200821,EXP,,BE-AUROBINDO-AUR-APL-2020-040476,AUROBINDO,,60.0,YR,,F,Y,,,20200821.0,,HP,BE,BE,2020,Q3,Adult
181789971,18178997,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK",,,Y,,,,,1.5,MG,,/wk,2020,Q3,Torsade de pointes,,2020,Q3,1,I,,20200810.0,20200821,20200821,EXP,,BE-AUROBINDO-AUR-APL-2020-040476,AUROBINDO,,60.0,YR,,F,Y,,,20200821.0,,HP,BE,BE,2020,Q3,Adult
181789971,18178997,5,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK",,,Y,,,,,1.5,MG,,/wk,2020,Q3,Ventricular extrasystoles,,2020,Q3,1,I,,20200810.0,20200821,20200821,EXP,,BE-AUROBINDO-AUR-APL-2020-040476,AUROBINDO,,60.0,YR,,F,Y,,,20200821.0,,HP,BE,BE,2020,Q3,Adult
181790222,18179022,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MILLIGRAM DAILY;,,,U,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,/wk,2020,Q3,Chest pain,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181790222,18179022,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MILLIGRAM DAILY;,,,U,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,/wk,2020,Q3,Dyspepsia,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181790222,18179022,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MILLIGRAM DAILY;,,,U,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,/wk,2020,Q3,Dyspnoea exertional,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181790222,18179022,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MILLIGRAM DAILY;,,,U,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,/wk,2020,Q3,Haematuria,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181790222,18179022,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MILLIGRAM DAILY;,,,U,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,/wk,2020,Q3,Inflammation,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181790222,18179022,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MILLIGRAM DAILY;,,,U,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,/wk,2020,Q3,Localised infection,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181790222,18179022,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MILLIGRAM DAILY;,,,U,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,/wk,2020,Q3,Musculoskeletal pain,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181790222,18179022,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MILLIGRAM DAILY;,,,U,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,/wk,2020,Q3,Pain,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,,,,125469.0,1.5,MG,,/wk,2020,Q3,Chest pain,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,,,,125469.0,1.5,MG,,/wk,2020,Q3,Dyspepsia,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,,,,125469.0,1.5,MG,,/wk,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,,,,125469.0,1.5,MG,,/wk,2020,Q3,Haematuria,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,,,,125469.0,1.5,MG,,/wk,2020,Q3,Inflammation,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,,,,125469.0,1.5,MG,,/wk,2020,Q3,Localised infection,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,,,,125469.0,1.5,MG,,/wk,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG / WOCHE, SCHEMA, FERTIGSPRITZEN",,,U,,,,125469.0,1.5,MG,,/wk,2020,Q3,Pain,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG,,,U,,,,,1.5,MG,,,2020,Q3,Chest pain,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG,,,U,,,,,1.5,MG,,,2020,Q3,Dyspepsia,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG,,,U,,,,,1.5,MG,,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG,,,U,,,,,1.5,MG,,,2020,Q3,Haematuria,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG,,,U,,,,,1.5,MG,,,2020,Q3,Inflammation,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG,,,U,,,,,1.5,MG,,,2020,Q3,Localised infection,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG,,,U,,,,,1.5,MG,,,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG,,,U,,,,,1.5,MG,,,2020,Q3,Pain,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181845161,18184516,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2020,Q3,Euglycaemic diabetic ketoacidosis,,2020,Q3,1,I,,20200821.0,20200824,20200824,EXP,GB-MHRA-EYC 00227015,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-043617",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,,,20200822.0,,PH,GB,GB,2020,Q3,Elderly
181927801,18192780,1,PS,Dulaglutide 1.5mg,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",1.5,MG,,, 2019S00247,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,/wk,2020,Q3,Abdominal distension,,2020,Q3,1,I,20200805.0,20200813.0,20200825,20200825,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202008005600,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20200825.0,,HP,CN,CN,2020,Q3,Adult
181927801,18192780,1,PS,Dulaglutide 1.5mg,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",1.5,MG,,, 2019S00247,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,/wk,2020,Q3,Decreased appetite,,2020,Q3,1,I,20200805.0,20200813.0,20200825,20200825,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202008005600,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20200825.0,,HP,CN,CN,2020,Q3,Adult
181927801,18192780,1,PS,Dulaglutide 1.5mg,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",1.5,MG,,, 2019S00247,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,/wk,2020,Q3,Hypophagia,,2020,Q3,1,I,20200805.0,20200813.0,20200825,20200825,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202008005600,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20200825.0,,HP,CN,CN,2020,Q3,Adult
181935991,18193599,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, QW",,,,, UNKNOWN,,,1.5,MG,,/wk,2020,Q3,Asymptomatic bacteriuria,,2020,Q3,1,I,,20200811.0,20200825,20200825,EXP,,BR-NOVOPROD-748690,NOVO NORDISK,,62.0,YR,,F,Y,,,20200825.0,,CN,BR,BR,2020,Q3,Adult
181935991,18193599,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, QW",,,,, UNKNOWN,,,1.5,MG,,/wk,2020,Q3,Fall,,2020,Q3,1,I,,20200811.0,20200825,20200825,EXP,,BR-NOVOPROD-748690,NOVO NORDISK,,62.0,YR,,F,Y,,,20200825.0,,CN,BR,BR,2020,Q3,Adult
181935991,18193599,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, QW",,,,, UNKNOWN,,,1.5,MG,,/wk,2020,Q3,Spinal fracture,,2020,Q3,1,I,,20200811.0,20200825,20200825,EXP,,BR-NOVOPROD-748690,NOVO NORDISK,,62.0,YR,,F,Y,,,20200825.0,,CN,BR,BR,2020,Q3,Adult
181953822,18195382,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, QD (1.5 MG, 1?0?0?0)",,,,,,,,1.5,MG,,QD,2020,Q3,Blood pressure decreased,,2020,Q3,2,F,,20200902.0,20200825,20200910,EXP,,DE-MYLANLABS-2020M1072792,MYLAN,,70.0,YR,,M,Y,101.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
181953822,18195382,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, QD (1.5 MG, 1?0?0?0)",,,,,,,,1.5,MG,,QD,2020,Q3,Constipation,,2020,Q3,2,F,,20200902.0,20200825,20200910,EXP,,DE-MYLANLABS-2020M1072792,MYLAN,,70.0,YR,,M,Y,101.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
181953822,18195382,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, QD (1.5 MG, 1?0?0?0)",,,,,,,,1.5,MG,,QD,2020,Q3,Drug interaction,,2020,Q3,2,F,,20200902.0,20200825,20200910,EXP,,DE-MYLANLABS-2020M1072792,MYLAN,,70.0,YR,,M,Y,101.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
181953822,18195382,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, QD (1.5 MG, 1?0?0?0)",,,,,,,,1.5,MG,,QD,2020,Q3,Dysuria,,2020,Q3,2,F,,20200902.0,20200825,20200910,EXP,,DE-MYLANLABS-2020M1072792,MYLAN,,70.0,YR,,M,Y,101.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
181953822,18195382,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, QD (1.5 MG, 1?0?0?0)",,,,,,,,1.5,MG,,QD,2020,Q3,Nocturia,,2020,Q3,2,F,,20200902.0,20200825,20200910,EXP,,DE-MYLANLABS-2020M1072792,MYLAN,,70.0,YR,,M,Y,101.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
181953822,18195382,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, QD (1.5 MG, 1?0?0?0)",,,,,,,,1.5,MG,,QD,2020,Q3,Polyuria,,2020,Q3,2,F,,20200902.0,20200825,20200910,EXP,,DE-MYLANLABS-2020M1072792,MYLAN,,70.0,YR,,M,Y,101.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
181953822,18195382,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, QD (1.5 MG, 1?0?0?0)",,,,,,,,1.5,MG,,QD,2020,Q3,Product monitoring error,,2020,Q3,2,F,,20200902.0,20200825,20200910,EXP,,DE-MYLANLABS-2020M1072792,MYLAN,,70.0,YR,,M,Y,101.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
181953822,18195382,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, QD (1.5 MG, 1?0?0?0)",,,,,,,,1.5,MG,,QD,2020,Q3,Product prescribing error,,2020,Q3,2,F,,20200902.0,20200825,20200910,EXP,,DE-MYLANLABS-2020M1072792,MYLAN,,70.0,YR,,M,Y,101.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
181953822,18195382,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, QD (1.5 MG, 1?0?0?0)",,,,,,,,1.5,MG,,QD,2020,Q3,Pyrexia,,2020,Q3,2,F,,20200902.0,20200825,20200910,EXP,,DE-MYLANLABS-2020M1072792,MYLAN,,70.0,YR,,M,Y,101.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Arthropod bite,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Device issue,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Drug interaction,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Fatigue,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Feeling abnormal,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Inflammation,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Migraine,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Pruritus,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Psoriasis,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Sinusitis,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Swelling,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Therapeutic product effect incomplete,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Weight decreased,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182003021,18200302,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Wrong technique in product usage process,,2020,Q3,1,I,2019.0,20190612.0,20200827,20200827,EXP,,US-ABBVIE-19K-163-2819139-00,ABBVIE,,55.0,YR,,M,Y,105.33,KG,20200827.0,,CN,US,US,2020,Q3,Adult
182032611,18203261,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Blood pressure decreased,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,DE-SYNTHON BV-IN51PV20_55010,SYNTHON,,70.0,YR,,M,Y,101.0,KG,20200827.0,,PH,DE,DE,2020,Q3,Elderly
182032611,18203261,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Constipation,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,DE-SYNTHON BV-IN51PV20_55010,SYNTHON,,70.0,YR,,M,Y,101.0,KG,20200827.0,,PH,DE,DE,2020,Q3,Elderly
182032611,18203261,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Dysuria,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,DE-SYNTHON BV-IN51PV20_55010,SYNTHON,,70.0,YR,,M,Y,101.0,KG,20200827.0,,PH,DE,DE,2020,Q3,Elderly
182032611,18203261,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,DE-SYNTHON BV-IN51PV20_55010,SYNTHON,,70.0,YR,,M,Y,101.0,KG,20200827.0,,PH,DE,DE,2020,Q3,Elderly
182032611,18203261,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Nocturia,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,DE-SYNTHON BV-IN51PV20_55010,SYNTHON,,70.0,YR,,M,Y,101.0,KG,20200827.0,,PH,DE,DE,2020,Q3,Elderly
182032611,18203261,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Polyuria,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,DE-SYNTHON BV-IN51PV20_55010,SYNTHON,,70.0,YR,,M,Y,101.0,KG,20200827.0,,PH,DE,DE,2020,Q3,Elderly
182032611,18203261,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Product monitoring error,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,DE-SYNTHON BV-IN51PV20_55010,SYNTHON,,70.0,YR,,M,Y,101.0,KG,20200827.0,,PH,DE,DE,2020,Q3,Elderly
182032611,18203261,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Product prescribing error,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,DE-SYNTHON BV-IN51PV20_55010,SYNTHON,,70.0,YR,,M,Y,101.0,KG,20200827.0,,PH,DE,DE,2020,Q3,Elderly
182032611,18203261,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MILLIGRAM, 1?0?0?0",,,,,,,,1.5,MG,,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,DE-SYNTHON BV-IN51PV20_55010,SYNTHON,,70.0,YR,,M,Y,101.0,KG,20200827.0,,PH,DE,DE,2020,Q3,Elderly
182082391,18208239,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,,USE AS DIRECTED,,,,,,,,,,,,2020,Q3,Electrocardiogram QT prolonged,,2020,Q3,1,I,20200807.0,20200820.0,20200828,20200828,EXP,GB-MHRA-ADR 24514121,GB-ACCORD-197633,ACCORD,,62.0,YR,,F,Y,92.0,KG,20200828.0,,HP,GB,GB,2020,Q3,Adult
182083301,18208330,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",1.5,MG,Y,U,,,,1.5,MG,,/wk,2020,Q3,Septic shock,,2020,Q3,1,I,20200625.0,20200820.0,20200828,20200828,EXP,FR-AFSSAPS-AN20200863,FR-MYLANLABS-2020M1073535,MYLAN,,50.0,YR,,F,Y,,,20200828.0,,MD,FR,FR,2020,Q3,Adult
182087811,18208781,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,UNKNOWN,QD,2020,Q3,Blood pressure decreased,,2020,Q3,1,I,,20200821.0,20200828,20200828,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51986,HIKMA,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182087811,18208781,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,UNKNOWN,QD,2020,Q3,Constipation,,2020,Q3,1,I,,20200821.0,20200828,20200828,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51986,HIKMA,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182087811,18208781,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,UNKNOWN,QD,2020,Q3,Dysuria,,2020,Q3,1,I,,20200821.0,20200828,20200828,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51986,HIKMA,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182087811,18208781,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,UNKNOWN,QD,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,1,I,,20200821.0,20200828,20200828,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51986,HIKMA,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182087811,18208781,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,UNKNOWN,QD,2020,Q3,Nocturia,,2020,Q3,1,I,,20200821.0,20200828,20200828,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51986,HIKMA,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182087811,18208781,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,UNKNOWN,QD,2020,Q3,Polyuria,,2020,Q3,1,I,,20200821.0,20200828,20200828,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51986,HIKMA,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182087811,18208781,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,UNKNOWN,QD,2020,Q3,Product monitoring error,,2020,Q3,1,I,,20200821.0,20200828,20200828,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51986,HIKMA,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182087811,18208781,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,UNKNOWN,QD,2020,Q3,Product prescribing error,,2020,Q3,1,I,,20200821.0,20200828,20200828,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51986,HIKMA,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182087811,18208781,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,UNKNOWN,QD,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200821.0,20200828,20200828,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51986,HIKMA,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182098261,18209826,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG UNK,,,U,,,,,,,,,2020,Q3,Blood pressure decreased,,2020,Q3,1,I,,20200824.0,20200828,20200828,EXP,,DE-ANIPHARMA-2020-DE-000187,ANI,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182098261,18209826,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG UNK,,,U,,,,,,,,,2020,Q3,Constipation,,2020,Q3,1,I,,20200824.0,20200828,20200828,EXP,,DE-ANIPHARMA-2020-DE-000187,ANI,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182098261,18209826,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG UNK,,,U,,,,,,,,,2020,Q3,Dysuria,,2020,Q3,1,I,,20200824.0,20200828,20200828,EXP,,DE-ANIPHARMA-2020-DE-000187,ANI,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182098261,18209826,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG UNK,,,U,,,,,,,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,1,I,,20200824.0,20200828,20200828,EXP,,DE-ANIPHARMA-2020-DE-000187,ANI,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182098261,18209826,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG UNK,,,U,,,,,,,,,2020,Q3,Nocturia,,2020,Q3,1,I,,20200824.0,20200828,20200828,EXP,,DE-ANIPHARMA-2020-DE-000187,ANI,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182098261,18209826,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG UNK,,,U,,,,,,,,,2020,Q3,Polyuria,,2020,Q3,1,I,,20200824.0,20200828,20200828,EXP,,DE-ANIPHARMA-2020-DE-000187,ANI,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182098261,18209826,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG UNK,,,U,,,,,,,,,2020,Q3,Product monitoring error,,2020,Q3,1,I,,20200824.0,20200828,20200828,EXP,,DE-ANIPHARMA-2020-DE-000187,ANI,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182098261,18209826,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG UNK,,,U,,,,,,,,,2020,Q3,Product prescribing error,,2020,Q3,1,I,,20200824.0,20200828,20200828,EXP,,DE-ANIPHARMA-2020-DE-000187,ANI,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182098261,18209826,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG UNK,,,U,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200824.0,20200828,20200828,EXP,,DE-ANIPHARMA-2020-DE-000187,ANI,,70.0,YR,,M,Y,101.0,KG,20200828.0,,PH,DE,DE,2020,Q3,Elderly
182104391,18210439,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG/WEEK, SCHEME, PRE?FILLED SYRINGE",,,U,,,,,1.5,MG,,,2020,Q3,Chest pain,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182104391,18210439,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG/WEEK, SCHEME, PRE?FILLED SYRINGE",,,U,,,,,1.5,MG,,,2020,Q3,Dyspepsia,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182104391,18210439,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG/WEEK, SCHEME, PRE?FILLED SYRINGE",,,U,,,,,1.5,MG,,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182104391,18210439,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG/WEEK, SCHEME, PRE?FILLED SYRINGE",,,U,,,,,1.5,MG,,,2020,Q3,Haematuria,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182104391,18210439,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG/WEEK, SCHEME, PRE?FILLED SYRINGE",,,U,,,,,1.5,MG,,,2020,Q3,Inflammation,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182104391,18210439,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG/WEEK, SCHEME, PRE?FILLED SYRINGE",,,U,,,,,1.5,MG,,,2020,Q3,Localised infection,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182104391,18210439,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG/WEEK, SCHEME, PRE?FILLED SYRINGE",,,U,,,,,1.5,MG,,,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182104391,18210439,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG/WEEK, SCHEME, PRE?FILLED SYRINGE",,,U,,,,,1.5,MG,,,2020,Q3,Pain,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182136691,18213669,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,N,D,,,,0.75,MG,,QW,2020,Q3,Pancreatitis,,2020,Q3,1,I,20200425.0,,20200831,20200831,DIR,,,FDA-CTU,,59.0,YR,,M,N,112.94,KG,20200817.0,N,PH,US,US,2020,Q3,Adult
182136691,18213669,2,SS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Oral,,,,N,D,,,,50.0,MG,,TID,2020,Q3,Pancreatitis,,2020,Q3,1,I,20200425.0,,20200831,20200831,DIR,,,FDA-CTU,,59.0,YR,,M,N,112.94,KG,20200817.0,N,PH,US,US,2020,Q3,Adult
182159021,18215902,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, ONCE A DAY,Q24H",,,U,,,,,1.5,MG,,QD,2020,Q3,Blood pressure decreased,,2020,Q3,1,I,,20200821.0,20200901,20200901,EXP,,DE-AUROBINDO-AUR-APL-2020-045244,AUROBINDO,,70.0,YR,,M,Y,,,20200901.0,,CN,FR,DE,2020,Q3,Elderly
182159021,18215902,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, ONCE A DAY,Q24H",,,U,,,,,1.5,MG,,QD,2020,Q3,Constipation,,2020,Q3,1,I,,20200821.0,20200901,20200901,EXP,,DE-AUROBINDO-AUR-APL-2020-045244,AUROBINDO,,70.0,YR,,M,Y,,,20200901.0,,CN,FR,DE,2020,Q3,Elderly
182159021,18215902,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, ONCE A DAY,Q24H",,,U,,,,,1.5,MG,,QD,2020,Q3,Dysuria,,2020,Q3,1,I,,20200821.0,20200901,20200901,EXP,,DE-AUROBINDO-AUR-APL-2020-045244,AUROBINDO,,70.0,YR,,M,Y,,,20200901.0,,CN,FR,DE,2020,Q3,Elderly
182159021,18215902,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, ONCE A DAY,Q24H",,,U,,,,,1.5,MG,,QD,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,1,I,,20200821.0,20200901,20200901,EXP,,DE-AUROBINDO-AUR-APL-2020-045244,AUROBINDO,,70.0,YR,,M,Y,,,20200901.0,,CN,FR,DE,2020,Q3,Elderly
182159021,18215902,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, ONCE A DAY,Q24H",,,U,,,,,1.5,MG,,QD,2020,Q3,Nocturia,,2020,Q3,1,I,,20200821.0,20200901,20200901,EXP,,DE-AUROBINDO-AUR-APL-2020-045244,AUROBINDO,,70.0,YR,,M,Y,,,20200901.0,,CN,FR,DE,2020,Q3,Elderly
182159021,18215902,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, ONCE A DAY,Q24H",,,U,,,,,1.5,MG,,QD,2020,Q3,Polyuria,,2020,Q3,1,I,,20200821.0,20200901,20200901,EXP,,DE-AUROBINDO-AUR-APL-2020-045244,AUROBINDO,,70.0,YR,,M,Y,,,20200901.0,,CN,FR,DE,2020,Q3,Elderly
182159021,18215902,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, ONCE A DAY,Q24H",,,U,,,,,1.5,MG,,QD,2020,Q3,Product monitoring error,,2020,Q3,1,I,,20200821.0,20200901,20200901,EXP,,DE-AUROBINDO-AUR-APL-2020-045244,AUROBINDO,,70.0,YR,,M,Y,,,20200901.0,,CN,FR,DE,2020,Q3,Elderly
182159021,18215902,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, ONCE A DAY,Q24H",,,U,,,,,1.5,MG,,QD,2020,Q3,Product prescribing error,,2020,Q3,1,I,,20200821.0,20200901,20200901,EXP,,DE-AUROBINDO-AUR-APL-2020-045244,AUROBINDO,,70.0,YR,,M,Y,,,20200901.0,,CN,FR,DE,2020,Q3,Elderly
182159021,18215902,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, ONCE A DAY,Q24H",,,U,,,,,1.5,MG,,QD,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200821.0,20200901,20200901,EXP,,DE-AUROBINDO-AUR-APL-2020-045244,AUROBINDO,,70.0,YR,,M,Y,,,20200901.0,,CN,FR,DE,2020,Q3,Elderly
182185021,18218502,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN, PEN",DULAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,QW,2020,Q3,Vomiting,,2020,Q3,1,I,20191112.0,,20200831,20200831,DIR,,,FDA-CTU,,77.0,YR,,M,N,91.0,KG,20200217.0,N,PH,US,US,2020,Q3,Elderly
182247921,18224792,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML ONCE WEEKLY,,,,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200825.0,20200903,20200903,EXP,,PK-DEXPHARM-20200771,DEXCEL,"INAYAT FAISAL? BOKHARI SYED RIZWAN A? ALMAS TALAL? ROSEN RAQUEL M?DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE.?AMERICAN JOURNAL OF THERAPEUTICS, (2020 AUG 14) .  ELECTRONIC PUBLICATION DATE: 14 AUG 2020 ?JOURNAL CODE: 9441347. E?ISSN: 1536?3686. L?ISSN: 1075?2765.??",42.0,YR,A,M,Y,,,20200903.0,,HP,PK,PK,2020,Q3,Adult
182264011,18226401,4,C,dulaglutide ((MAMMIFERE/HAMSTER/CELLULES CHO)),DULAGLUTIDE,1,Subcutaneous,1.5 MG,,,Y,, UNKNOWN,,,1.5,MG,,,2020,Q3,Septic shock,,2020,Q3,1,I,20200625.0,20200825.0,20200903,20200903,EXP,FR-AFSSAPS-AN20200863,FR-TEVA-2020-FR-1821836,TEVA,,50.0,YR,A,F,Y,,,20200903.0,,MD,FR,FR,2020,Q3,Adult
182324222,18232422,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,2,F,,20200828.0,20200904,20200908,EXP,,PK-UCBSA-2020034734,UCB,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AMERICAN JOURNAL OF THERAPEUTICS. 2020?1?2",42.0,YR,,M,Y,,,20200908.0,,MD,PK,PK,2020,Q3,Adult
182324222,18232422,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,2,F,,20200828.0,20200904,20200908,EXP,,PK-UCBSA-2020034734,UCB,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AMERICAN JOURNAL OF THERAPEUTICS. 2020?1?2",42.0,YR,,M,Y,,,20200908.0,,MD,PK,PK,2020,Q3,Adult
182324222,18232422,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q3,Demyelination,,2020,Q3,2,F,,20200828.0,20200904,20200908,EXP,,PK-UCBSA-2020034734,UCB,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AMERICAN JOURNAL OF THERAPEUTICS. 2020?1?2",42.0,YR,,M,Y,,,20200908.0,,MD,PK,PK,2020,Q3,Adult
182324222,18232422,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,2,F,,20200828.0,20200904,20200908,EXP,,PK-UCBSA-2020034734,UCB,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AMERICAN JOURNAL OF THERAPEUTICS. 2020?1?2",42.0,YR,,M,Y,,,20200908.0,,MD,PK,PK,2020,Q3,Adult
182324222,18232422,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q3,Seizure,,2020,Q3,2,F,,20200828.0,20200904,20200908,EXP,,PK-UCBSA-2020034734,UCB,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AMERICAN JOURNAL OF THERAPEUTICS. 2020?1?2",42.0,YR,,M,Y,,,20200908.0,,MD,PK,PK,2020,Q3,Adult
182324222,18232422,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,,,,,,,,,2020,Q3,Vasculitis,,2020,Q3,2,F,,20200828.0,20200904,20200908,EXP,,PK-UCBSA-2020034734,UCB,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AMERICAN JOURNAL OF THERAPEUTICS. 2020?1?2",42.0,YR,,M,Y,,,20200908.0,,MD,PK,PK,2020,Q3,Adult
182325501,18232550,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q3,Gastrooesophageal reflux disease,,2020,Q3,1,I,20200819.0,,20200904,20200904,DIR,,,FDA-CTU,,68.0,YR,,M,N,,,20200819.0,N,PH,US,US,2020,Q3,Elderly
182361281,18236128,1,PS,Dulaglutide 0.75mg,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,, D191078D,,125469.0,0.75,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2020,Q3,Extra dose administered,,2020,Q3,1,I,20200809.0,20200810.0,20200906,20200906,PER,,US-ELI_LILLY_AND_COMPANY-US202008004378,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200906.0,,CN,US,US,2020,Q3,Elderly
182361281,18236128,2,SS,Dulaglutide 0.75mg,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,,,,125469.0,0.75,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2020,Q3,Extra dose administered,,2020,Q3,1,I,20200809.0,20200810.0,20200906,20200906,PER,,US-ELI_LILLY_AND_COMPANY-US202008004378,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200906.0,,CN,US,US,2020,Q3,Elderly
182418621,18241862,5,C,dulaglutide 1.5 mg,,2,,,,,,,,,,,,,,2020,Q3,Hypoxia,,2020,Q3,1,I,20200820.0,,20200908,20200908,DIR,,,FDA-CTU,,55.0,YR,,M,N,110.8,KG,20200908.0,N,PH,US,US,2020,Q3,Adult
182418621,18241862,5,C,dulaglutide 1.5 mg,,2,,,,,,,,,,,,,,2020,Q3,Pulmonary embolism,,2020,Q3,1,I,20200820.0,,20200908,20200908,DIR,,,FDA-CTU,,55.0,YR,,M,N,110.8,KG,20200908.0,N,PH,US,US,2020,Q3,Adult
182418621,18241862,5,C,dulaglutide 1.5 mg,,2,,,,,,,,,,,,,,2020,Q3,Tachycardia,,2020,Q3,1,I,20200820.0,,20200908,20200908,DIR,,,FDA-CTU,,55.0,YR,,M,N,110.8,KG,20200908.0,N,PH,US,US,2020,Q3,Adult
182465361,18246536,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, QD",,,,,,,,1.5,MG,,QD,2020,Q3,Blood pressure decreased,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,DE-BAYER-2020-182641,BAYER,,70.0,YR,E,M,Y,101.0,KG,20200909.0,,HP,NL,DE,2020,Q3,Elderly
182465361,18246536,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, QD",,,,,,,,1.5,MG,,QD,2020,Q3,Constipation,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,DE-BAYER-2020-182641,BAYER,,70.0,YR,E,M,Y,101.0,KG,20200909.0,,HP,NL,DE,2020,Q3,Elderly
182465361,18246536,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, QD",,,,,,,,1.5,MG,,QD,2020,Q3,Dysuria,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,DE-BAYER-2020-182641,BAYER,,70.0,YR,E,M,Y,101.0,KG,20200909.0,,HP,NL,DE,2020,Q3,Elderly
182465361,18246536,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, QD",,,,,,,,1.5,MG,,QD,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,DE-BAYER-2020-182641,BAYER,,70.0,YR,E,M,Y,101.0,KG,20200909.0,,HP,NL,DE,2020,Q3,Elderly
182465361,18246536,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, QD",,,,,,,,1.5,MG,,QD,2020,Q3,Nocturia,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,DE-BAYER-2020-182641,BAYER,,70.0,YR,E,M,Y,101.0,KG,20200909.0,,HP,NL,DE,2020,Q3,Elderly
182465361,18246536,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, QD",,,,,,,,1.5,MG,,QD,2020,Q3,Polyuria,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,DE-BAYER-2020-182641,BAYER,,70.0,YR,E,M,Y,101.0,KG,20200909.0,,HP,NL,DE,2020,Q3,Elderly
182465361,18246536,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, QD",,,,,,,,1.5,MG,,QD,2020,Q3,Product monitoring error,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,DE-BAYER-2020-182641,BAYER,,70.0,YR,E,M,Y,101.0,KG,20200909.0,,HP,NL,DE,2020,Q3,Elderly
182465361,18246536,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, QD",,,,,,,,1.5,MG,,QD,2020,Q3,Product prescribing error,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,DE-BAYER-2020-182641,BAYER,,70.0,YR,E,M,Y,101.0,KG,20200909.0,,HP,NL,DE,2020,Q3,Elderly
182465361,18246536,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, QD",,,,,,,,1.5,MG,,QD,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,DE-BAYER-2020-182641,BAYER,,70.0,YR,E,M,Y,101.0,KG,20200909.0,,HP,NL,DE,2020,Q3,Elderly
182476691,18247669,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML ONCE WEEKLY,,,,,,,,,,,,2020,Q3,Condition aggravated,Condition aggravated,2020,Q3,1,I,,20200825.0,20200909,20200909,EXP,,PK-ALVOGEN-2020-ALVOGEN-114199,ALVOGEN,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020.",42.0,YR,,M,Y,,,20200909.0,,HP,PK,PK,2020,Q3,Adult
182476691,18247669,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML ONCE WEEKLY,,,,,,,,,,,,2020,Q3,Confusional state,Confusional state,2020,Q3,1,I,,20200825.0,20200909,20200909,EXP,,PK-ALVOGEN-2020-ALVOGEN-114199,ALVOGEN,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020.",42.0,YR,,M,Y,,,20200909.0,,HP,PK,PK,2020,Q3,Adult
182476691,18247669,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML ONCE WEEKLY,,,,,,,,,,,,2020,Q3,Drug interaction,Drug interaction,2020,Q3,1,I,,20200825.0,20200909,20200909,EXP,,PK-ALVOGEN-2020-ALVOGEN-114199,ALVOGEN,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020.",42.0,YR,,M,Y,,,20200909.0,,HP,PK,PK,2020,Q3,Adult
182476691,18247669,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML ONCE WEEKLY,,,,,,,,,,,,2020,Q3,Seizure cluster,Seizure cluster,2020,Q3,1,I,,20200825.0,20200909,20200909,EXP,,PK-ALVOGEN-2020-ALVOGEN-114199,ALVOGEN,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020.",42.0,YR,,M,Y,,,20200909.0,,HP,PK,PK,2020,Q3,Adult
182588581,18258858,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200907.0,20200911,20200911,EXP,,"PK-BRECKENRIDGE PHARMACEUTICAL, INC.-2089675",BRECKENRIDGE,"^DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE^ BY FAISAL INAYAT, MBBS @ DEPARTMENT OF MEDICINE, ALLAMA IQBAL MEDICAL COLLEGE, LAHORE, PAKISTAN? SYED RIZWAN A. BOKHARI, MD AND  RAQUEL M. ROSEN, MD @ DIVISION OF NEPHROLOGY, BASSETT MEDICAL CENTER, COOPERSTOWN, NY? TALAL ALMAS, BS @ 3DEPARTMENT OF MEDICINE, ROYAL COLLEGE OF SURGEONS, DUBLIN, IRELAND",42.0,YR,,M,Y,,,20200911.0,,HP,US,PK,2020,Q3,Adult
182669681,18266968,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5MG/0.5ML,,,,,,,,1.0,DF,,,2020,Q3,Disease recurrence,,2020,Q3,1,I,,20200904.0,20200915,20200915,EXP,,PK-ACCORD-200874,ACCORD,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020. DOI: 10.1097/MJT.0000000000001241.",42.0,YR,,M,Y,,,20200915.0,,MD,PK,PK,2020,Q3,Adult
182669681,18266968,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5MG/0.5ML,,,,,,,,1.0,DF,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200904.0,20200915,20200915,EXP,,PK-ACCORD-200874,ACCORD,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020. DOI: 10.1097/MJT.0000000000001241.",42.0,YR,,M,Y,,,20200915.0,,MD,PK,PK,2020,Q3,Adult
182669681,18266968,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5MG/0.5ML,,,,,,,,1.0,DF,,,2020,Q3,Seizure,,2020,Q3,1,I,,20200904.0,20200915,20200915,EXP,,PK-ACCORD-200874,ACCORD,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020. DOI: 10.1097/MJT.0000000000001241.",42.0,YR,,M,Y,,,20200915.0,,MD,PK,PK,2020,Q3,Adult
182702691,18270269,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Gout,,2020,Q3,1,I,,20200907.0,20200916,20200916,EXP,,US-AUROBINDO-AUR-APL-2020-047265,AUROBINDO,,73.0,YR,,F,Y,,,20200916.0,,HP,US,US,2020,Q3,Elderly
182709501,18270950,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG/0.5 ML, ONCE WEEKLY",,,D,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200908.0,20200915,20200915,EXP,,"PK-ARBOR PHARMACEUTICALS, LLC-US-2020ARB000746",ARBOR,"INAYAT F, BOKHARI SRA., ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020?1?2",42.0,YR,,M,Y,,,20200915.0,,MD,PK,US,2020,Q3,Adult
182709501,18270950,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG/0.5 ML, ONCE WEEKLY",,,D,,,,,,,,,2020,Q3,Seizure,,2020,Q3,1,I,,20200908.0,20200915,20200915,EXP,,"PK-ARBOR PHARMACEUTICALS, LLC-US-2020ARB000746",ARBOR,"INAYAT F, BOKHARI SRA., ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020?1?2",42.0,YR,,M,Y,,,20200915.0,,MD,PK,US,2020,Q3,Adult
182781581,18278158,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20160518.0,20200909.0,20200917,20200917,EXP,,US-ASTRAZENECA-2020SF16742,ASTRAZENECA,,19484.0,DY,,F,Y,,,20200917.0,,,US,US,2020,Q3,Elderly
182781581,18278158,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Chronic kidney disease,,2020,Q3,1,I,20160518.0,20200909.0,20200917,20200917,EXP,,US-ASTRAZENECA-2020SF16742,ASTRAZENECA,,19484.0,DY,,F,Y,,,20200917.0,,,US,US,2020,Q3,Elderly
182781581,18278158,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,End stage renal disease,,2020,Q3,1,I,20160518.0,20200909.0,20200917,20200917,EXP,,US-ASTRAZENECA-2020SF16742,ASTRAZENECA,,19484.0,DY,,F,Y,,,20200917.0,,,US,US,2020,Q3,Elderly
182781581,18278158,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Hyperkalaemia,,2020,Q3,1,I,20160518.0,20200909.0,20200917,20200917,EXP,,US-ASTRAZENECA-2020SF16742,ASTRAZENECA,,19484.0,DY,,F,Y,,,20200917.0,,,US,US,2020,Q3,Elderly
182781581,18278158,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Hyperparathyroidism secondary,,2020,Q3,1,I,20160518.0,20200909.0,20200917,20200917,EXP,,US-ASTRAZENECA-2020SF16742,ASTRAZENECA,,19484.0,DY,,F,Y,,,20200917.0,,,US,US,2020,Q3,Elderly
182781581,18278158,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Nephrogenic anaemia,,2020,Q3,1,I,20160518.0,20200909.0,20200917,20200917,EXP,,US-ASTRAZENECA-2020SF16742,ASTRAZENECA,,19484.0,DY,,F,Y,,,20200917.0,,,US,US,2020,Q3,Elderly
182848701,18284870,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, 1X/WEEK",,,,,,,,1.5,MG,INJECTION,/wk,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,PK-PRINSTON PHARMACEUTICAL INC.-2020PRN00310,PRINSTON PHARMACEUTICAL,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200918.0,,HP,PK,PK,2020,Q3,Adult
182848701,18284870,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, 1X/WEEK",,,,,,,,1.5,MG,INJECTION,/wk,2020,Q3,Seizure,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,PK-PRINSTON PHARMACEUTICAL INC.-2020PRN00310,PRINSTON PHARMACEUTICAL,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200918.0,,HP,PK,PK,2020,Q3,Adult
182900191,18290019,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2020,Q3,Colitis,,2020,Q3,1,I,,20200911.0,20200921,20200921,EXP,,CA-MYLANLABS-2020M1079597,MYLAN,,73.0,YR,,F,Y,,,20200921.0,,CN,CA,CA,2020,Q3,Elderly
182900191,18290019,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2020,Q3,Colitis ulcerative,,2020,Q3,1,I,,20200911.0,20200921,20200921,EXP,,CA-MYLANLABS-2020M1079597,MYLAN,,73.0,YR,,F,Y,,,20200921.0,,CN,CA,CA,2020,Q3,Elderly
182900191,18290019,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2020,Q3,Decreased activity,,2020,Q3,1,I,,20200911.0,20200921,20200921,EXP,,CA-MYLANLABS-2020M1079597,MYLAN,,73.0,YR,,F,Y,,,20200921.0,,CN,CA,CA,2020,Q3,Elderly
182900191,18290019,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2020,Q3,Frequent bowel movements,,2020,Q3,1,I,,20200911.0,20200921,20200921,EXP,,CA-MYLANLABS-2020M1079597,MYLAN,,73.0,YR,,F,Y,,,20200921.0,,CN,CA,CA,2020,Q3,Elderly
182900191,18290019,15,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2020,Q3,Rectal haemorrhage,,2020,Q3,1,I,,20200911.0,20200921,20200921,EXP,,CA-MYLANLABS-2020M1079597,MYLAN,,73.0,YR,,F,Y,,,20200921.0,,CN,CA,CA,2020,Q3,Elderly
182919571,18291957,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,U,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200916.0,20200922,20200922,EXP,,PK-ORCHID HEALTHCARE-2091005,ORCHID,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020 AUG 14.",42.0,YR,,M,Y,,,20200922.0,,MD,PK,PK,2020,Q3,Adult
182919571,18291957,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,U,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200916.0,20200922,20200922,EXP,,PK-ORCHID HEALTHCARE-2091005,ORCHID,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020 AUG 14.",42.0,YR,,M,Y,,,20200922.0,,MD,PK,PK,2020,Q3,Adult
182919571,18291957,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,U,,,,,,,,2020,Q3,Seizure,,2020,Q3,1,I,,20200916.0,20200922,20200922,EXP,,PK-ORCHID HEALTHCARE-2091005,ORCHID,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020 AUG 14.",42.0,YR,,M,Y,,,20200922.0,,MD,PK,PK,2020,Q3,Adult
182945501,18294550,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, 1X/WEEK",,,,,,,,1.5,MG,INJECTION,/wk,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200909.0,20200922,20200922,EXP,,PK-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00286,JUBILANT,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200922.0,,HP,PK,PK,2020,Q3,Adult
182945501,18294550,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, 1X/WEEK",,,,,,,,1.5,MG,INJECTION,/wk,2020,Q3,Seizure,,2020,Q3,1,I,,20200909.0,20200922,20200922,EXP,,PK-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00286,JUBILANT,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200922.0,,HP,PK,PK,2020,Q3,Adult
182967911,18296791,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, 1X/WEEK",,,,,,,,1.5,MG,INJECTION,/wk,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200909.0,20200922,20200922,EXP,,"PK-OXFORD PHARMACEUTICALS, LLC-2020OXF00110",OXFORD PHARMACEUTICALS,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200922.0,,HP,PK,PK,2020,Q3,Adult
182967911,18296791,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, 1X/WEEK",,,,,,,,1.5,MG,INJECTION,/wk,2020,Q3,Seizure,,2020,Q3,1,I,,20200909.0,20200922,20200922,EXP,,"PK-OXFORD PHARMACEUTICALS, LLC-2020OXF00110",OXFORD PHARMACEUTICALS,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200922.0,,HP,PK,PK,2020,Q3,Adult
182968791,18296879,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, 1X/WEEK",,,,,,,,1.5,MG,,/wk,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200909.0,20200922,20200922,EXP,,"PK-VIRTUS PHARMACEUTICALS, LLC-2020VTS00067",VIRTUS PHARMACEUTICALS,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200922.0,,HP,PK,PK,2020,Q3,Adult
182968791,18296879,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, 1X/WEEK",,,,,,,,1.5,MG,,/wk,2020,Q3,Seizure,,2020,Q3,1,I,,20200909.0,20200922,20200922,EXP,,"PK-VIRTUS PHARMACEUTICALS, LLC-2020VTS00067",VIRTUS PHARMACEUTICALS,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200922.0,,HP,PK,PK,2020,Q3,Adult
183006641,18300664,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,,,,,,0.75,MG,,QW,2020,Q3,Tachycardia,,2020,Q3,1,I,,,20200923,20200923,DIR,,,FDA-CTU,,80.0,YR,,M,N,107.05,KG,20200922.0,N,PH,US,US,2020,Q3,Elderly
183066421,18306642,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML ONCE WEEKLY,,,,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200910.0,20200924,20200924,EXP,,PK-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-262011,RANBAXY,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020?1?2",42.0,YR,,M,Y,,,20200924.0,,HP,PK,PK,2020,Q3,Adult
183066421,18306642,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML ONCE WEEKLY,,,,,,,,,,,,2020,Q3,Seizure,,2020,Q3,1,I,,20200910.0,20200924,20200924,EXP,,PK-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-262011,RANBAXY,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020?1?2",42.0,YR,,M,Y,,,20200924.0,,HP,PK,PK,2020,Q3,Adult
183119991,18311999,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.5,MG,,QW,2020,Q3,Pancreatitis acute,,2020,Q3,1,I,20200614.0,,20200924,20200924,DIR,,,FDA-CTU,,66.0,YR,,M,N,117.03,KG,20200819.0,N,PH,US,US,2020,Q3,Elderly
183145981,18314598,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2020,Q3,Product use in unapproved indication,,2020,Q3,1,I,20191008.0,20191011.0,20200926,20200926,PER,,US-ALVOGEN-2020-ALVOGEN-113354,ALVOGEN,,68.0,YR,,M,Y,,,20200926.0,,MD,US,US,2020,Q3,Elderly
183145981,18314598,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2020,Q3,Rash,,2020,Q3,1,I,20191008.0,20191011.0,20200926,20200926,PER,,US-ALVOGEN-2020-ALVOGEN-113354,ALVOGEN,,68.0,YR,,M,Y,,,20200926.0,,MD,US,US,2020,Q3,Elderly
183208411,18320841,13,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML ONCE WEEKLY,,,,,,,,,,,/wk,2020,Q3,Confusional state,,2020,Q3,1,I,,20200915.0,20200929,20200929,EXP,,PK-MICRO LABS LIMITED-ML2020-02829,MICRO LABS,"INAYAT F, BOKHARI S, ALMAS T, ROSEN R. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE.. AM?J?THER. 2020?1?2.",42.0,YR,,M,Y,,,20200929.0,,MD,PK,PK,2020,Q3,Adult
183208411,18320841,13,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML ONCE WEEKLY,,,,,,,,,,,/wk,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200915.0,20200929,20200929,EXP,,PK-MICRO LABS LIMITED-ML2020-02829,MICRO LABS,"INAYAT F, BOKHARI S, ALMAS T, ROSEN R. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE.. AM?J?THER. 2020?1?2.",42.0,YR,,M,Y,,,20200929.0,,MD,PK,PK,2020,Q3,Adult
183208411,18320841,13,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML ONCE WEEKLY,,,,,,,,,,,/wk,2020,Q3,Seizure,,2020,Q3,1,I,,20200915.0,20200929,20200929,EXP,,PK-MICRO LABS LIMITED-ML2020-02829,MICRO LABS,"INAYAT F, BOKHARI S, ALMAS T, ROSEN R. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE.. AM?J?THER. 2020?1?2.",42.0,YR,,M,Y,,,20200929.0,,MD,PK,PK,2020,Q3,Adult
183286991,18328699,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,20200909.0,20200925.0,20200930,20200930,EXP,GB-MHRA-ADR 24521045,GB-ACCORD-203175,ACCORD,,49.0,YR,,M,Y,88.0,KG,20200930.0,,CN,GB,GB,2020,Q3,Adult
183286991,18328699,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Retching,,2020,Q3,1,I,20200909.0,20200925.0,20200930,20200930,EXP,GB-MHRA-ADR 24521045,GB-ACCORD-203175,ACCORD,,49.0,YR,,M,Y,88.0,KG,20200930.0,,CN,GB,GB,2020,Q3,Adult
183286991,18328699,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Sensation of foreign body,,2020,Q3,1,I,20200909.0,20200925.0,20200930,20200930,EXP,GB-MHRA-ADR 24521045,GB-ACCORD-203175,ACCORD,,49.0,YR,,M,Y,88.0,KG,20200930.0,,CN,GB,GB,2020,Q3,Adult
183286991,18328699,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q3,Throat irritation,,2020,Q3,1,I,20200909.0,20200925.0,20200930,20200930,EXP,GB-MHRA-ADR 24521045,GB-ACCORD-203175,ACCORD,,49.0,YR,,M,Y,88.0,KG,20200930.0,,CN,GB,GB,2020,Q3,Adult
163030392,16303039,21,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,20130309.0,20201019.0,20190513,20201027,EXP,,US-ASTRAZENECA-2019SE62929,ASTRAZENECA,,20521.0,DY,,M,Y,97.5,KG,20201027.0,,,US,US,2020,Q4,Elderly
163030392,16303039,21,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Gastrooesophageal reflux disease,,2020,Q4,2,F,20130309.0,20201019.0,20190513,20201027,EXP,,US-ASTRAZENECA-2019SE62929,ASTRAZENECA,,20521.0,DY,,M,Y,97.5,KG,20201027.0,,,US,US,2020,Q4,Elderly
163030392,16303039,21,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,2,F,20130309.0,20201019.0,20190513,20201027,EXP,,US-ASTRAZENECA-2019SE62929,ASTRAZENECA,,20521.0,DY,,M,Y,97.5,KG,20201027.0,,,US,US,2020,Q4,Elderly
163065072,16306507,70,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20140202.0,20201216.0,20190513,20201224,EXP,,US-ASTRAZENECA-2019SE63918,ASTRAZENECA,,19788.0,DY,,F,Y,129.3,KG,20201224.0,,,US,US,2020,Q4,Elderly
163065072,16306507,70,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,20140202.0,20201216.0,20190513,20201224,EXP,,US-ASTRAZENECA-2019SE63918,ASTRAZENECA,,19788.0,DY,,F,Y,129.3,KG,20201224.0,,,US,US,2020,Q4,Elderly
163065072,16306507,70,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,2,F,20140202.0,20201216.0,20190513,20201224,EXP,,US-ASTRAZENECA-2019SE63918,ASTRAZENECA,,19788.0,DY,,F,Y,129.3,KG,20201224.0,,,US,US,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Back pain,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Blood pressure fluctuation,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Blood pressure increased,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Cataract,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Condition aggravated,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Cough,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Dehydration,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Diarrhoea,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Dyspnoea,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Feeding disorder,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Gastroenteritis viral,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Heart rate decreased,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Heart rate irregular,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Intentional product use issue,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Lung disorder,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Malaise,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Nausea,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Off label use,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Oxygen saturation increased,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Pain in extremity,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Pneumonia,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Product use issue,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
164922184,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2020,Q4,Vomiting,,2020,Q4,4,F,,20201112.0,20190628,20201123,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,E,F,Y,86.0,KG,20201123.0,,MD,CA,CA,2020,Q4,Elderly
170382586,17038258,34,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Abscess limb,,2020,Q4,6,F,20180112.0,20201116.0,20191115,20201124,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20201124.0,,,US,US,2020,Q4,Elderly
170382586,17038258,34,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,6,F,20180112.0,20201116.0,20191115,20201124,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20201124.0,,,US,US,2020,Q4,Elderly
170382586,17038258,34,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Cholecystitis acute,,2020,Q4,6,F,20180112.0,20201116.0,20191115,20201124,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20201124.0,,,US,US,2020,Q4,Elderly
170382586,17038258,34,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Cholecystitis infective,,2020,Q4,6,F,20180112.0,20201116.0,20191115,20201124,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20201124.0,,,US,US,2020,Q4,Elderly
170382586,17038258,34,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,6,F,20180112.0,20201116.0,20191115,20201124,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20201124.0,,,US,US,2020,Q4,Elderly
170382586,17038258,34,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Clostridial sepsis,,2020,Q4,6,F,20180112.0,20201116.0,20191115,20201124,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20201124.0,,,US,US,2020,Q4,Elderly
170382586,17038258,34,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Fournier's gangrene,,2020,Q4,6,F,20180112.0,20201116.0,20191115,20201124,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20201124.0,,,US,US,2020,Q4,Elderly
170382586,17038258,34,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Necrotising soft tissue infection,,2020,Q4,6,F,20180112.0,20201116.0,20191115,20201124,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20201124.0,,,US,US,2020,Q4,Elderly
170382586,17038258,34,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Perineal abscess,,2020,Q4,6,F,20180112.0,20201116.0,20191115,20201124,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20201124.0,,,US,US,2020,Q4,Elderly
170382586,17038258,34,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Perirectal abscess,,2020,Q4,6,F,20180112.0,20201116.0,20191115,20201124,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20201124.0,,,US,US,2020,Q4,Elderly
170382586,17038258,34,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,6,F,20180112.0,20201116.0,20191115,20201124,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20201124.0,,,US,US,2020,Q4,Elderly
170382586,17038258,34,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Renal tubular necrosis,,2020,Q4,6,F,20180112.0,20201116.0,20191115,20201124,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20201124.0,,,US,US,2020,Q4,Elderly
170382586,17038258,34,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Urinary tract infection,,2020,Q4,6,F,20180112.0,20201116.0,20191115,20201124,EXP,,US-ASTRAZENECA-2019SF60246,ASTRAZENECA,,21911.0,DY,,F,Y,141.7,KG,20201124.0,,,US,US,2020,Q4,Elderly
172018882,17201888,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2020,Q4,Colitis,,2020,Q4,2,F,,20201216.0,20191226,20201230,EXP,,CA-MYLANLABS-2019M1126389,MYLAN,,73.0,YR,,F,Y,,,20201230.0,,CN,CA,CA,2020,Q4,Elderly
172018882,17201888,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2020,Q4,Colitis ulcerative,,2020,Q4,2,F,,20201216.0,20191226,20201230,EXP,,CA-MYLANLABS-2019M1126389,MYLAN,,73.0,YR,,F,Y,,,20201230.0,,CN,CA,CA,2020,Q4,Elderly
172018882,17201888,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2020,Q4,Decreased activity,,2020,Q4,2,F,,20201216.0,20191226,20201230,EXP,,CA-MYLANLABS-2019M1126389,MYLAN,,73.0,YR,,F,Y,,,20201230.0,,CN,CA,CA,2020,Q4,Elderly
172018882,17201888,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2020,Q4,Frequent bowel movements,,2020,Q4,2,F,,20201216.0,20191226,20201230,EXP,,CA-MYLANLABS-2019M1126389,MYLAN,,73.0,YR,,F,Y,,,20201230.0,,CN,CA,CA,2020,Q4,Elderly
172018882,17201888,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2020,Q4,Rectal haemorrhage,,2020,Q4,2,F,,20201216.0,20191226,20201230,EXP,,CA-MYLANLABS-2019M1126389,MYLAN,,73.0,YR,,F,Y,,,20201230.0,,CN,CA,CA,2020,Q4,Elderly
175116283,17511628,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,3,F,20200820.0,20201013.0,20200307,20201015,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-013243",BOEHRINGER INGELHEIM,,23.0,YR,A,M,Y,100.0,KG,20201015.0,,MD,DE,DE,2020,Q4,Youth
175116283,17511628,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Ketoacidosis,,2020,Q4,3,F,20200820.0,20201013.0,20200307,20201015,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-013243",BOEHRINGER INGELHEIM,,23.0,YR,A,M,Y,100.0,KG,20201015.0,,MD,DE,DE,2020,Q4,Youth
180899874,18089987,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK (0.75/1.5 MG, QW)",,,U,,,,,1.5,MG,,/wk,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK (0.75/1.5 MG, QW)",,,U,,,,,1.5,MG,,/wk,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK (0.75/1.5 MG, QW)",,,U,,,,,1.5,MG,,/wk,2020,Q4,Hypoglycaemia,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK (0.75/1.5 MG, QW)",,,U,,,,,1.5,MG,,/wk,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK (0.75/1.5 MG, QW)",,,U,,,,,1.5,MG,,/wk,2020,Q4,Weight increased,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
181333602,18133360,7,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, WEEKLY",,,,,,,,1.5,MG,,,2020,Q4,Electrocardiogram QT prolonged,,2020,Q4,2,F,,20201104.0,20200811,20201118,EXP,,BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-257089,RANBAXY,,60.0,YR,,F,Y,,,20201119.0,,HP,BE,BE,2020,Q4,Adult
181462223,18146222,25,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, QW (0.75/1.5 MG, QW)",,,U,U,,,,1.5,MG,,/wk,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,25,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, QW (0.75/1.5 MG, QW)",,,U,U,,,,1.5,MG,,/wk,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,25,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, QW (0.75/1.5 MG, QW)",,,U,U,,,,1.5,MG,,/wk,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,25,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, QW (0.75/1.5 MG, QW)",,,U,U,,,,1.5,MG,,/wk,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,25,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, QW (0.75/1.5 MG, QW)",,,U,U,,,,1.5,MG,,/wk,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,25,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, QW (0.75/1.5 MG, QW)",,,U,U,,,,1.5,MG,,/wk,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181920825,18192082,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,INJECTION,/wk,2020,Q4,Anal fistula,,2020,Q4,5,F,20200812.0,20201106.0,20200825,20201113,EXP,,AU-CELGENEUS-AUS-20200804512,CELGENE,,66.0,YR,,M,Y,150.0,KG,20201113.0,,HP,AU,AU,2020,Q4,Elderly
181920825,18192082,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,INJECTION,/wk,2020,Q4,Febrile neutropenia,,2020,Q4,5,F,20200812.0,20201106.0,20200825,20201113,EXP,,AU-CELGENEUS-AUS-20200804512,CELGENE,,66.0,YR,,M,Y,150.0,KG,20201113.0,,HP,AU,AU,2020,Q4,Elderly
181920825,18192082,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,INJECTION,/wk,2020,Q4,Lung abscess,,2020,Q4,5,F,20200812.0,20201106.0,20200825,20201113,EXP,,AU-CELGENEUS-AUS-20200804512,CELGENE,,66.0,YR,,M,Y,150.0,KG,20201113.0,,HP,AU,AU,2020,Q4,Elderly
182710472,18271047,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1 DOSAGE FORM, ONCE WEEKLY",,,,,,,,1.0,DF,,,2020,Q4,Disease recurrence,,2020,Q4,2,F,,20200930.0,20200916,20201013,EXP,,PK-LUPIN PHARMACEUTICALS INC.-2020-05900,LUPIN,,42.0,YR,,M,Y,,,20201013.0,,MD,US,PK,2020,Q4,Adult
182710472,18271047,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1 DOSAGE FORM, ONCE WEEKLY",,,,,,,,1.0,DF,,,2020,Q4,Drug interaction,,2020,Q4,2,F,,20200930.0,20200916,20201013,EXP,,PK-LUPIN PHARMACEUTICALS INC.-2020-05900,LUPIN,,42.0,YR,,M,Y,,,20201013.0,,MD,US,PK,2020,Q4,Adult
182710472,18271047,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1 DOSAGE FORM, ONCE WEEKLY",,,,,,,,1.0,DF,,,2020,Q4,Seizure,,2020,Q4,2,F,,20200930.0,20200916,20201013,EXP,,PK-LUPIN PHARMACEUTICALS INC.-2020-05900,LUPIN,,42.0,YR,,M,Y,,,20201013.0,,MD,US,PK,2020,Q4,Adult
183317702,18331770,22,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,7.5,MG,,/wk,2020,Q4,Colitis,,2020,Q4,2,F,,20200930.0,20200930,20201009,EXP,,CA-JNJFOC-20200941497,JOHNSON AND JOHNSON,,73.0,YR,E,F,Y,,,20201009.0,,CN,CA,CA,2020,Q4,Elderly
183317702,18331770,22,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,7.5,MG,,/wk,2020,Q4,Colitis ulcerative,,2020,Q4,2,F,,20200930.0,20200930,20201009,EXP,,CA-JNJFOC-20200941497,JOHNSON AND JOHNSON,,73.0,YR,E,F,Y,,,20201009.0,,CN,CA,CA,2020,Q4,Elderly
183317702,18331770,22,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,7.5,MG,,/wk,2020,Q4,Decreased activity,,2020,Q4,2,F,,20200930.0,20200930,20201009,EXP,,CA-JNJFOC-20200941497,JOHNSON AND JOHNSON,,73.0,YR,E,F,Y,,,20201009.0,,CN,CA,CA,2020,Q4,Elderly
183317702,18331770,22,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,7.5,MG,,/wk,2020,Q4,Frequent bowel movements,,2020,Q4,2,F,,20200930.0,20200930,20201009,EXP,,CA-JNJFOC-20200941497,JOHNSON AND JOHNSON,,73.0,YR,E,F,Y,,,20201009.0,,CN,CA,CA,2020,Q4,Elderly
183317702,18331770,22,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,7.5,MG,,/wk,2020,Q4,Rectal haemorrhage,,2020,Q4,2,F,,20200930.0,20200930,20201009,EXP,,CA-JNJFOC-20200941497,JOHNSON AND JOHNSON,,73.0,YR,E,F,Y,,,20201009.0,,CN,CA,CA,2020,Q4,Elderly
183361781,18336178,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,DAILY DOSE: 1.5 MG MILLGRAM(S) EVERY WEEKS,,,U,,,,,1.5,MG,,/wk,2020,Q4,Euglycaemic diabetic ketoacidosis,,2020,Q4,1,I,20200807.0,20200929.0,20201001,20201001,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-051615",BOEHRINGER INGELHEIM,,65.0,YR,E,F,Y,80.0,KG,20201001.0,,MD,DE,DE,2020,Q4,Elderly
183505501,18350550,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML ONCE WEEKLY,,,,,,,,,,,,2020,Q4,Drug interaction,,2020,Q4,1,I,,20200929.0,20201006,20201006,EXP,,PK-PAIPHARMA-2020-PK-000007,PHARMACEUTICAL ASSOC,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM.DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE..AMERICAN JOURNAL OF THERAPEUTICS.2020;.",42.0,YR,,M,Y,,,20201006.0,,MD,PK,PK,2020,Q4,Adult
183505501,18350550,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG/0.5 ML ONCE WEEKLY,,,,,,,,,,,,2020,Q4,Seizure,,2020,Q4,1,I,,20200929.0,20201006,20201006,EXP,,PK-PAIPHARMA-2020-PK-000007,PHARMACEUTICAL ASSOC,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM.DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE..AMERICAN JOURNAL OF THERAPEUTICS.2020;.",42.0,YR,,M,Y,,,20201006.0,,MD,PK,PK,2020,Q4,Adult
183561955,18356195,20,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2020,Q4,Colitis,,2020,Q4,5,F,,20201028.0,20201007,20201102,EXP,,CA-PFIZER INC-2020385258,PFIZER,,73.0,YR,,F,Y,,,20201102.0,,CN,CA,CA,2020,Q4,Elderly
183561955,18356195,20,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2020,Q4,Colitis ulcerative,,2020,Q4,5,F,,20201028.0,20201007,20201102,EXP,,CA-PFIZER INC-2020385258,PFIZER,,73.0,YR,,F,Y,,,20201102.0,,CN,CA,CA,2020,Q4,Elderly
183561955,18356195,20,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2020,Q4,Decreased activity,,2020,Q4,5,F,,20201028.0,20201007,20201102,EXP,,CA-PFIZER INC-2020385258,PFIZER,,73.0,YR,,F,Y,,,20201102.0,,CN,CA,CA,2020,Q4,Elderly
183561955,18356195,20,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2020,Q4,Frequent bowel movements,,2020,Q4,5,F,,20201028.0,20201007,20201102,EXP,,CA-PFIZER INC-2020385258,PFIZER,,73.0,YR,,F,Y,,,20201102.0,,CN,CA,CA,2020,Q4,Elderly
183561955,18356195,20,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2020,Q4,Rectal haemorrhage,,2020,Q4,5,F,,20201028.0,20201007,20201102,EXP,,CA-PFIZER INC-2020385258,PFIZER,,73.0,YR,,F,Y,,,20201102.0,,CN,CA,CA,2020,Q4,Elderly
183565491,18356549,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Acute myocardial infarction,,2020,Q4,1,I,20200810.0,20200819.0,20201007,20201007,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-067469,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,110.2,KG,20201007.0,,HP,US,US,2020,Q4,Adult
183565491,18356549,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,1,I,20200810.0,20200819.0,20201007,20201007,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-067469,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,110.2,KG,20201007.0,,HP,US,US,2020,Q4,Adult
183565491,18356549,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Atrial fibrillation,,2020,Q4,1,I,20200810.0,20200819.0,20201007,20201007,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-067469,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,110.2,KG,20201007.0,,HP,US,US,2020,Q4,Adult
183565491,18356549,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Cardiac failure congestive,,2020,Q4,1,I,20200810.0,20200819.0,20201007,20201007,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-067469,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,110.2,KG,20201007.0,,HP,US,US,2020,Q4,Adult
183565491,18356549,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Cardiomyopathy,,2020,Q4,1,I,20200810.0,20200819.0,20201007,20201007,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-067469,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,110.2,KG,20201007.0,,HP,US,US,2020,Q4,Adult
183565491,18356549,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Myocardial ischaemia,,2020,Q4,1,I,20200810.0,20200819.0,20201007,20201007,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-067469,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,110.2,KG,20201007.0,,HP,US,US,2020,Q4,Adult
183575993,18357599,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,/wk,2020,Q4,Anal fistula,,2020,Q4,3,F,20200812.0,20201029.0,20201007,20201106,EXP,,AU-ABBVIE-20P-008-3522652-00,ABBVIE,,66.0,YR,,M,Y,150.0,KG,20201106.0,,MD,AU,AU,2020,Q4,Elderly
183575993,18357599,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,/wk,2020,Q4,Febrile neutropenia,,2020,Q4,3,F,20200812.0,20201029.0,20201007,20201106,EXP,,AU-ABBVIE-20P-008-3522652-00,ABBVIE,,66.0,YR,,M,Y,150.0,KG,20201106.0,,MD,AU,AU,2020,Q4,Elderly
183575993,18357599,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,/wk,2020,Q4,Lung abscess,,2020,Q4,3,F,20200812.0,20201029.0,20201007,20201106,EXP,,AU-ABBVIE-20P-008-3522652-00,ABBVIE,,66.0,YR,,M,Y,150.0,KG,20201106.0,,MD,AU,AU,2020,Q4,Elderly
183589284,18358928,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,SOLUTION,/wk,2020,Q4,Fournier's gangrene,,2020,Q4,4,F,,20201021.0,20201008,20201028,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-051922",BOEHRINGER INGELHEIM,,56.0,YR,A,M,Y,,,20201028.0,,MD,US,US,2020,Q4,Adult
183589284,18358928,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,SOLUTION,/wk,2020,Q4,Sepsis,,2020,Q4,4,F,,20201021.0,20201008,20201028,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-051922",BOEHRINGER INGELHEIM,,56.0,YR,A,M,Y,,,20201028.0,,MD,US,US,2020,Q4,Adult
183688331,18368833,13,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, 1/WEEK",,,,,,,,1.5,MG,,/wk,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,13,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, 1/WEEK",,,,,,,,1.5,MG,,/wk,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,13,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, 1/WEEK",,,,,,,,1.5,MG,,/wk,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,13,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, 1/WEEK",,,,,,,,1.5,MG,,/wk,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,13,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, 1/WEEK",,,,,,,,1.5,MG,,/wk,2020,Q4,Weight increased,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183733521,18373352,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Intramuscular,"1.5 MG, SINGLE",,,Y,,,,125469.0,1.5,MG,,,2020,Q4,Diarrhoea,,2020,Q4,1,I,20200120.0,20200930.0,20201012,20201012,EXP,GB-MHRA-EYC 00229326,GB-ELI_LILLY_AND_COMPANY-GB202010000415,ELI LILLY AND CO,,57.0,YR,,F,Y,89.2,KG,20201012.0,,MD,GB,GB,2020,Q4,Adult
183733521,18373352,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Intramuscular,"1.5 MG, SINGLE",,,Y,,,,125469.0,1.5,MG,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,20200120.0,20200930.0,20201012,20201012,EXP,GB-MHRA-EYC 00229326,GB-ELI_LILLY_AND_COMPANY-GB202010000415,ELI LILLY AND CO,,57.0,YR,,F,Y,89.2,KG,20201012.0,,MD,GB,GB,2020,Q4,Adult
183733521,18373352,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Intramuscular,"1.5 MG, SINGLE",,,Y,,,,125469.0,1.5,MG,,,2020,Q4,Incorrect route of product administration,,2020,Q4,1,I,20200120.0,20200930.0,20201012,20201012,EXP,GB-MHRA-EYC 00229326,GB-ELI_LILLY_AND_COMPANY-GB202010000415,ELI LILLY AND CO,,57.0,YR,,F,Y,89.2,KG,20201012.0,,MD,GB,GB,2020,Q4,Adult
183733521,18373352,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Intramuscular,"1.5 MG, SINGLE",,,Y,,,,125469.0,1.5,MG,,,2020,Q4,Product prescribing error,,2020,Q4,1,I,20200120.0,20200930.0,20201012,20201012,EXP,GB-MHRA-EYC 00229326,GB-ELI_LILLY_AND_COMPANY-GB202010000415,ELI LILLY AND CO,,57.0,YR,,F,Y,89.2,KG,20201012.0,,MD,GB,GB,2020,Q4,Adult
183733521,18373352,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Intramuscular,"1.5 MG, SINGLE",,,Y,,,,125469.0,1.5,MG,,,2020,Q4,Vomiting,,2020,Q4,1,I,20200120.0,20200930.0,20201012,20201012,EXP,GB-MHRA-EYC 00229326,GB-ELI_LILLY_AND_COMPANY-GB202010000415,ELI LILLY AND CO,,57.0,YR,,F,Y,89.2,KG,20201012.0,,MD,GB,GB,2020,Q4,Adult
183805182,18380518,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,INJECTION,/wk,2020,Q4,Metastases to bone,,2020,Q4,2,F,20200913.0,20201013.0,20201013,20201016,EXP,,FR-ROCHE-2690711,ROCHE,,56.0,YR,,F,Y,,,20201017.0,,MD,FR,FR,2020,Q4,Adult
183833161,18383316,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,N,,,,125469.0,1.5,MG,,,2020,Q4,Lipase increased,,2020,Q4,1,I,20200809.0,20201005.0,20201014,20201014,EXP,GB-MHRA-EYC 00229454,GB-ELI_LILLY_AND_COMPANY-GB202010002103,ELI LILLY AND CO,,65.0,YR,,M,Y,88.3,KG,20201014.0,,HP,GB,GB,2020,Q4,Elderly
183833161,18383316,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,N,,,,125469.0,1.5,MG,,,2020,Q4,Liver function test abnormal,,2020,Q4,1,I,20200809.0,20201005.0,20201014,20201014,EXP,GB-MHRA-EYC 00229454,GB-ELI_LILLY_AND_COMPANY-GB202010002103,ELI LILLY AND CO,,65.0,YR,,M,Y,88.3,KG,20201014.0,,HP,GB,GB,2020,Q4,Elderly
183833161,18383316,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,N,,,,125469.0,1.5,MG,,,2020,Q4,Pancreatitis acute,,2020,Q4,1,I,20200809.0,20201005.0,20201014,20201014,EXP,GB-MHRA-EYC 00229454,GB-ELI_LILLY_AND_COMPANY-GB202010002103,ELI LILLY AND CO,,65.0,YR,,M,Y,88.3,KG,20201014.0,,HP,GB,GB,2020,Q4,Elderly
184028061,18402806,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,/wk,2020,Q4,Asthenia,,2020,Q4,1,I,,20201014.0,20201019,20201019,EXP,,DE-ASTRAZENECA-2020SF34637,ASTRAZENECA,,51.0,YR,,M,Y,,,20201019.0,,MD,DE,DE,2020,Q4,Adult
184028061,18402806,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,/wk,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201014.0,20201019,20201019,EXP,,DE-ASTRAZENECA-2020SF34637,ASTRAZENECA,,51.0,YR,,M,Y,,,20201019.0,,MD,DE,DE,2020,Q4,Adult
184116141,18411614,9,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG WEEK,,,U,,,,,,,,,2020,Q4,Asthenia,,2020,Q4,1,I,,20201014.0,20201021,20201021,EXP,,DE-ANIPHARMA-2020-DE-000241,ANI,,51.0,YR,,M,Y,,,20201021.0,,MD,DE,DE,2020,Q4,Adult
184116141,18411614,9,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MG WEEK,,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201014.0,20201021,20201021,EXP,,DE-ANIPHARMA-2020-DE-000241,ANI,,51.0,YR,,M,Y,,,20201021.0,,MD,DE,DE,2020,Q4,Adult
184152241,18415224,2,SS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN, PEN)",DULAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,INJECTION,QW,2020,Q4,Diarrhoea,,2020,Q4,1,I,20201006.0,,20201022,20201022,DIR,,,FDA-CTU,,64.0,YR,,F,N,115.67,KG,20201007.0,N,PH,US,US,2020,Q4,Adult
184188063,18418806,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, WEEKLY (1/W)",4.5,MG,,,,,,0.75,MG,,/wk,2020,Q4,Hypoglycaemic encephalopathy,,2020,Q4,3,F,20200512.0,20201119.0,20201023,20201201,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202010005391,ELI LILLY AND CO,AZUMA. K ET AL..A CASE OF HYPOGLYCEMIC ENCEPHALOPATHY WHICH SUSPECTED OVERDOSE OF PREVIOUSLY USED INSULIN SELF-INJECTION.THE 94TH CHUBU BRANCH MEETING OF JAPAN DIABETES MELLITUS SOCIETY 2020;:77.,57.0,YR,,F,Y,,,20201201.0,,MD,JP,JP,2020,Q4,Adult
184188063,18418806,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, WEEKLY (1/W)",4.5,MG,,,,,,0.75,MG,,/wk,2020,Q4,Wrong drug,,2020,Q4,3,F,20200512.0,20201119.0,20201023,20201201,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202010005391,ELI LILLY AND CO,AZUMA. K ET AL..A CASE OF HYPOGLYCEMIC ENCEPHALOPATHY WHICH SUSPECTED OVERDOSE OF PREVIOUSLY USED INSULIN SELF-INJECTION.THE 94TH CHUBU BRANCH MEETING OF JAPAN DIABETES MELLITUS SOCIETY 2020;:77.,57.0,YR,,F,Y,,,20201201.0,,MD,JP,JP,2020,Q4,Adult
184195883,18419588,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2020,Q4,Acute kidney injury,,2020,Q4,3,F,20200910.0,20201215.0,20201023,20201222,EXP,,US-ABBVIE-20K-163-3571802-00,ABBVIE,,73.0,YR,,M,Y,112.59,KG,20201222.0,,CN,US,US,2020,Q4,Elderly
184195883,18419588,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2020,Q4,Dyspnoea,,2020,Q4,3,F,20200910.0,20201215.0,20201023,20201222,EXP,,US-ABBVIE-20K-163-3571802-00,ABBVIE,,73.0,YR,,M,Y,112.59,KG,20201222.0,,CN,US,US,2020,Q4,Elderly
184195883,18419588,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2020,Q4,Hypersensitivity,,2020,Q4,3,F,20200910.0,20201215.0,20201023,20201222,EXP,,US-ABBVIE-20K-163-3571802-00,ABBVIE,,73.0,YR,,M,Y,112.59,KG,20201222.0,,CN,US,US,2020,Q4,Elderly
184195883,18419588,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2020,Q4,Lymphoedema,,2020,Q4,3,F,20200910.0,20201215.0,20201023,20201222,EXP,,US-ABBVIE-20K-163-3571802-00,ABBVIE,,73.0,YR,,M,Y,112.59,KG,20201222.0,,CN,US,US,2020,Q4,Elderly
184329521,18432952,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"2 MG, QW",,,U,,,,,2.0,MG,,/wk,2020,Q4,Asthenia,,2020,Q4,1,I,,20201023.0,20201027,20201027,EXP,,NVSC2020DE285953,NOVARTIS,,51.0,YR,,M,Y,,,20201027.0,,HP,DE,DE,2020,Q4,Adult
184329521,18432952,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"2 MG, QW",,,U,,,,,2.0,MG,,/wk,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201023.0,20201027,20201027,EXP,,NVSC2020DE285953,NOVARTIS,,51.0,YR,,M,Y,,,20201027.0,,HP,DE,DE,2020,Q4,Adult
184669971,18466997,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:OTHER;?,,,,,,,,0.75,MG,,,2020,Q4,Fatigue,,2020,Q4,1,I,20200824.0,,20201104,20201104,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20201018.0,N,PH,US,US,2020,Q4,Elderly
184669971,18466997,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:OTHER;?,,,,,,,,0.75,MG,,,2020,Q4,Nausea,,2020,Q4,1,I,20200824.0,,20201104,20201104,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20201018.0,N,PH,US,US,2020,Q4,Elderly
184669971,18466997,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:OTHER;?,,,,,,,,0.75,MG,,,2020,Q4,Vomiting,,2020,Q4,1,I,20200824.0,,20201104,20201104,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20201018.0,N,PH,US,US,2020,Q4,Elderly
184670151,18467015,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q4,Blood loss anaemia,,2020,Q4,1,I,20200812.0,,20201104,20201104,DIR,,,FDA-CTU,,70.0,YR,,M,N,93.0,KG,20201018.0,N,PH,US,US,2020,Q4,Elderly
184670151,18467015,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q4,Gastrointestinal haemorrhage,,2020,Q4,1,I,20200812.0,,20201104,20201104,DIR,,,FDA-CTU,,70.0,YR,,M,N,93.0,KG,20201018.0,N,PH,US,US,2020,Q4,Elderly
184670151,18467015,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q4,Large intestine polyp,,2020,Q4,1,I,20200812.0,,20201104,20201104,DIR,,,FDA-CTU,,70.0,YR,,M,N,93.0,KG,20201018.0,N,PH,US,US,2020,Q4,Elderly
184673391,18467339,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN, PEN",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2020,Q4,Pancreatitis acute,,2020,Q4,1,I,20200901.0,,20201104,20201104,DIR,,,FDA-CTU,,59.0,YR,,M,N,,,20201028.0,N,PH,US,US,2020,Q4,Adult
184677851,18467785,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN, PEN",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q4,Abdominal distension,,2020,Q4,1,I,20200508.0,,20201104,20201104,DIR,,,FDA-CTU,,79.0,YR,,M,N,,,20201018.0,N,PH,US,US,2020,Q4,Elderly
184677851,18467785,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN, PEN",DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2020,Q4,Constipation,,2020,Q4,1,I,20200508.0,,20201104,20201104,DIR,,,FDA-CTU,,79.0,YR,,M,N,,,20201018.0,N,PH,US,US,2020,Q4,Elderly
184679071,18467907,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,1,I,20200820.0,,20201104,20201104,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20201026.0,N,PH,US,US,2020,Q4,Elderly
184789481,18478948,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Thyroiditis acute,,2020,Q4,1,I,,20201029.0,20201109,20201109,EXP,,GB-AUROBINDO-AUR-APL-2020-055051,AUROBINDO,,51.0,YR,,M,Y,,,20201109.0,,PH,GB,GB,2020,Q4,Adult
184943071,18494307,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,, UNKNOWN,,,,,,,2020,Q4,Thyroiditis acute,,2020,Q4,1,I,,20201104.0,20201112,20201112,EXP,GB-MHRA-EYC 00231345,GB-TEVA-2020-GB-1847163,TEVA,,51.0,YR,A,M,Y,,,20201112.0,,PH,GB,GB,2020,Q4,Adult
184981831,18498183,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM DONNERSTAG,,,U,,,,,1.5,MG,,,2020,Q4,Anuria,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM DONNERSTAG,,,U,,,,,1.5,MG,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM DONNERSTAG,,,U,,,,,1.5,MG,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM DONNERSTAG,,,U,,,,,1.5,MG,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM DONNERSTAG,,,U,,,,,1.5,MG,,,2020,Q4,Fatigue,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MILLIGRAM DONNERSTAG,,,U,,,,,1.5,MG,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
185011771,18501177,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"2 MILLIGRAM, QW",,,,,,,,2.0,MG,,/wk,2020,Q4,Asthenia,,2020,Q4,1,I,,20201106.0,20201113,20201113,EXP,,DE-MYLANLABS-2020M1093518,MYLAN,,51.0,YR,,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Adult
185011771,18501177,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"2 MILLIGRAM, QW",,,,,,,,2.0,MG,,/wk,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201106.0,20201113,20201113,EXP,,DE-MYLANLABS-2020M1093518,MYLAN,,51.0,YR,,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Adult
185019511,18501951,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG (DONNERSTAG),,,U,,,,,1.5,MG,,,2020,Q4,Anuria,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG (DONNERSTAG),,,U,,,,,1.5,MG,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG (DONNERSTAG),,,U,,,,,1.5,MG,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG (DONNERSTAG),,,U,,,,,1.5,MG,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG (DONNERSTAG),,,U,,,,,1.5,MG,,,2020,Q4,Fatigue,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5 MG (DONNERSTAG),,,U,,,,,1.5,MG,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185060051,18506005,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q4,Anuria,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q4,Fatigue,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, THURSDAY",,,,,,,,1.5,MG,,,2020,Q4,Anuria,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, THURSDAY",,,,,,,,1.5,MG,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, THURSDAY",,,,,,,,1.5,MG,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, THURSDAY",,,,,,,,1.5,MG,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, THURSDAY",,,,,,,,1.5,MG,,,2020,Q4,Fatigue,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,"1.5 MG, THURSDAY",,,,,,,,1.5,MG,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185612611,18561261,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Eye disorder,,2020,Q4,1,I,20200510.0,20200511.0,20201130,20201130,EXP,,DE-SHIRE-DE202016021AA,TAKEDA,,68.0,YR,,F,Y,,,20201130.0,,HP,DE,DE,2020,Q4,Elderly
185612611,18561261,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Gastrointestinal haemorrhage,,2020,Q4,1,I,20200510.0,20200511.0,20201130,20201130,EXP,,DE-SHIRE-DE202016021AA,TAKEDA,,68.0,YR,,F,Y,,,20201130.0,,HP,DE,DE,2020,Q4,Elderly
185612611,18561261,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,20200510.0,20200511.0,20201130,20201130,EXP,,DE-SHIRE-DE202016021AA,TAKEDA,,68.0,YR,,F,Y,,,20201130.0,,HP,DE,DE,2020,Q4,Elderly
185612611,18561261,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Haemoglobin decreased,,2020,Q4,1,I,20200510.0,20200511.0,20201130,20201130,EXP,,DE-SHIRE-DE202016021AA,TAKEDA,,68.0,YR,,F,Y,,,20201130.0,,HP,DE,DE,2020,Q4,Elderly
185612611,18561261,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Internal haemorrhage,,2020,Q4,1,I,20200510.0,20200511.0,20201130,20201130,EXP,,DE-SHIRE-DE202016021AA,TAKEDA,,68.0,YR,,F,Y,,,20201130.0,,HP,DE,DE,2020,Q4,Elderly
185612611,18561261,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Melaena,,2020,Q4,1,I,20200510.0,20200511.0,20201130,20201130,EXP,,DE-SHIRE-DE202016021AA,TAKEDA,,68.0,YR,,F,Y,,,20201130.0,,HP,DE,DE,2020,Q4,Elderly
185612611,18561261,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Ocular hyperaemia,,2020,Q4,1,I,20200510.0,20200511.0,20201130,20201130,EXP,,DE-SHIRE-DE202016021AA,TAKEDA,,68.0,YR,,F,Y,,,20201130.0,,HP,DE,DE,2020,Q4,Elderly
185763251,18576325,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,0.75,MG,,/wk,2020,Q4,Acute coronary syndrome,,2020,Q4,1,I,20201029.0,20201125.0,20201203,20201203,EXP,,DE-ASTRAZENECA-2020SF58365,ASTRAZENECA,,71.0,YR,,M,Y,70.7,KG,20201203.0,,MD,DE,DE,2020,Q4,Elderly
185763251,18576325,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,0.75,MG,,/wk,2020,Q4,Chest pain,,2020,Q4,1,I,20201029.0,20201125.0,20201203,20201203,EXP,,DE-ASTRAZENECA-2020SF58365,ASTRAZENECA,,71.0,YR,,M,Y,70.7,KG,20201203.0,,MD,DE,DE,2020,Q4,Elderly
185763251,18576325,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,0.75,MG,,/wk,2020,Q4,Coronary artery disease,,2020,Q4,1,I,20201029.0,20201125.0,20201203,20201203,EXP,,DE-ASTRAZENECA-2020SF58365,ASTRAZENECA,,71.0,YR,,M,Y,70.7,KG,20201203.0,,MD,DE,DE,2020,Q4,Elderly
185763251,18576325,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,0.75,MG,,/wk,2020,Q4,Left ventricular dysfunction,,2020,Q4,1,I,20201029.0,20201125.0,20201203,20201203,EXP,,DE-ASTRAZENECA-2020SF58365,ASTRAZENECA,,71.0,YR,,M,Y,70.7,KG,20201203.0,,MD,DE,DE,2020,Q4,Elderly
185763251,18576325,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,0.75,MG,,/wk,2020,Q4,Weight decreased,,2020,Q4,1,I,20201029.0,20201125.0,20201203,20201203,EXP,,DE-ASTRAZENECA-2020SF58365,ASTRAZENECA,,71.0,YR,,M,Y,70.7,KG,20201203.0,,MD,DE,DE,2020,Q4,Elderly
185868001,18586800,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Atelectasis,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Chills,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Cough,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Haemoptysis,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Headache,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Pain,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Pulmonary fibrosis,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Pulmonary oedema,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
186077761,18607776,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,,,,,2020,Q4,Metabolic acidosis,,2020,Q4,1,I,202009.0,20201207.0,20201211,20201211,EXP,ES-AEMPS-701916,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-067413",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,,,20201211.0,,MD,ES,ES,2020,Q4,Adult
186077761,18607776,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,,,,,2020,Q4,Renal failure,,2020,Q4,1,I,202009.0,20201207.0,20201211,20201211,EXP,ES-AEMPS-701916,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-067413",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,,,20201211.0,,MD,ES,ES,2020,Q4,Adult
186077761,18607776,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,202009.0,20201207.0,20201211,20201211,EXP,ES-AEMPS-701916,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-067413",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,,,20201211.0,,MD,ES,ES,2020,Q4,Adult
186181321,18618132,2,C,dulaglutide 0.75 mg,,2,,,,,,,,,,,,,,2020,Q4,Cough,,2020,Q4,1,I,20201213.0,,20201215,20201215,DIR,,,FDA-CTU,,37.0,YR,,F,N,106.0,KG,20201215.0,N,PH,US,US,2020,Q4,Adult
186181321,18618132,2,C,dulaglutide 0.75 mg,,2,,,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20201213.0,,20201215,20201215,DIR,,,FDA-CTU,,37.0,YR,,F,N,106.0,KG,20201215.0,N,PH,US,US,2020,Q4,Adult
186196791,18619679,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,125469.0,,,,,2020,Q4,Metabolic acidosis,,2020,Q4,1,I,202009.0,20201203.0,20201215,20201215,EXP,ES-AEMPS-701916,ES-ELI_LILLY_AND_COMPANY-ES202012002229,ELI LILLY AND CO,,43.0,YR,,F,Y,,,20201215.0,,MD,ES,ES,2020,Q4,Adult
186196791,18619679,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,125469.0,,,,,2020,Q4,Renal failure,,2020,Q4,1,I,202009.0,20201203.0,20201215,20201215,EXP,ES-AEMPS-701916,ES-ELI_LILLY_AND_COMPANY-ES202012002229,ELI LILLY AND CO,,43.0,YR,,F,Y,,,20201215.0,,MD,ES,ES,2020,Q4,Adult
186196791,18619679,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,125469.0,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,202009.0,20201203.0,20201215,20201215,EXP,ES-AEMPS-701916,ES-ELI_LILLY_AND_COMPANY-ES202012002229,ELI LILLY AND CO,,43.0,YR,,F,Y,,,20201215.0,,MD,ES,ES,2020,Q4,Adult
186202741,18620274,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK (WEEKLY, ADMINISTERED THROUGH SELF-INJECTABLE PEN)",,,U,, UNKNOWN,,,,,INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201027.0,20201216,20201216,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-08401,LUPIN,,50.0,YR,,F,Y,,,20201215.0,,MD,US,US,2020,Q4,Adult
186314971,18631497,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK (1-0-0-0)",,,,,,,,1.5,MG,INJECTION,/wk,2020,Q4,Cardiac failure,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061444,AUROBINDO,,67.0,YR,,M,Y,114.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186314971,18631497,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK (1-0-0-0)",,,,,,,,1.5,MG,INJECTION,/wk,2020,Q4,Cough,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061444,AUROBINDO,,67.0,YR,,M,Y,114.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186314971,18631497,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK (1-0-0-0)",,,,,,,,1.5,MG,INJECTION,/wk,2020,Q4,Dyspnoea exertional,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061444,AUROBINDO,,67.0,YR,,M,Y,114.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186314971,18631497,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK (1-0-0-0)",,,,,,,,1.5,MG,INJECTION,/wk,2020,Q4,Peripheral swelling,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061444,AUROBINDO,,67.0,YR,,M,Y,114.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186339361,18633936,5,C,Dulaglutide 0.75 mg weeky,,2,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20201217.0,,20201218,20201218,DIR,,,FDA-CTU,,69.0,YR,,M,N,113.0,KG,20201218.0,Y,PH,US,US,2020,Q4,Elderly
186339361,18633936,5,C,Dulaglutide 0.75 mg weeky,,2,,,,,,,,,,,,,,2020,Q4,Encephalopathy,,2020,Q4,1,I,20201217.0,,20201218,20201218,DIR,,,FDA-CTU,,69.0,YR,,M,N,113.0,KG,20201218.0,Y,PH,US,US,2020,Q4,Elderly
186417961,18641796,3,C,dulaglutide 0.75mg subq every sunday,,2,,,,,,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,20201129.0,,20201219,20201219,DIR,,,FDA-CTU,,37.0,YR,,F,N,94.2,KG,20201219.0,N,PH,US,US,2020,Q4,Adult
186417961,18641796,3,C,dulaglutide 0.75mg subq every sunday,,2,,,,,,,,,,,,,,2020,Q4,Cough,,2020,Q4,1,I,20201129.0,,20201219,20201219,DIR,,,FDA-CTU,,37.0,YR,,F,N,94.2,KG,20201219.0,N,PH,US,US,2020,Q4,Adult
186417961,18641796,3,C,dulaglutide 0.75mg subq every sunday,,2,,,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20201129.0,,20201219,20201219,DIR,,,FDA-CTU,,37.0,YR,,F,N,94.2,KG,20201219.0,N,PH,US,US,2020,Q4,Adult
186417961,18641796,3,C,dulaglutide 0.75mg subq every sunday,,2,,,,,,,,,,,,,,2020,Q4,Heart rate increased,,2020,Q4,1,I,20201129.0,,20201219,20201219,DIR,,,FDA-CTU,,37.0,YR,,F,N,94.2,KG,20201219.0,N,PH,US,US,2020,Q4,Adult
186417961,18641796,3,C,dulaglutide 0.75mg subq every sunday,,2,,,,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,1,I,20201129.0,,20201219,20201219,DIR,,,FDA-CTU,,37.0,YR,,F,N,94.2,KG,20201219.0,N,PH,US,US,2020,Q4,Adult
186488611,18648861,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Diarrhoea,,2020,Q4,1,I,20201001.0,,20201221,20201221,DIR,,,FDA-CTU,,59.0,YR,,M,N,,,20201112.0,N,PH,US,US,2020,Q4,Adult
186493391,18649339,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,1,I,20200729.0,,20201222,20201222,DIR,,,FDA-CTU,,73.0,YR,,M,N,70.0,KG,20201222.0,N,PH,US,US,2020,Q4,Elderly
186493391,18649339,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Lactic acidosis,,2020,Q4,1,I,20200729.0,,20201222,20201222,DIR,,,FDA-CTU,,73.0,YR,,M,N,70.0,KG,20201222.0,N,PH,US,US,2020,Q4,Elderly
186493391,18649339,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Pancreatitis necrotising,,2020,Q4,1,I,20200729.0,,20201222,20201222,DIR,,,FDA-CTU,,73.0,YR,,M,N,70.0,KG,20201222.0,N,PH,US,US,2020,Q4,Elderly
186493391,18649339,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,1,I,20200729.0,,20201222,20201222,DIR,,,FDA-CTU,,73.0,YR,,M,N,70.0,KG,20201222.0,N,PH,US,US,2020,Q4,Elderly
186844261,18684426,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Drug effect less than expected,,2020,Q4,1,I,2020.0,20200917.0,20201230,20201230,PER,,US-INDIVIOR US-INDV-126469-2020,RECKITT BENCKISER,,35.0,YR,,F,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186844261,18684426,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Drug withdrawal syndrome,,2020,Q4,1,I,2020.0,20200917.0,20201230,20201230,PER,,US-INDIVIOR US-INDV-126469-2020,RECKITT BENCKISER,,35.0,YR,,F,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186844261,18684426,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Inappropriate schedule of product administration,,2020,Q4,1,I,2020.0,20200917.0,20201230,20201230,PER,,US-INDIVIOR US-INDV-126469-2020,RECKITT BENCKISER,,35.0,YR,,F,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186896291,18689629,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,/wk,2020,Q4,Euglycaemic diabetic ketoacidosis,,2020,Q4,1,I,,20201229.0,20201231,20201231,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-073117",BOEHRINGER INGELHEIM,"JOSHI M, LIEB D, GRESENS A, JENKINS E, ARE SGLT-2 INHIBITORS SAFE IN PATIENTS UNDERGOING BARIATRIC SURGERY?. ENDOCRINE PRACTICE. 2020; 26(2): 118-",36.0,YR,A,M,Y,,,20201231.0,,HP,US,US,2020,Q4,Adult
186896291,18689629,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,/wk,2020,Q4,Metabolic acidosis,,2020,Q4,1,I,,20201229.0,20201231,20201231,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-073117",BOEHRINGER INGELHEIM,"JOSHI M, LIEB D, GRESENS A, JENKINS E, ARE SGLT-2 INHIBITORS SAFE IN PATIENTS UNDERGOING BARIATRIC SURGERY?. ENDOCRINE PRACTICE. 2020; 26(2): 118-",36.0,YR,A,M,Y,,,20201231.0,,HP,US,US,2020,Q4,Adult
